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A prominent feature of lentivirus infections is involvement of the central nervous system
(CNS).The ovine Maedi-Visna Virus (MVV) is the prototypic lentivirus, which like all
other known lentiviruses, results in infection of the CNS with protracted
neuropathology.The complications in deciphering the mechanisms of lentivirus-induced
neuropathology arise because of discordance between extent of pathological changes and
scarcity of virus antigen-positive cells in the CNS.These and other observations have lent
support to the indirect bystander damage hypothesis, whereby released soluble factors of
host and/or viral origin may result in extensive tissue damage.Brain
macrophages/microglia are frequently viral antigen-positive in lentivirus-infected neural
tissues.Primary ovine glial cultures were set up to study the cellular events that may
contribute to MW-initiated neuropathology.The ovine glial cells showed both
morphological as well as phenotypic similarities to glial cells from other species. The
role of microglial cells in visna neuropathology was studied further by use of highly
enriched (purity > 98%) primary cultures.Ovine microglial cells showed extensive
phenotypic similarities with cells of the monocyte/macrophage lineage.However, they
also exhibited distinct morphological characteristics.Further, ovine microglial cultures
could be productively infected with MTVV in vitro.This was demonstrated by a
combination of immunocytochemical and molecular assays.Assessment of ovine
cytokine production in MW-infected microglial cells in vitro demonstrated significant
increases in the message RNA levels of pro-inflammatory cytokines tumour necrosis
factor-a and interleukin-6.Intrathecal infection experiments carried out in
immunosuppressed animals had previously demonstrated an association between early
visna lesions and the virus dose. Severe combined immunodeficient (SCID) mice were
used to assess whether MVV-infected microglial cells could contribute to
neuropathological changes commonly associated with lentivirus infections and
independent of specific cellular immune responses. Intrastriatal injection of MVV-
infected ovine microglial cells into SCID mice resulted in significantly increased acute
gliosis in vivo.The neurotoxicity of MVV-infected microglial cells in visna
neuropathology was also demonstrated by in vitro cultures of murine neuronal cells.The
supernatants from ovine microglial cells infected with MVV in vitro contained factors,
which resulted in both morphological changes and loss of murine trigeminal cultures.
Similar observations were made with a synthetic peptide homologue encoded by the
MVV regulatory protein Tat.The findings in this thesis demonstrate that infection of
ovine microglial cells with MVV can result in release of soluble factors, which may
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In 1933, in an attempt to improve the wool industry, the government of Iceland
allowed the importation of 20 Karakul sheep, a breed known for its wool quality, from
Halle in Germany. After passing the quarantine checks, these imported sheep were
distributed to different farms throughout Iceland. By the time the clinical symptoms
of an apparently new disease were recognised, the disease had already spread to other
farms in the country, culminating in the first epidemic, which occurred between 1939-
52. The second epidemic occurred between 1954-65 in the western part of Iceland.
The disease was eradicated by the end of 1965 because of a mass slaughter policy
adopted by the government of Iceland (Palsson, 1976).
The clinical symptoms of this new disease were first recognised by Gislason in 1947,
in adult ewes of 3 years or over, and invariably during or immediately after the
lambing season. The earliest clinical sign was dyspnoea (shortness of breath or maedi
in Icelandic). Other lung diseases, such as sheep pulmonary adenomatosis (SPA), or
Jaagsiekte, and parasitic pneumonia complicated the early diagnosis of this new
disease. However, unlike SPA or parasitic pneumonia, maedi-affected sheep
displayed neither any noticeable nasal discharges, nor coughing (Gislason, 1964).
Affected animals succumbed to the inevitable fatal outcome of the disease, some 3-8
months after showing the first clinical symptoms. Again, this was in contrast to
chronic diseases such as parasitic pneumonia (Sigurdsson et al., 1952).
The rapid spread of the new disease was suspected to be due to the husbandry
practices in Iceland, where large numbers of animals from different farms were
housed in close proximity during winter months. This was followed by free hill
grazing during summer months, where animals from different flocks were allowed to
mix with each other. It was also realised that the spread occurred via nasal secretions
and vertically from ewes to lambs. Retrospectively, lack of an epidemic in Germany
was attributed to the different animal husbandry practised in that country (Palsson,
1974).
After a few years, when maedi had already become prevalent on farms scattered
around the country, a new clinical disease of the central nervous system (CNS) was
diagnosed. This wasting disease (or visna in Icelandic) always occurred as a
complication of maedi. Clinical visna, like maedi, was a slow disease in its onset and
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progression. Both maedi- and visna-affected animals invariably followed a protracted
course of slow progression to fulminant disease, resulting in inevitable death. This
slowness of disease progression and rapid end-stage differed from other chronic
diseases, for example paratuberculosis (Sigurdsson, 1954).
The epidemiological studies by Gislason had already indicated that the new disease
was caused by a contagious agent and that the minimum incubation time was
approximately 2 to 3 years. Experimentally, maedi and visna could be transmitted to
healthy animals by inoculation with infected tissues such as brain, spinal cord, lung
and spleen. These and other similar observations, taken together, led to the
understanding that the causative agent (s) was a virus. In 1954, Sigurdsson used the
term lentivirus [from Latin lentus slow], to aptly describe the clinical course of maedi-
visna.
Earlier work had shown that tissue culture passaged agent (s), isolated from natural
cases of maedi and visna was transmissible experimentally. There was also some
compelling evidence that both maedi and visna may share a common causative agent.
This was based on observations that inoculations of sheep with brain homogenates
from visna cases also resulted in clinical maedi and vice versa (Sigurdsson et al.,
1960; Sigurdadottir and Thormar, 1964). This was further supported by the very
similar cytopathic effects (CPE) of different maedi and visna isolates under tissue
culture conditions (Thormar and Helgadottir, 1965). However, it was not until 1967
(Gudnadottier and Palsson) that a single viral agent, which was filterable, was
isolated. This newly isolated virus resulted in clinical maedi-visna when used in
experimental infections of sheep. This infective viral agent was named the Maedi-
Visna Virus (MW).
1.2 Global distribution of MW
Clinical symptoms similar to maedi-visna have been reported in other countries under
different regional nomenclature. These include Graaf-Reinet in South Africa,
Zwoegerziekte in Holland, La bouhite in France, ovine/Montana progressive
pneumonia and ovine lentivirus in USA. Other pathological manifestation associated
with MW infection include non-suppurative arthritis and indurating interstitial
mastitis (Cutlip et al., 1985; Anderson et al., 1985; van der Molen et al., 1985).
The same causative agent has also been recognised in other countries worldwide.
These were originally based on clinical symptoms and serological analyses, and
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subsequently confirmed by sequence data (De Boer et al., 1970; Cutlip and Laird,
1976; Seimen et al., 1985; Sonigo et al., 1985; Braun et al., 1987; Watt et al., 1990;
Querat era/., 1990; Staskus et al., 1991; Sargan et al., 1991 Giangaspero et al., 1993).
1.3 Classification of lentiviruses
The classification of viruses used in this thesis are according to the recommendations
put forward by the International Committee on Taxonomy of Viruses (ICTV)
(Classification and Nomenclature of Viruses, Fifth report, 1991).
The ovine MW is a lentivirus genus of Retroviridae family of viruses (Table 1.1).
Retroviruses are a unique family of viruses because they contain an RNA dependent
DNA polymerase (or reverse transcriptase) by which the positive single-stranded
RNA genome codes for a double-stranded viral DNA (Baltimore, 1970; Temin and
Mizutani, 1970). Members of the Retroviridae family of viruses share a common
genome arrangement, which is the basis of their inclusion in this family: structural
genes gag (group-associated antigens), pol (polymerase), and env (envelope) are
arranged in a 5' to 3' orientation. These structural genes are flanked by Long
Terminal Repeats (LTR), which contain elements for control of viral gene expression
(Fig. 1.1). In addition to structural genes, complex retroviruses, which include
lentiviruses also have small Open Reading Frames (ORF), which code for
regulatory/auxiliary proteins (reviewed by Cullen, 1992).
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Table 1.1 Classification of Retroviruses
Classifications are according to ICTV (1991). Abbreviations used are as follows:
Human Immunodeficiency Viruses type-1/2 (HIV-1/2), Simian Immunodeficiency
Virus (SIV), Caprine Arthritis-Encephalitis Virus (CAEV), Equine Infectious







MammaliantypeBOncoviruses MLV-relatedViruses (MammaliantypeCRetrovirus Group) TypeDRetrovirusGro p AvianTypeCRetrovirusGro p SpumavirusGro p (FoamyVirusG oup) HTLV-BLVGroup
MouseammaryTu ourViruses MurineLeukaemiaVirus,MuLV
MammaliantypeCviruse Reticuloendotheliosisviruses ReptiliantypeCviruses
Mason-PfizerMonkeyVirus (Squirrelmonkeyretrovirus) (Langurvir s,PO-l-Lu) AvianLeukosisViru (Aviansarcomandleuk e iaviruses,ASLV) HumanFoamyVirus (Simianfoamyv rus) (Felinesyncytiavirus) (Bovinesyncytiarus) HumanT-CellLy photropicVirusType 1;HTLV-1) (HumanT-celllymphotropicvirustype2;HTLV-2) (SimianT-celllymphotropicvirus,STLV)(Bovineleukaemiairus,BLV)
Murinesarcomadleuka miaviruses Felinesarcomandl ukae iaviruses Gibbonapeleukaemiavirus GuineapigtypeCvirus PorcinetypCv rus Woollym nkeysarcomavirus Avianret culoendotheliosisviru Viperretrovirus
LentivirusGro p
HumanImmunodeficiencyVirus
Primateimmunodeficiencyviruses Ovine/CaprineA tivirus s EquineAntiv ruses FelineAntiv ruses BovineAnti iruses
H1V-1/H1V-2 SIV MVV/CAEV EIAV FIV B1V
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1.4 Molecular biology of lentiviruses
1.4.1 Reverse transcription
The viral enzyme, reverse transcriptase (RT), is coded by the pol gene in retroviruses
(Verma, 1977; Goff, 1990). Retroviruses use different species of cellular transfer
RNA (tRNA) molecules packaged into the mature virion as primers; MW utilises
tRNALys1'2 (Sonigo et al., 1985; Coffin, 1990). Moreover, an essential requirement
for RT-mediated reactions is the presence of divalent cations. Retroviral RTs utilise
either Mg2+ (e.g., by MMTV, SRV, lentiviruses and spumaviruses), or Mn2+ (e.g., by
ASLV and MuLV) (Nanduri and Modak, 1990; Tirumalai and Modak, 1990).
Retroviruses have a high mutation rate, which is partly due to lack of an editing
activity by RT (Coffin, 1990; Katz and Skalka, 1990). This high error rate may have
played an important part in the evolution of retroviruses. This is one of the
mechanisms used by this family of viruses to evade the host immune system. It is
estimated that the error rate may be as high as 1 in 1700-4000 in the case of HIV-1
(Preston et al., 1988; Roberst et al., 1988). Similar high mutation rates have been
observed with CAEV infections in vivo (Turelli et al., 1996). This high error rate is
believed to result in generation of quasi-species of viruses. This emerging virus pool
may differ greatly from the original pool of viruses at the time of infection (Payne et
al., 1987).
1.4.2 RNase-H ORF
The pol gene of retroviruses also codes for a protein with RNase-H activity. RNase-H
degrades RNA in an RNA-DNA hybrid. This enzyme is involved in the removal of
viral RNA during proviral strand synthesis (Moelling et al., 1971; Goff, 1990)
1.4.3 Proviral DNA synthesis
Reverse transcription in lentiviruses results in synthesis of a duplex viral DNA from a
diploid RNA genome (Fig. 1.1). Shortly after the receptor-mediated entry of virion
into permissive cells, reverse transcription of viral genome takes place in the uncoated
viral nucleoprotein complex (NC) within the cytoplasm. This NC is referred to as the
pre-integration complex. In HIV-1, reverse transcription of viral genome can be
detected within two hours of infection, and it is associated with the pre-integration
complex in the cytoplasm (Farnet and Haseltine; 1991 Munis et al., 1992).
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Fig.1.1 Genome organisation of Retroviruses
The genome of lentiviruses consists of two identical full-length RNA transcripts that
are linked by non-covalent bonds. The LTR contains the promoter sites that drive
viral transcription. The untranslated leader (L) sequence contains the dimer linkage
site (DLS). The L sequence also contains the packaging sequence (VF). A is
representative of an RNA genome, with cellular tRNA bound to the primer binding
site (PB). B represents the proviral form of the genome, with cap present on all
transcripts. C represents the spliced proviral genome of MVV.
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Earlier experiments had shown that in vitro infection of sheep choroid plexus (SCP)
cells with MVV resulted in detectable amounts of duplex proviral DNA. The newly
synthesised proviral DNA may exist in different forms; i.e., both circular (open circle
or type I) and linear. The newly synthesised proviral DNA (within the pre-integration
complex) is transported into the nucleus, where it may be integrated into the host-cell
genome. Presence of a nuclear localisation signal (NLS) in the form of a nucleophilic
motif on the matrix (MA) protein of HIV-1 directs the transport of pre-integration
complex into the nucleus of infected cell (Harris et al., 1981; Lee and Coffin, 1990).
1.4.4 Integration of proviral DNA into host-cell genome
Retroviral integration depends on the pol gene-derived protein, integrase (IN). This
protein is released from the Gag-Pol polyprotein precursor by a proteolytic cleavage
(Varmus and Brown, 1989; Brown, 1990; Goff, 1992; Whitcomb and Hughes, 1992).
Biochemical analyses of sheep choroid plexus (SCP) infected in vitro had shown that
the majority of MVV DNA existed as free and linear duplex DNA. Circular DNA
constituted only 0.1-0.3 percentage of the viral DNA. Both forms were found
predominantly in the nucleus of infected cells in the early phase of infection (five
hours post-infection) (Harris et al., 1981). There is some evidence from HIV-1 that
non-integrated free DNA may be used as a template for virus gene expression, and
may contribute to HIV CNS dementia (Teo et al., 1997).
HIV-1 can integrate into host-cell genome. Moreover, IN mutants of both HIV-1 and
CAEV are not infectious, indicating the importance of integration in life cycles of
these viruses (Wiskerchen and Muesing, 1995). Similarly, MVV infection of
fibroblasts in vitro may result in integration of virus into host-cell genome. However,
the frequency of this event is very low. Recently, it has been shown that only one out
of 200 infected cells was positive for integrated provirus by chromosomal in situ
hybridisation technique (C. Woodall, per. comm.). This is in agreement with previous
observations that many copies of viral DNA (100-200) per cell are found as free, non-
integrated linear DNA in the nucleus of infected cells (Harris et al., 1981).
1.4.5 Role of viral LTR in virus gene expression
Transcription of proviral genes in infected cells is under the control of flanking LTRs.
The lentiviral 5' LTR is involved in initiation of transcription. It contains core
promoter elements CCAAT (CAT box) and TAATA (TATA box), which bind the
cellular TFIID complex: a pre-requisite for initiation of basal transcription by cellular
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RNA pol II. U3 also contains negative regulatory elements (NRE), which down
regulate transcription (Rosen et al., 1985; Hirano and Wong, 1988; Flanagan et al.,
1989; 1992). Functional NRE elements have also been found in the LTR of MW
isolates (Hess et al., 1985; Sargan et al., 1991).
In MVV, which shows a more restricted cellular tropism compared to human and
primate lentiviruses, the LTR appears less complex (Gabuzda et al., 1989). The LTR
of the prototypic laboratory strain of MVV, the Icelandic K1514, contains two 43-bp
direct repeats with multiple non-consensus copies of the AP-1 binding site. However,
consensus AP-1 (TGAGTCA) and AP-4 (GCAGCTG) binding sites are located
upstream from the TATA box in K1514 LTR (Gabuzda et al., 1989; Hess et al., 1989,
Gdovin and Clements, 1992). The proximal AP-1 site in K1514 LTR is functional.
This site also plays a crucial role in mediating viral activation in macrophages
(Gabuzda et al., 1989).
Other, non-LTR sequences may also play a role in regulation of viral sequences.
Transient transcription assays have identified a downstream region beyond the
transcription start site in a North American MW strain, OLV-CU1, required for
virus-specific tram-activation (Campbell and Avery, 1996).
1.4.6 Temporal regulation of transcription
Infection experiments carried out in vitro with MVV result in a lytic cycle of
approximately three days (Brahic et al., 1977). The virus life cycle in fibroblastoid
cells such skin fibroblasts and SCP cells is approximately 20 hours. Molecular
analysis of these in vitro infections with MVV indicated an ordered pattern of
transcription, i.e., an early phase (19-24 hours post-infection) followed by a late phase
(40-72 hours post-infection). By completion of the lytic cycle, the number of MW
viral genomic RNA copies increases from 100-200 copies (24 hours post-infection),
to more than 1000 copies (72 hours post-infection) (Brahic et al., 1977; Haase et al.,
1982).
In the early phase of transcription, small, multiply spliced transcripts (1.2- and 1.6 kb
or 1.4- and 1.7 kb, depending on the study) predominate in the cytoplasm with very
little viral RNA detected in the nucleus. This is followed by a preponderance of
unspliced genomic (9.4 kb) and singly spliced subgenomic transcripts (4.3- and 3.7
kb, and 4.9- 4.3- 4-kb, depending on study) in the late phase of transcription. In this
late phase, the complete range of spliced and unspliced transcripts are found both in
10
Tat (formerly ORF S in MVV and tat III in HIV-1) is coded by a multiply spliced
transcript in MVY (1.5- to 2-kb, depending on study), and predominates in the early
phase of infection in vitro. MW Tat is encoded from a single exon, 5' to the env
gene, and with a molecular weight of 10 kDa (Vigne et al., 1987; Davis and Clements,
1989).
Tat influences the expression of all viral transcripts by increasing the steady-state
levels of viral mRNA (Hess et al., 1989). In addition to its mRNA kinetics, Tat like
Rev, is also a modular protein. MW Tat contains functional domains, with minimal
similarity to HIV-1 Tat (Carroll etal., 1991; Jones and Peterlin, 1994; Fig. 1.3).
In human lentiviruses (HIV-1 and HIV-2), SIV, ELAV, and BIV, Tat-directed trans-
activation of viral genes is mediated via a trans-activation response (TAR) element.
TAR is an RNA sequence with a stem-loop secondary structure, present in the R
region of LTR (reviewed by Gardner et al., 1994). Moreover, MVV genome, like
CAEV and FIV, does not encode a TAR element (Carroll et al., 1991; Sparger et al.,
1992).
There are conflicting reports with regard to the actual role of ungulate lentiviral Tat
proteins in virus infection. In one study, tat deletion-mutants of CAEV showed
greater than 1000-fold reduction in virus titres (in fibroblastoid cells), compared to the
wild-type control virus. This prompted the authors to draw the conclusion that CAEV
Tat was required for efficient virus replication (Saltarelli et al., 1993). A second
study attempted to delineate the role of CAEV Tat employing a similar genetic
approach. Deletion mutants of tat had no effect on CAEV replication either in vitro
(in both fibroblastoid cells and primary macrophages) or in vivo (Harmache et al.,
1995). However, a common finding in both studies was that Tat showed only a
moderate trans-activation in CAT assays. This moderate trans-activation compared
to the high trans-activation by HIV-1 Tat (>1500-fold) has been cited as the basis for
suggestions that Tat is dispensable in MW and CAEV infections (Kolson et al.,
1994)
Harmache and co-workers (1995) showed that partial and complete mutation of Tat
ORF appeared to confer no inhibitory phenotype upon virus infection, both in vitro
and in vivo. Moreover, animals infected with these constructs sero-converted,
indicating that basal promoter activity was sufficient for virus replication. However,
it is not clear whether tat mutations may affect the outcome of the clinical disease.
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1.4.9 The VifORF
MW vif (formerly ORF Q) is a homologue of HIV-1 vif transcript, and part of the
env gene transcribed as a 4.8 kb message, late in transcription (Rabson et al., 1985;
Vigne et al., 1987). MW vif encodes a protein with a molecular weight of 29 kDa,
which can be detected in the cytoplasm of MVV-infected cells, and was not
associated with cell-free virions (Audoly et al., 1992).
Deletion mutant studies on the CAEV vif indicate that Vif is essential for efficient
virus infection in vitro (Harmache et al., 1995). Moreover, it was shown that this
defect was not at the level of reverse transcription or transcription, but rather at the
late stages of virion assembly and release
Deletion mutants of CAEV vif were shown to result in severely impaired virus
replication, critical in establishing a persistent infection and pathogenesis. The
smallest mutation was near a C-terminal motif. Moreover, this motif (Ser-Leu-Gln-
X-Leu-Ala) is highly conserved in all known lentiviral Vif sequences. This motif has
an overall hydrophobic profile, and would be expected to interact with the cell
membrane. The possible interaction of Vif through its hydrophobic moiety may play
a role in virion assembly and budding (Oberste and Gonda, 1992).
There are some functional similarities between Vif proteins of HIV-1 and ungulate
lentiviruses. In the absence of Vif, HIV-1 virus infectivity is greatly reduced.
However, this reduction appears to be cell-type dependent (Fan and Peden, 1992;
Gabuzda et al., 1992; Gabuzda et al., 1994). Furthermore, Vif was shown to be
required for efficient uncoating and release of viral RNA in the cytoplasm and also in
complete synthesis of viral DNA (Sova and Volsky, 1993; von Schwelder et al.,
1993).
1.4.10 Deoxyuridine triphosphotase (dUTPase) ORF
Unlike primate and bovine lentiviruses, dUTPase-related sequences are found in
EIAV, CAEV, MVV and FIV. This was based on sequence homologies with
dUTPases of E.coli and herpesviruses (Sonigo et al., 1985; Stephens et al., 1986;
McGeoch, 1990). Moreover, purified preparations from EIAV and FIV infected cells
demonstrated dUTPase activity (Elder et al., 1992).
Mutations in the dUTPse ORFs of MVV and CAEV have been reported to result in a
delayed replication in caprine macrophages in vitro (Turelli et al., 1996). However, a
dUTPase mutation ofMW was shown to be dispensable for virus replication in ovine
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macrophages in vitro and also to the outcome of the clinical disease in experimental
infections in vivo (Petursson et al., 1998).
Experimental infections of goats with CAEV with wild-type virus, deletion mutants or
single-point mutants (DU-G) in the dUTPase ORJF, showed no significant differences
in the outcome of the clinical disease (Turelli et. al., 1997). However, one of THE
animals infected with a dUTPase bearing a single base mutation showed a reversion
(G to A) to an active dUTPase, suggesting that a functional dUTPase ORF is favoured
by the virus. Using similar genetic approaches in EIAV, dUTPase function appears to
be necessary for efficient virus replication in equine macrophages in vitro (Threadgill
et al., 1993). The levels of integrated viral DNA was 2- to 3-fold lower in mutant
viruses than in wild-type virus. Moreover, steady-state levels of full-length viral
transcripts were reduced by over 100-fold. This was found to be due to
misincorporation of dUTP into the proviral genome (Steagall et al., 1995).
Mutational analyses of dUTPase ORF indicate that Antiviruses, which encode this
gene, prefer a functional protein product. However, lack of a dUTPase activity does
not appear to be detrimental to infection/replication of these viruses.
1.4.11 Endonuclease ORF
By analogy with primate Antiviruses, this protease is probably involved in the
cleavage of Gag-Pol precursors. Studies from HIV-1 indicate that the endonuclease is
released by an autolytic cleavage from Gag-Pol dimers (Navia and McKeever, 1990).
1.5 Structural proteins of MW
In Antiviruses, structural proteins are encoded by a set of late, singly spliced
transcripts. The presence of RRE on these transcripts prevents their multiple splicing.
Moreover, these mRNA species are polycistronic. Structural proteins of MVV are
gag-coded proteins, which are involved in virion assembly and e«v-coded
glycoproteins. Env glycoproteins partake in coating of mature virion, budding from
the infected cell, and binding to cellular receptor for the next generation of infection
(reviewed by Narayan, et al., 1993) (Fig. 1.2).
1.5.1 Gag proteins
The MW gag-coded proteins are translated from a single full-length genomic
transcript (9.4 kb) (Vigne et al., 1982, 1987). This transcript is translated into a Gag-
Pol precursor protein, PrlSO8*8"^1, and is post-translationally processed into virion-
associated proteins. These are proteases (PR, plO); RT (p68/p61); and endonuclease
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(EN, p35). A second gag-coded precursor, Pr55gag is also post-transitionally cleaved
by the viral protease into protein components that form the mature viral particle.
These are: major core protein or capsid (CA, p25); matrix protein (MA, pi6); and
nucleoprotein, (NC, pl4) (Vigne et al., 1982) (Fig. 1.2). Both Gag-Pol and Gag
precursors are generated from the same full-length transcript, by a ribosomal (-1)
frameshiting mechanism, a feature common to lentiviruses.
1.5.2 Env proteins
In MW, env-coded proteins are translated from singly spliced mRNA molecules
(4.3- and 3.7-kb). Unlike gag-coded mRNAs, which are translated on free ribosomes,
translation of e«v-coded messages takes place on membrane-bound ribosomes. The
product of env-coded transcripts is a precursor molecule, Prgpl50env (Prl00env).
Similar to other secretory proteins, the MW Prl00env is guided into the lumen of
endoplasmic reticulum by presence of a signal peptide, with a nonpolar sequence, and
subsequently removed by an endopeptidase in the lumen of ER. The Prgpl50env is
transported into the Golgi complex for further glycosylation/oligomerisation. By
analogy to HIV-1 Env proteins, MW gpl50env is cleaved, by a cellular endoprotease,
into the N-terminal surface (SU) glycoprotein, gpl35, and the C-terminal
transmembrane (TM) gp45 (Vigne et al., 1982, 1987; Sonigo et al 1985). In MW,
the putative receptor-binding gpl35 is non-covalently linked to the TM gp46, which
has an anchor domain in the cytoplasmic membrane and is involved in cell fusion that
follows receptor binding (Doms et al., 1993). In H3V-1, extensive glycosylation
(mannose, N-acetylglucosamine, galactose, fructose, and other complex
carbohydrates) is important for the proper folding of gpl20 and the recognition of
CD4 receptor (Domes et al., 1993). Moreover, proteolytic cleavage of HIV-1
Prgpl60env, the precursor equivalent of MVV gpl50, is critical to virion infectivity
(McCune et al., 1988).
HIV-1 Pr gpl60env assumes either a dimeric or a tetrameric quaternary structure in the
lumen of ER. This multimeric structure remains as such throughout its
synthesis/modification through the Golgi complex and its assembly on the virion
(Weiss et al., 1993). This in situ multimerisation of gplbO^ coincides with the
ability to bind CD4 in the lumen of ER, indicating the importance of the quaternary
structure in receptor binding. Moreover, disulphide bonds are also formed early in the
maturation of gpl60env (Earl et al., 1991). This quaternary structure is a vital
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determinant in the recognition of viral antigenic epitopes by the host immune system
(Border et al., 1994).
DNA sequence comparison between two closely related, MVV strains, K1514 and its
antigenic variant LV1-1 demonstrated a hypervariable cluster (nucleotides 7864
through 7890), spanning 250 bp on either side of TM carboxy terminus (Braun et al.,
1987). These hypervariable clusters contribute to the antigenic variations (escape
mutants) associated with lentiviruses (Clements et al., 1981; Salinovich et al., 1986).
Two closely related MW 1514 virus strains, whose sequences differed by less than
one per cent, and mainly in the env region, differed greatly in antibody neutralisation
assays (Braun et al., 1987).
Extensive sequence analyses have predicated five hypervariable loops (N-terminal V1
through to C-terminal V5) within the SU subunit of HIV-1 gpl20 (Myers et al.,
1993). The V3 loop has received the most attention, because of its importance in cell
tropism of HIV-1 (Moore and Nara, 1991). Mutations in this region result in
noninfectious virus (Grimalia et al., 1992). The region that binds CD4 is between V4
and V5 (Myers et al., 1993). Env is anchored to the cytoplasmic membrane via its
non-covalent interaction with gp41, and via a hydrophobic domain in the N-terminal
of gp41 (Gallaher et al., 1989). Exchanges of the V3 loop convert a macrophage-
tropic (M-tropic) virus (nonacidic amino acids at position 325) to a T-cell tropic virus
(T-tropic) (acidic amino acids or alanine residues at position 325) (Milich et al., 1993;
Schulz et al., 1993). Moreover, basic amino acids and hydrophobic amino acids in
positions 311 and 325 of V3 confer syncyctium producing (SI) and nonsyncytium
inducing (NSI) phenotypes respectively (DeJong et al., 1992).
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Fig. 1.2 Protein processing and virion assembly
Processing of MW precursor proteins based on the positioning of splice donor and
splice acceptor sites (A). The arrangement of a prototypic lentivirus virion is depicted
in diagram B. The research on HIV-1 has shown that the gpl20-derived membrane
spikes are composed of oligomers rather than monomers. By analogy with HIV-1, the
MW virion core is believed to contain the diploid RNA genome, PR, RT and IN.
(adapted from Narayan et al., 1993).
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Cells of the monocyte/macrophage lineage are the major targets for infection and
replication of lentiviruses in vivo (Narayan et al., 1982; Hirsch et al., 1991; Onuma et
al., 1992; Sellon et al., 1992; Toyosaki et al., 1993; Pederson et al., 1993). The EIAV
viral antigens were detected in the Kupffer cells in the liver of horses with acute
EIAV infection. This was the very first report of in vivo infection of macrophages by
a lentivirus (McGuire et al., 1971).
Lentiviruses can be divided into two groups based on their cellular tropism in vivo.
The first group includes MW, CAEV and EIAV. These viruses appear to
productively infect predominantly cells of monocyte/macrophage lineage (Narayan
and Clements, 1989). The second group, which includes HIV-1, HIV-2, SIV, FIV and
BIV, productively infect cells of lymphocyte lineage as well as cells of
monocyte/macrophage lineage (Daniel et al., 1985; Kestler et al., 1990; Torten et al.,
1991).
Co-infection with CAEV and MW has indicated that cells of ovine and caprine
origin can sustain the productive infection of these two viruses concomitantly, both in
vitro and in vivo (Jolly and Narayan, 1989). These two viruses are closely related,
both antigenitically and based on their amino acid sequences. This molecular
relatedness can be between 75% in the gag-pol genes and 80 % in the case of env
gene (Saltarelli et a\., 1990). However, infection of ovine/caprine cells with these two
virus groups was shown to be both group-specific and saturable (Jolly and Narayan,
1989).
MW specific receptor (s) is yet to be fully characterised. However, one report has
shown an association between the putative receptor and the major histocompatibilty
complex (MHC) class II antigens (Dalziel et al, 1991). A second report has identified
a 50-kDa protein that may either associate with and/or be part of the cellular receptor
for MVV entry into the cells (Crane et al., 1991).
In early asymptomatic HIV-1 infection, slow replicating non-syncytium-inducing
(NSI) M-tropic HIV-1 strains predominate (Schuitemaker et al., 1992). During the
course of infection, there is a shift in virus strains with a preferential tropism for T-
cells (Connor and Ho, 1994; Schuitemaker et al., 1992). In 50% of the infected
individuals, the shift to T-tropism is also concomitant with emergence of syncytium-
inducing (SI) viral variants, followed by a rapid disease progression (Koot et al.,
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1993). This preferential tropism was associated with the V3 loop of the gpl20
(DeJong et al., 1992). Surprisingly, the amino acid at position 325 of the gpl20
which confers M-tropism (non-acidic) or T-tropism (acidic or alanine) also plays a
role in whether the variants are SI or NSI (Milich et al., 1993). In one study, all
tissues tested for HIV-1 viral sequences were infected with predominantly M-tropic
variants, regardless of tissue of origin (Donaldson et al., 1994).
CD4 molecule was shown to be the major receptor for HIV-1 (Dalgleish et al., 1984).
However, some contradictory observations with regard to the tropism of HIV-1 for
different cell types had indicated that CD4 is not the only cellular receptor mediating
infection by HIV-1. For example, transient transfection of CD4 into cells of non-
human origin did not render these cells susceptible to HIV. Moreover, consistent and
puzzling observations were made in Africa, where groups of high-risk individuals
who had been exposed to the HIV virus on numerous occasions were found
seronegative. Also some groups of seropositive individuals did not progress to full¬
blown AIDS for a long time post-exposure and were referred to as "slow progressors"
(reviewed by Weiss, 1996).
The first indications that a second receptor was involved came from observations
demonstrating that soluble P-chemokines secreted by CD8+ T cells could suppress
HIV infectivity (Jansson et al., 1996; Cocchi et al., 1996). This observation was
supported by the elevated circulating chemokine levels in exposed but uninfected
individuals (Paxton et al., 1996). Secondly, a member of chemokine family, FUSIN
(formerly LESTER) was shown to be needed for membrane fusion and entry of T
cell-adapted HIV-1 strains (Feng et al., 1996). This was followed by cloning and
characterisation of chemokine receptors used by the M-tropic strains of HIV-1 (Deng
et al., 1996; Dragic et al., 1996; Alkhatib et al., 1996).
Chemokines are members of the cytokine superfamily. This family consists of some
50 related proteins, ranging from 68 to 120 amino acids (in the mature form). They
are divided into three classes based on the cysteine amino acids arrangement within
the protein (reviewed by Schall et al., 1994).
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1.7 Lentiviral persistence
It is not clear whether persistent infection with lentiviruses results in a latent infection
or a chronic infection. According to definitions put forward in Field's Virology
(1994) a transient viraemia in the acute phase of a virus infection may be followed by:
• A latent infection established when a virus persists in a non-infectious form with
intermittent periods of viral reactivation and shedding. Moreover, latent viruses
must cause productive infection of permissive cells, under certain conditions, i.e.,
they must be responsive to reactivation during the course of infection. The
prototypic example of a virus causing a latent infection is the human Epstein-Barr
virus (EBV), or;
• A chronic infection established when the immune system substantially reduces
viral replication, but cannot clear the infection. Therefore, there is an ongoing,
low level of productive infection. Hepatitis B is an example of a chronic
infection.
All lentiviral infections result in a protracted period of clinical latency. This had led
to the suggestions that this period of clinical latency is a reflection of viral latency. It
is now accepted that lentiviral replication takes place at all stages of infection
(Michael et al., 1992; Bagnarelli et al., 1992; Piatak et al., 1993; Pantaleo et al., 1993;
Emberston et al., 1993). This is because of availability of sensitive techniques such as
polymerase chain reaction (PCR).
A consistent finding with in vivo infections with MW is the low levels of cell-
associated circulating virus (Petursson et al., 1976; Griffin et al., 1978). This has
been shown to be as low as 104 infected cells leaving a cannulated peripheral lymph
node over a 20-day period, detected by co-cultivation assays (Bird et al., 1993).
Although this number could be higher with a more sensitive technique such as PCR, it
is nevertheless indicative of a cell-associated and restricted infection (Brahic et al.,
1981 Staskus et al., 1991). In acute MW infection experiments, very few infected
cells are detected in efferent lymph. This low level of infectivity appears to reflect the
monocytes/macrophages and dendritic cells (DC) population (between 1 to 8%) in the
lymph node (LN) (Blacklaws et al., 1995). Moreover, these observations would
suggest that the monocyte/macrophage and DC population in the LN is most likely to
be a reservoir of infection in vivo.
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In lentiviruses, regulatory proteins Rev and Tat determine the extent of latency in
tissue culture models. A similar pattern of viral transcription was found in
asymptomatic HIV-1 positive individuals (Seshama et al., 1992). Activation of viral
LTR via stimuli such as phorbol esters, in vitro, results in a transition from a latent
infection to a productive infection (Folks et al., 1987; Pomerantz et al., 1990).
However, such a clear dichotomy between latency and productive infection does not
appear to exist in lentiviral infections in vivo.
Emberston and co-workers (1993), using in situ PCR combined with immunostaining
techniques, detected large numbers of latently infected CD4+ lymphocytes and
macrophages in the lymphoid tissues of apparently asymptomatic HIY+ individuals.
However, a small population of lymphocytes (one in 100-400) was positive for both
viral DNA and RNA. The infection in monocytes/macrophages was more restricted
to proviral DNA. Further, Pantaleo and co-workers (1993) detected cells, which
contained both viral DNA and RNA.
Therefore, a consensus has been established with regard to state of lentivirus infection
in vivo and that is, a greater number of cells are positive for proviral DNA than
previously thought. Moreover, a small proportion of these infected cells are
transcriptionally active at levels similar to those found in productive infection (Brahic
et al., 1981; Staskus et al., 1991; Emberston et al., 1993; Pantaleo et al., 1993).
Hence, it has been suggested that a state of "cellular latency" or "restricted latency"
exist in vivo, based on the criteria that viral regulatory transcripts (rev/tat) are detected
with minimal productive infection.
1.7.1 Cellular and viral determinants of latency
The host range of viruses is determined by both cellular and viral factors. The
restriction imposed by the cellular factors upon the infective agent may operate at
different levels. This restriction could be at an early step, for example, lack of
appropriate receptor (s) for virus entry. Lack of appropriate molecular machinery, to
interact and upregulate viral gene expression may contribute to defective infection.
Incompatible intracellular processing pathways necessary for assembly and release of
infective progeny may also contribute to a defective infection/latency. Viral
determinants too could play a role in latency/productive infection. These can include
viral sequences outside the env region, for example within the LTR, or the site of
integrated provirus.
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An example of cellular restriction placed upon lentiviral infection is demonstrated by
immature precursor cells. Precursor bone marrow cells show a reduced ability to
support a productive infection, compared to cultured macrophages (Narayan et al.,
1982; Gendelman et al., 1985,1986). This block in MW transcription was linked to
the cellular maturation of monocyte into macrophages (Brahic et al., 1981;
Gendelman et al., 1986). Similarly, maturation of blood-derived monocytes into
macrophages in vitro resulted in increased permissiveness to CAEV and EIAV
infections (Anderson et al., 1983; Maury, 1994).
The association between cellular maturation/differentiation and lentivirus life cycle is
via induction of cellular transcription factors (TF), for example AP-1 complex, which
binds the LTR elements (Gabuzda et al., 1989). Similar observations regarding the
importance of LTR elements as determinants of virus infectivity have been reported
for HIV-1 infection (reviewed by Ignatius Ou and Gaynor, 1993).
Not all cells of monocyte/macrophage lineage appear to respond equally to lentiviral
infection. Some reports have demonstrated the inability of certain tissue macrophages
to support a productive infection by MVV, for example the Kupffer cells (Gendelman
et al., 1984). This has led to the suggestion that perhaps only a subset of cells of the
monocyte/macrophage lineage have the ability to support a productive infection by
lentiviruses. There are no data at present to support this hypothesis.
The restriction imposed upon viral replication may be due to the intracellular
processing of viral components. MW and CAEV can productively infect ovine
primary macrophages and goat synovial membrane epithelial cells with similar
kinetics. However, CAEV failed to replicate productively in ovine SCP cells. This
was found to be due an abnormal proteolytic processing of envelope glycoproteins
(Chebloune et al., 1996). Such intracellular processing may have implicationsfor the
outcome of clinical disease. Infection of SCP by two closely related MW molecular
clones, KV1772-kv72/67 and LV1-1KS1 resulted in similar kinetics of infection.
However, LV-1-1KS1 replicated less efficiently in primary macrophages.
Furthermore, intracerebral inoculation of sheep with both clones gave a completely
different picture; clone KV1772-kv72/67 resulted in characteristic visna lesions in the
CNS, whereas LV-1-1KS1 failed to do so (Torsteinsdottir et al., 1997).
It is known that cells of different lineages may process intracellular proteins
differently. For example, intracellular processing/assembly of MVV in fibroblasts
and macrophages is rather cell-type specific. MW infection of fibroblasts results in
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assembly of viral particles on the plasma membrane. However, in macrophage
infections with MW, virus assembly takes place within intracytoplasmic vacuoles
(Dubois-Dalcq, et al., 1979; Lee et al., 1996). In HIV-1 infection of human glial
cells, it has been shown that lack of a productive infection may be due to a block in
the intracellular processing of the gpl60 (Shahabuddin et al., 1996). Similarly,
infection of primary macaque macrophages with two molecular clones
SIVmac219/17E (M-tropic), and SIVmac219 (infects macrophages but less
efficiently) which differ only in the Env region resulted in differential processing of
viral gpl60 in macrophages. However, viral gpl60 processing was identical for both
molecular clones in lymphocytes (Stephens et al., 1995).
Other example of cellular restriction placed upon virus replication is EHV-1 infection
of astrocytes in vitro, which results in a persistent infection with preponderance of
multiply spliced transcripts, mainly nef and rev (Tornatore et al., 1994). Infected
monocyte/macrophage cells can be activated into a productive infection after
stimulation, for example by phorbol esters. This results in a productive infection by
appearance of predominantly genomic and sub-genomic transcripts (Muesing et al.,
1985; Pomerantz et al., 1990). In contrast, in an attempt to stimulate viral gene
expression in infected astrocytes by cytokines, only an increase in multiply spliced
transcripts was detectable. There was no (detectable) increase in the levels of
genomic and sub-genomic transcripts (Tornatore et al., 1994). The precise reason for
this latency is not known.
Apart from the restriction imposed upon the virus by viral/cellular factors, a major
component in the outcome of any viral infection is the role of host-derived immune
responses toward the invading pathogen.
1.8 Immune responses to MW
The first stage in targeted (specific) elimination of a viral pathogen, is the recognition
of invading pathogen. Specific immune activation requires the presentation of antigen
in the context of MHC molecules (Zinkernagel and Doherty, 1974). Specific (MHC-
restricted) cellular immune responses are initiated after MW infection in vivo. This
is in the form of antibody production (via CD4+ T help), and CD8+-mediated effector
functions (Griffin et al., 1978; Bird et al., 1993; Lee et al., 1994; Blacklaws et al.,
1995).
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1.8.1 Humoral immune responses
Following in vivo infection with MVV, an initial viraemia and antigenaemia (mainly
p25) is initiated. Of the 20 or more antigens recognised by immune serum, Env and
Gag antigens are the most prominent (Petursson et al., 1976; Bird et al., 1993).
Neutralising antibodies were among the first specific immune responses observed in
MVV-infected animals, at 2-3 months post-infection. (Sigurdsson et al., 1960). These
antibodies remain detectable for years after seroconversion. Generation of
neutralising antibodies against MVV Env glycoproteins does not result in elimination
of virus, but prevents the re-infection and release of infectious progeny virions.
Moreover, coincident with appearance of neutralising antibodies is a reduction in
circulating virus (Petursson et al., 1976; Griffin et al., 1978).
The generation of specific immune responses against MW were best illustrated by
cannulation of regional peripheral lymph nodes, where initiation of immune responses
takes place. The first antibodies are generated against viral p25 (capsid or major core
protein). The detection of soluble p25 immune complexes as early as 2 days may be
indicative of virus replication (Blacklaws et al., 1995). These early antibody
responses closely resemble the humoral immunity in HIV-1 infections (Stramer et al.,
1989).
Kinetic studies have shown that neutralisation by MVV-specific immune serum is
inefficient (Kennedy-Stoskopf and Narayan, 1986). Treatment of viral particles with
neuraminidase, which removes sialic acid side chains on Env glycoproteins increased
the efficiency of neutralisation in vitro (Huso et al., 1988). This suggests that
carbohydrate side-chains may obscure antigenic epitopes, making antibody
binding/neutralisation less efficient.
The mode of action ofMW neutralising antibodies is dependent on the cell type used
in vitro. In fibroblast cultures, neutralising antibodies prevent both binding of the
virion to the receptor and replication of already internalised viral particles. On the
other hand, these antibodies enhanced virion entry in macrophages via Fc receptors
(FcR), and inhibition of virus replication was intracellular, presumably via
degradation in the phagosomes (Jolly et al., 1989).
The HIV-1 epitopes that are used by the immune system to generate neutralising
antibodies are diverse. The major epitope used for neutralisation is near CD4 binding
site on gpl20 (Kang et al., 1991). Moreover, HIV-1 neutralising antibodies were
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reported to be, by comparison to those generated against MVV/CAEV, more efficient
in preventing infection in vitro (Nara el al., 1987). However, HIV-1 neutralisation
assays were carried out on laboratory-adapted T cell lines. In light of new discoveries
in differential receptor usage by T-tropic and M-tropic virus strains, use of such
assays may result in artificially high values. This has been complemented by the poor
neutralisation obtained with sera from infected individuals, and use of mAbs to
neutralise primary HIV-1 isolates (Moore, 1995).
The poor neutralisation capacity of mAbs generated against the most antigenic
domain of gpl20 (V3 loop), is because the V3 loops are less immunogenic in
oligomeric gpl20 than monomelic gpl20. Moreover, the bulk of V3 loop is cryptic in
M-tropic strains of HIV-1. This is significant, since M-tropic viruses predominate in
the early phases of infection (Bou-Habib et al., 1994).
The observations made on the antigenicity of HIV-1 gpl20 would suggest that
topology of intact envelope glycoproteins has a significant bearing on the efficiency
of neutralisation in vivo. This in turn questions the apparent potency of neutralising
antibodies observed in vitro and in prevention of disease in vivo. For example, in
SIVmac infection of rhesus monkeys, neutralising antibodies are detected and may
provide some protective immunity (Zhang et al., 1988).
In MW, a 24 amino acid hydrophobic stretch at the amino terminus of TM domain
has been identified which mediates fusion. Antisera from some infected animals with
MVV and CAEV and mAbs generated against this peptide prevented fusion in vitro
(Crane et al., 1991). In HIV-1, anti-fusion antibodies may function by dissociating
gpl20-gp41 complex, rendering the virion inactive (Poignard et al., 1996).
1.8.1.1 Infection-enhancing antibodies
Non-neutralising infection-enhancing antibodies are generated in infection with
lentiviruses, which operate via FcR (Jolly et al., 1989; Robinson and Michell, 1990).
In HIV-1, a correlation has been suggested between the appearance of enhancing
antibodies and progression to disease (Kliks et al., 1993). Similarly, enhancing
antibodies are detected in MW infections (Jolley et al., 1989).
1.8.1.2 Antibody-dependent complement-mediated (ADC) cytotoxicity
Complement fixing antibodies can be detected at 2-3 weeks after inoculation with
MW (de Boer, 1970). In HIV-1, the Clq-binding sites on the gp41 have been
mapped (Thielens et al., 1993). Moreover, structural similarities have been identified
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on gpl20 and Clq, and Clq can compete with gpl20 for binding to gp41. This may
result in release of gpl20 from the virions (Stoiber et al., 1994).
1.8.1.3 Antibody-dependent cell cytotoxicity (ADCC)
Cells with cytotoxic potentials may bind opsonized particles via FcRs, resulting in
death of infected cells, by a mechanism referred to as antibody-dependent cell
cytotoxicity (ADCC). In HIV-1, antibodies triggering ADCC are predominantly of
IgGi isotype, and to a lesser extent of IgG2 isotype. These neutralising antibodies are
directed against the Env proteins (Ljunggren et al., 1988). MW-specific ADCC
activity has not been detected in immune serum from infected animals (Rayburn,
1992).
Natural killer cells, which are part of non-specific immune responses, may interact via
their surface FcyRIII with the IgG antibodies generated against the viral antigens.
Cell killing via NK cells is mediated by the perforin pathway. The precise reason for
lack of an ADCC killing in MVV infection is not known. However, there is a
correlation with loss of ADCC activity and disease progression in PfiV-1 infection. It
is known that NK activity is dependent on cytokines such as INF-y and IL-12 and that
monocyte/macrophage cells are the main source of IL-12. Therefore, loss of
NK/ADCC activities may be linked to the loss of monocyte/macrophage functions in
progression to clinical disease.
There are no reports on NK activity in MVV infection. It may be that ADCC-fixing
antibodies in MW-infections differ from those in primate lentivirus infections. It is
proposed that lack of ADCC activity in MW-infected animals correlates with the
lack of serum IgG2 (Rayburn, Ph.D thesis, 1992). It is plausible that the NK activity
is not initiated in MVV infection due to: a) lack of optimum cytokine environment; b)
because of dysfunctional monocyte/macrophage cells, or; c) an inherently low NK
activity in ungulates.
1.8.2 Cellular immune response in MW infections
An increase in CD8+ lymphocyte population is observed in the lungs, CNS, and
synovial fluids of MW-infected animals (Lujan et al., 1993; Harkiss et al., 1991;
Torsteinsdottir et al., 1992,1994). However, these CD8+ T cells do not appear to be
readily cytolytic as prior in vitro culture in the presence of IL-2 is necessary for
detection of CTL-mediated lysis (Blacklaws et al., 1994; Lee et al., 1994).
27
The precise role of CD8+ lymphocytes in control of MYV infection is unclear.
Antibody depletion of CD8+ cells in vivo prior to experimental infection has been
carried out. Preliminary data suggest that depletion of CD8+ cells does not result in
an increase in infected cells in peripheral lymph nodes. Although depletion
experiments were successful, a concomitant increase was observed in the frequency of
precursor CTLs (CTLp). It is not clear what role, if any, this population may play in
control of virus infection. However, depletion of CD4+ cells resulted in a decrease in
virus-infected cells in efferent lymph (B. A. Blacklaws, personal communication).
Delayed type hypersensitivity (DTH) responses are CD4+ T cell driven. In certain
viral infections, for example Measles virus, there is a defect in DTH response during
the immunosuppressive phase of acute measles (reviewd by Griffin et al, 1992).
Ungulate lentiviruses do not infect T lymphocytes. Cell-mediated immunity (CMI) in
the form of CD4+ T cell proliferation to viral antigens is continually detected after
MVV infection in vivo (Rayburn, Ph.D. thesis, 1992; Bird et al., 1993; Blacklaws et
al., 1995). These proliferative responses are predominantly against Gag antigens
(Rayburn, Ph.D. thesis, 1992). Moreover, MVV infection does not appear to result in
significant reductions in DTH responses, recall antigens or mitogens (Pyrah et al.,
1996; P. Bird, unpublished data).
Cytotoxic T lymphocyte (CTL) activities mediated by CD8+ T cells in HIV-1 infected
individuals are readily detected, prior to appearance of neutralising antibodies, and
correlate with temporary clearance of viraemia in primary phase of infection (Borrow
et al., 1994). These primed CTLs can be lytic at low ratios of one CTL to 1000
infected CD4+ cells (Yang et al., 1997). Suppressive activities of CD8+ T cells can
also be nonlytic (Walker et al., 1986). The CTL responses in HIV-1 mediate the
suppression of virus replication by both lytic and nonlytic mechanisms (Yang et al.,
1997). In CD8+-mediated nonlytic pathway, release of chemokines, for example
macrophage inflammatory protein-1 (MIP-1) and releases upon activation normally T
cell expressed and secreted (RANTES), results in suppression of virus replication
(Yang etal., 1997).
1.8.3 Non-specific (innate) immune responses in MW infections
Non-MHC-restricted innate immune responses are the first line of defence against
pathogens. These are soluble factors, such as interferons, NTC cells and cells of
mononuclear phagocytes lineage, which include macrophages.
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Macrophages are the main cell-type permissive to all lentiviruses in vivo. Moreover,
macrophages isolated from MW-infected animals can be targets for CTL killing (Lee
et ai, 1994). It is therefore feasible to assume that loss of infected
monocyte/macrophages because of CTL activity may compromise the innate
immunity against pathogens and result in disease.
1.9 Why do lentiviruses persist?
Despite rigorous immunity mounted against lentiviruses by the host immune system,
the infection persists, culminating in clinical disease and inevitable death. Viruses,
during their co-evolution with their hosts, have evolved a myriad of strategies to
evade the host immune system.
1.9.1 Immune determinants of viral persistence
1.9.1.1 Antigenic variants
Humoral immune responses mounted against lentiviruses do not appear to be effective
in eliminating the virus (see above). The envelope glycoproteins are the most
prominent targets for neutralising antibodies, since they are the most exposed viral
components that take part in initial receptor-binding activities. However, the kinetics
of neutralisation would suggest that these antibodies are inefficient in their mode of
action. This is partly due to the extensive glycosylation of envelope glycoproteins. In
small ruminant lentiviruses, treatment of viral particles with neuraminidase, which
removes sialic acids, resulted in enhanced neutralisation by immune sera.
Desialylation also rendered the virus more prone to protease digestion (Huso et al.,
1988). This observation would imply that carbohydrates on the viral surface are
important in both protecting viral proteins from digestion by proteases and in
protecting the virus from rapid neutralisation by antibodies
In HIV-1, heavily glycosylated gpl20 results in diminished neutralisation by anti-
envelope antibodies. The shedding of viral envelope proteins may also be used as a
decoy to evade the immune system. Since the topology of oligomeric gp 120 is a vital
determinant for neutralisation, therefore, the shed gpl20 may result in a deviated
humoral response against the monomelic form of gpl20. Moreover, the V3 loop is a
dominant immunogen in generating antibodies. However, this region is also highly
variable in its amino acid sequence, resulting in antigenic variants that may become
escape mutants (reviewed by Poignard et al., 1996).
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The error prone RT of lentiviruses can also result in antigenic variants (drift) that may
escape the host immune system. The best example of antigenic drift is the episodic
EIAV. In EIAV infection, emerging virus variants are proceeded by quasi-species-
specific neutralising antibodies. These result in diminished viraemia, before the
emergence of new escape variants (Rwambo et al., 1990).
MW may employ antigenic drift as a method of escaping the host immune system.
However, the importance of this strategy in persistence and pathology of MVV is
unclear. In long-term experimental infections with MW, the emergence of antigenic
variants was a rare event: an estimated 16% escaped type-specific antisera (Thormar
et al., 1983; Lutley et al., 1983). However, use of antisera may underestimate the rate
of antigenic drift in these experiments. Epitope-overlapping mAbs raised against
MVV gpl35 and tested on strain 1514 and its antigenic mutants (LV-1 to LV-6
isolated from a single infected animal) showed the existence of antigenic variants,
whereas polyclonal anti-gpl35 sera failed to detect these differences (Stanley et al.,
1987).
Gag-derived proteins are also highly immunogenegic in MW (Raybum, 1992).
However, unlike anti-gpl35 mAbs, mAbs raised against the major core protein of
MW failed to detect antigenic variants (Stanley et al., 1987).
Hypergammaglobulinemia and increased B cell activation occur in HIV-1 infections.
The carboxyl terminus of gp41 has the capacity to induce poly-clonal B-cell
activation in normal B lymphocytes, causing them to differentiate into
immunoglobulin-secreting plasma cells. This immunogenegic domain is part of the
transmembrane region of gp41, and therefore not involved in receptor-mediated
infection of permissive cells (Chirmule et al., 1990).
1.9.1.2 CTL repertoire usage
Cell mediated immune responses take place in all lentiviruses, and to varying degrees.
However, these cellular immune responses, like humoral immune responses are
unable to clear the infection.
In HIV-1 infections, patients may be categorised into slow progressors or fast
progressors, with different underlying determinants, for example second receptor
usage, or the genotype of MHC alleles. In one study, the fast progressors had a
vigorous and oligoclonal expansion of T cells, whereas slow progressors had a less
vigorous, but broader T cell repertoire (Pantaleo et al, 1994). Anti-Gag CTL
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responses were detected in 75% of subjects compared to 26% against Env and Nef
(Bourgault et al., 1991). Moreover, in a longitudinal study, Gag-specific CTLp
frequencies early in infection were paralleled by increasing numbers of HIV-1
infected CD4+ T cells (Klein et al., 1995). However, some reports have shown lack of
a consistent correlation between disease severity and CTL frequencies (O'Toole et al.,
1992).
Since HIV-1 has been shown to have a high turnover in vivo, it is also possible that
the CTL repertoire generated against viral epitopes is lagging behind emergence of
new viral variants. There are, however, no reported studies on the epitope usage by
CTL in MVV infection.
1,9.2 Viral determinants of persistence
Viruses can evade the immune system by different mechanisms, for example, by
infecting immunologically inert sites such as the nervous system. This is best
exemplified by herpes simplex, which persists in the sensory ganglia.
Viral proteins are processed intracellularly and presented to CD8+ T lymphocyte in
the context of MHC-I. Cells bearing such complexes are recognised and may be lysed
by CD8+ CTL. Several viruses interfere with the intracellular pathway/expression of
MHC-I and therefore evade the immune system. For example, IPC47 of herpes
simplex which sits on TAP molecule in the endoplasmic reticulum and thereby
interferes with MHC pathway. Other example is the EBNA1 of EBV which contains
a 20 amino acid stretch of glycine/alanine, that interferes with cellular proteasome
machinery (reviewed in Fields Virology, 1994).
Virus-coded proteins may also have direct immunosupressive properties. Within the
\if ORF of MW, a sequence was identified that showed high similarity to the
immunosuppressive sequence from the retroviral transmembrane protein pl5E.
Synthetic peptides of this sequence inhibited lymphoproliferation stimulated by either
IL-2 or T-cell antigen receptor. These peptides also inhibited the enzymatic activity
of protein kinase C (PKC) (Ruegg et al., 1990).
There are no indications that infection with ruminant lentiviruses results in
downregulation of MHC-I. However, there is some evidence that HIV-1 can
downregulate the expression of MHC-I on, the surface of infected cells. Reduced
expression of MHC-I may result in enhanced killing by NK cells. However, co-
culture of HIV-infected cells with NK cells showed little or no killing. Since killing
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by NK cells is also dependent on the presence of cytokines, it is postulated that
diminished NK-mediated killing is partly due to impaired cytokine production (Zheng
and Zucker-Franklin, 1992).
1.10 Pathology of MW infection
An inevitable result of a protracted infection with all lentiviruses is organ-specific
pathology. The pathology in MW infections may manifest as interestitial pnumonia
(maedi), arthritis of joints, mastitis and leukoencephalomyelitis (visna). Henceforth,
the clinical disease associated with the CNS because of MW infection will be
referred to visna.
The first reports of both natural and experimental visna were by Sigurdsson and co¬
workers (1957, 1962). Extensive description of neuropathology was carried out by
intracerebral (i.e.) infections of animals (Georgsson et al., 1976).
The earliest sign of clinical visna is cachexia. This is followed by change by
progressive ataxia (fore- and hind limb), and subsequently hind leg paralysis within a
few months of showing emaciation. There appears to be no loss of appetite until and
during the last stages of clinical disease. Sometimes the disease progresses in waves
with slight intervening remission. The clinical disease may manifest as early as six
months post-infection (p.i), although this may depend on breed susceptibility
(Georgsson et al., 1976; Watt et al., 1990). The end-stage fatal disease is concomitant
with fine trembling of facial muscles, blindness and seizures, all signs of extensive
CNS involvement.
1.10.1 Histopathology of visna
All lentiviral infections can result in CNS pathology. However, the extent of
neuropathies may differ among lentiviruses. (Sigurdsson et al., 1956; 1994McIlwraith
and Kitchen; 1978Bredesen et al., 1988; Letvin and King, 1990; Dow et al., 1990;
Gonda et al., 1994).
The most striking feature of MW neuropathology is the extensive lymphocytic
infiltration, which is in the form of perivascular infiltrates or "cuffs", around blood
vessels and in brain parenchyma. Leptoemeninges of both brain and spinal cord show
inflammatory reaction. The brain lesions are asymmetric and widespread, however,
certain anatomical regions show a predilection for lymphocytic infiltrates. These
include the areas immediately adjacent to ventricular system in sub-ependyma.
Consequently, lesions are found more frequently in the white matter than in the grey
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matter. Lesions seldom present in cerebral or cerebellar cortex and if present are in
the form of perivascular cuffs spreading from overlying meningitis. The choroid
plexus is frequently inflamed with lymphoid follicle formation and often with
germinal centres. Glial nodules are rare, and if present seem to be focal and
widespread and can be randomly located. The end stage visna may result in
liquifaction necrosis and loss of neuroparenchyma (reviewed by Petursson et al.,
1976).
Visna pathology associated with the peripheral nervous system (PNS) appears to be a
rare event, and may arise as a result of inflammatory infiltrates from the adjacent
meninges. However, Sigurdsson and co-workers (1962) reported isolated
inflammatory foci in peripheral nerves at some distance from the nerve roots, with
isolated cases of degenerative myelinated tracks.
Like MW, HIV-1 infection may also result in neuropathology. The first isolations of
HIV-1 from the brains of AIDS patients were reported by Shaw and co-workers
(1985) and Ho and co-workers (1985). HIV encephalopathies include HIV-
encephalitis (presence of HIV virus in brain parenchyma), and AIDS-dementia
complex or HIV-associated dementia (both refer to clinical syndrome). A hallmark of
the CNS disease is the presence of multi-nucleated giant cells (MGC). MGC are
formed by the fusion (syncytium) of infected macrophage-type cells in the brain
parenchyma (reviewed by Glass and Johnson, 1996).
Intravenous infection of rhesus macaques with SIV also results in CNS lesions similar
to visna. The CNS infection with SIV is an early event, as virus can be detected
within seven days post-infection. At the earliest stage, the infection localised mainly
to perivascular CD68+ mononuclear cells. Moreover, early viral replication coincided
with neuropathological changes, consisting of gliosis, perivacular cuffs, microglial
reactivity and MHC-II up-regulation. Interestingly, early CNS changes were more
widespread than infection of macaques via i.e. route. Similarly, infections of rhesus
macaques with either SIVmac or SIVsm (sooty mangabey) also result in
encephalopathies with MGC (Lackner et al., 1991). MGC are prominent in HIV-1 and




The initial lesions in all lentiviruses appear similar. These consist of meningitis,
perivascular infiltration, especially of the deep white matter, and inflammation of the
choroid plexus.
Myelin abnormalities are present in lentiviral infections of the CNS. In visna,
myelinated nerve fibres with only minimal changes may traverse through
inflammatory foci. The dissociation of myelinated nerve fibres by inflammatory
exudate may cause loss of myelin intensity (white pallor). However, complete
destruction of myelin is only observed in necrotic lesions. Moreover, sharply
demarcated plaques of primary demyelination may also occur. The initial
lymphocytic infiltrates in visna are similar to CNS lesions observed in experimental
allergic encephalitis (EAE) and lymphocytic choriomeningitis virus (LCMV). In
visna, demyelination appears to be secondary in appearance, i.e., damage to myelin
after initial damage to the neurones or axons, although occasionally plaques of
primary demyelination similar to multiple sclerosis (MS) are also noted. Primary
demyelination, if present, is a late manifestation of visna infection (Georgsson et al.,
1994).
Unlike visna neuropathology, vacuolar myelopathy is a common finding in HIV-1
neuropathies. Involvement of white matter in HIV results in leukeoencephalopathy,
and diffuse myelin pallor. Diffuse myelin pallor does not appear to be due to loss of
myelin, and may correlate with dementia. Leukoencephalopathy may include myelin
breakdown, macrophage infiltration and presence of MGC. Inflammatory foci in
visna brains include gliosis. Similarly, both astrocytosis and microgliosis are
common findings in HIV-1. B cell lymphomas are associated with neurological
complications with HIV and SIV infections. There are no lymphomas in visna
infection of the CNS. (reviewed by Glass and Johnson, 1996).
1.11 Lentiviral CNS tropism
In visna-infected brains, the phenotypic assignment of virus-infected cells has been
based on cellular morphology. However, use of antigenic markers such as CD68 and
Ricinus cummunis agglutinin-1 (RCA-1) for cells of monocyte/macrophage lineage,
has confirmed the identity of virus-infected cells (Torsteinsdottir et al., 1992; Brodie
et al., 1995). The highly focal and restricted visna infection in CNS complements the
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restricted pattern of viral gene expression observed in other tissues, for example
maedi lungs, and lymph nodes.
In contrast to a low frequency of productively infected cells, MVV viral RNA
structural can be detected in a variety of cell types, including blood endothelial cells
(Haase, 1985; Zink et al., 1994; Brodie et. al., 1995). Both viral DNA and RNA were
found in infected cells within the inflammatory foci. Viral antigen-positive cells
constituted a smaller number of infected cells when compared to viral RNA-positive
cells. Viral RNA was also detected in cells that stained positive with markers for
oligodendrocytes and astrocytes (Stowring et al., 1985).
Sequence analyses of HIV-1 viruses isolated from different tissues from AIDS
patients show presence of virus quasi-species. However, HIV-1 isolates from brain
tissues show a preponderance of M-tropic viruses. Unlike blood-derived isolates,
brain-derived HIV-1 isolates are predominantly non-cytopathic inducing (NSI), grow
well in macrophages, and are less susceptible to neutralising sera (Ball et al., 1994;
Brew et al., 1996).
In both HIV and SIV infection of the CNS, viral antigen- and/or nucleic acid-positive
cells were predominantly stained with markers for monocytes and macrophages.
Moreover, in HIV encephalopathies, viral transcripts and antigens are also detected in
a variety of cell populations in the virus-infected brains. These include astrocytes,
oligodendrocytes, blood endothelial cells, and lymphocytic infiltrates (Wiley et al.,
1986; Li et al., 1991).
1.12 Route of lentiviral entry into the CNS
The earliest lesions after MW infection of CNS are small subependymal
inflammatory foci, usually around a venule or small vein in the parenchyma. These
initial "cuffs" are composed of lymphocytes (50-70%), plasma cells and
monocytes/macrophages (10%), some of which are virus-positive (Haase, 1985;
Torsteinsdottir et al., 1992). Although the perivascular cuffs in HIV-1 neuropathies
are minimal compared to visna, nevertheless, some of the mononuclear inflammatory
cells in such cuffs are also positive for viral proteins and transcripts (Wiley et al.,
1986). Similar observations have been made with SIV infections (Li et al, 1991).
These and similar observations prompted Peluso and co-workers (1985) to suggest
that entry of Antiviruses into the CNS took place by infected monocyte/macrophages
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(and possibly T cells with primate lentiviruses and FIV) via a "Trojan horse"
mechanism.
The extravasation of cells from systemic circulation in to neuroparenchyma is a multi-
step process, and requires the involvement of adhesion molecules on both the
endothelium and migrating cell (reviewed by Springer, 1990). Interestingly, in EAE
model of MS, induction of vascular cellular adhesion molecule-1 (VCAM-1) on
endothelial cell of BBB has been shown to facilitate the infiltration of lymphocytes in
to the parenchyma (reviewed by Miller and Karpus, 1994).
1.12.1 Role of Blood-brain barrier in lentiviral neuropathology
The presence of viral antigens/transcripts in endothelial cells of the blood-brain
barrier (BBB) indicates that these cells may be used as a route of entry by viruses
from blood into the CNS. Endothelial cells of BBB have been shown to harbour
lentiviral proteins and transcripts (Wiley et al., 1986; Zink et al., 1994; Brodie et al.,
1995). Furthermore, damage to BBB integrity has been reported in E1IV-1
neuropathies, which may correlate with AIDS complex dementia (reviewed by Glass
and Johnson, 1996).
Damage to the BBB resulting in vascular permeability has been documented in
several virus infections of the CNS, for example measles virus infection of the CNS
(reviewed by Gosgriff, 1989). Similarly, damage to the BBB has been demonstrated
in early lesions of MS (Kermode et al., 1988). The precise mechanism of how
damage is done to the enodothelial cells of the BBB in MS is not known. The damage
to the BBB could be due to direct infection by a virus, by certain cytokines, or by
antibodies against the endothelial cells of the BBB (reviewed by Miller and Karpus,
1994).
Lymphocytic choriomeningitis virus (LCMV) is an Arenavirus genus of Arenaviridae.
In adult mice, infection of the CNS with LCMV results in severe pathological changes
mediated by CD8+ T cells. Treatment of these mice with mAbs against CD8+ T cells
protects mice against disease. It is believed that virus specific CD8+ T cells damage
the infected endothelial cells of the BBB resulting in cerebral oedema (Buchmeier et
al., 1980).
In a murine model of MS, infection of a resistant strain (BALB/c) with an avirulent
mutant of a neurotropic strain of Semliki Forest virus (SFV-A7) results in MS.
Intraperitoneal infection of mice with SFV-A7 resulted in infection of vascular
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endothelium and perivascular neurones in cerebellar and spinal cord white matter.
Presence of viral antigens correlated with damaged BBB (Soliu-Hanninen et al.,
1994).
Therefore, either direct or indirect damage to BBB may contribute to neuropathology.
Viral antigens and transcripts have been detected in lentiviral infections of the CNS
(ut supra). However, the close proximity of perivascular macrophages to the
basement membrane of BBB may complicate the accurate identification of infected
cells because of intimate association of perivascular cells with the basal lamina of the
vessels. For example, in a SIV infection of rhesus monkeys, both endothelial cells
and perivascular cells appeared positive for viral proteins. However, use of double
immunostaining demonstrated that the majority of infected cells also stained positive
for CD68+ monocyte/macrophages (Lackner et al., 1991).
1.13 Independent evolution of lentiviruses in the CNS
Virus recovered from the brain of patients with HIV-induced neuropathological
disease shows envelope sequences different from the virus in the blood of the same
individual (Power et al., 1994). In one study, none of the V3 sequences obtained from
brain tissues was found among those from lung, peripheral blood mononuclear cells
(PBMC), and lymph node samples (Hughes et al., 1997). Moreover, comparison of
cloned sequences from the brain and spleen tissues from demented and non-demented
patients showed two amino acid substitutions in the V3 loop (histidine at position 305
and proline at position 329) that correlated with neurotropism and the clinical HIV
dementia (Power et al., 1994). Although other studies show a similar trend in the
sequences of V3 with its relation to neurotropism, there appears no conserved
sequence in this region that would confer universal neurotropism upon invading
viruses (Hughes et al., 1997). Nevertheless, these results imply an independent
evolution of neuropathic strains of HIV-1 in the brain compartment. Moreover, these
and similar analyses have indicated that CNS infection by HIV takes place early after
infection, and may be prior to commencement of clinical AIDS.
Korber and co-workers (1994) hypothesised that the reason for the preponderance of
M-tropic variants, with respect to the V3 sequences derived from nonlymphoid tissues
such as brain, is because viral infection of such tissues occurs early post-infection, and
at a time when the viral population is relatively homogenous in the V3 region.
Moreover, as disease progresses, quasi-species from lymphoid tissues may undergo
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more rapid sequence changes in regions such as V3, which is under selection
pressures such as neutralising antibodies and CTL. This is apparent from the rapid
changes in the population dynamics of HIV-1 in the PBMC after treatment with
antiviral protease inhibitors (Ho et al., 1995). However, cellular constraints,
independent of immune pressures may also contribute to the selection of viral variants
in non-lymphoid tissues, for example the CNS. This is best explained by the
restricted infection of MW in monocyte cells prior to maturation/differentiation into
macrophages.
Infection of macaques with SIVmac239, a molecular clone of T-tropic SIVmac,
results in productive infection of lymphocytes that can invade the CNS. Viral DNA
was recovered from the brain tissues of these animals. However, PCR analyses of
recovered env sequences revealed that a minimal virus replication had occurred in
vivo, and only one animal showed a change to M-tropic virus sequences. Moreover,
in spite of immunosuppression and AIDS, these animals did not show overt
neurological diseases (Stephens et al., 1995). Interestingly, multiple sequential
intracerebral passage of SIVmac239 in the brains of rhesus macaques resulted in the
selection and replication of an M-tropic neurovirulent strain, SIVmac239/17E-Br
(Sharma et al., 1992). This neurovirulent strain differed by only 16 amino acids from
the parent strain, located in the env region. Similar neurotropic determinants have
been located in the env sequences of HIV-1 isolates (Power et al., 1994).
Taken together, these observations demonstrate that cells of monocyte/macrophage
lineage are most consistently associated with both neurotropism and neurovirulence.
1.14 Immune status of the CNS
Historically the CNS has been regarded as an immune-privileged site. This has been
because of a) low to undetectable levels of MHC molecules in the parenchyma; b)
lack of a demonstrable lymphocytic drainage; and c) seclusion from the peripheral
immune system by a physical barrier, i.e. the blood-brain barrier (BBB). These
features may contribute to the impaired (delayed) rejection of xenografts transplanted
in the CNS. However, use of more sensitive techniques, together with availability of
better reagents have demonstrated that although the CNS may be a less active site in
immunological terms, it is by no means an immune privileged organ. This is apparent
from the trafficking T lymphocytes into the CNS, and detectable levels of MHC
molecules on cells of neuroparenchyma, including endothelial cells of the BBB.
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Moreover, antigens injected or grafted intrathecally (i.c) may be transported to the
deep cervical lymph nodes.
In the non-inflamed ovine CNS, constitutive MHC-I expression was detected on
endothelial cells in grey and white matter, choroid plexus and ependyma. Moreover,
MHC-I was also present but to a lesser extent, on pericytes, meninges, and apparently
pia-arachnoidal cells. On the other hand, MHC-II expression was less widespread,
and mainly detected on pericytes and on microglial cells in the white matter. Some
subependymal glial cells were also positive for the surface expression of MHC-II.
Glial cells were found negative for surface expression of both MHC class-I and II
(Georgsson et al., 1997).
Therefore, the presence of MHC molecules (class-I and II) in the CNS is indicative of
potential antigen presentation to both CD4+ and CD8+ T cells, and therefore potential
targets for immune-mediated pathology.
1.14.1 Immune determinants of visna neuropathology
There are several observations, which imply that CNS lesions in visna are immune-
mediated. This appears to be via a cell-mediated immunity (CMI), supported by the
observations that virus-infected cells can support a mixed lymphocyte reaction in
vitro. The CMI profiles of infected sheep showed a correlation with the CNS lesion
formation (Griffin et al., 1978, Torsteindottir et al., 1992). Moreover, pre-treatment
of animals with anti-thymocyte sera plus cyclophosphamide, results in a generalised
immunosuppression. Subsequent infection these animals with K1514 strain of Visna
did not result in a significant CNS lesion formation, when compared with untreated
controls (Nathanson et al., 1976). However, this treatment could only be sustained for
a short period due to inherent problems with this approach. Nevertheless, indications
were that immune responses directed toward the virus did play a role in early lesion
formation.
Free virus could be isolated from cerebrospinal fluid (CSF) of visna-infected animals
some 30 days p.i, with a progressive decline in the isolation of virus. In a similar
study, free virus could be detected from the CSF within two weeks of infection, which
also declined with time. No virus could be isolated from CSF after four months p.i.
This was concomitant with the maximum levels of neutralising antibodies in the CSF.
The ratio of CSF/serum neutralising antibodies varied from V* to eight. In one case,
lack of CSF neutralising antibody was correlated with severe clinical visna.
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Moreover, CSF pleocytosis has been shown to correlate with lesion severity in visna
(Petursson et al., 1976; Griffin et al., 1978; Nathanson et al., 1979; Georgsson et al.,
1979).
1.14.1.2 Role of humoral immunity in visna neuropathology
Since demyelination is observed in Visna infections of the CNS, it was postulated that
this might be due to generation of anti-myelin antibodies. No anti-myelin antibodies
were detected in Visna infections (Nathanson et al., 1981). Antibody-mediated
pathology has been reported in CAEV infection, where high titre antibodies to Env,
but not Gag antigens have been shown to correlate with the severity of arthritic joints.
However, there is no reported evidence that such a mechanism may play a role in the
CNS pathology (Bertoni et al., 1994; Perry et al., 1995).
In HIV-1 infection, a cross-reactivity has been observed between gp41 antibodies
with human astrocytes and astrocytoma cell lines. Since intrathecal anti-gp41
antibodies are also present in some 50% of AIDS patients, it was therefore suggested
that such antibodies may play a role in virally induced autoimmune disease. A panel
of mAbs against gp41 was used in a detailed study of brain sections of apparently
normal HIV- patients, and AIDS patients, with or without dementia. Cross-reactive
anti-gp41 epitopes were present in all brain tissue, irrespective of presence or absence
of HIV. However, there was a significant increase in the number of immunoreactive
cells in HIV+ samples (Spehar and Strand, 1994). Similar observations have been
made with anti-gpl20 antibodies, which cross-react with human brain proteins
(Trujillo et al., 1993). However, it is not clear what role, if any, these antibodies may
play in the CNS pathology.
1.14.1.3 Role of CD4+ T cells in visna neuropathology
Autoimmunity may be mediated by an antibody-independent, CD4+ T cells (DTH)
mechanism. For example, CD4+ T cell-mediated EAE, which results from
introduction of CNS antigens (brain and spinal cord homogenates), into the periphery.
EAE has been used as a murine model for the relapsing-remitting model of human
MS. Generation of encephalitogenic CD4+ T cells to major myelin proteins, for
example myelin basic protein (MBP) and proteolipid protein (PLP) results in EAE via
release of pro-inflammatory cytokines, for example macrophage inflammatory protein
la (MlP-la). These factors in turn cause the chemoattraction and activation of
monocyte/macrophage cells which in turn result in myelin damage via a bystander
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mechanism. Adaptive transfer of MBP-reactive CD4+ T cells into naive mice elicits
disease, and antibody depletion of Vp8+ cells in vivo reduces the severity of disease
in mice (reviewed by Miller, 1994).
Generation of naturally occurring encephalitogenic T cells may be a result of
similarities between self-epitopes and non-self, viral epitopes. An amino acid
similarity between the Visna polymerase and myelin prompted the suggestion that
visna-induced demyelination may be due to molecular mimicry. However, a synthetic
peptide encompassing the shared amino acid homology between Pol and myelin
protein failed to induce a cell-mediated response (Weise and Cranegie, 1988).
1.14.1.4 Role of CD8+ T cells in visna neuropathology
Although the CD4/CD8 ratio in systemic circulation does not change significantly
after infection with MVV (~2), there is a decrease in CD4/CD8 ratio (-0.8 - 1) in
CSF. This almost reversal of ratios was more pronounced in neuroparenchyma,
where CD4/CD8 ration was in the order of 0.8 compared to approximately two in
perivascular cuffs, implying a differential transport of CD8+ T cells into the
parenchyma (Torsteinsdottir et al., 1992). Since MVV-infected cells can be targets
for CTL in vitro, therefore, presence of CD8+ cells may contribute to neuropathology.
CD8+ T cells can directly contribute to neuropathology. Theiler's murine
encephalomyelitis virus (TMEV) is an Enterovirus genus of Picornaviridae family
and has been used a model for the chronic-progressive forms of human MS. TMEV
infection results in lifelong persistence in the CNS. In susceptible SJL/J (H-2S) mice,
infection is characterised by CNS perivascular inflammatory infiltrates of
mononuclear cells and primary demyelination (reviewed by Miller and Karpus, 1994).
Immunosuppression with mAbs against CD4 or CD8 molecules decreases the number
and extent of demyelination in suceptible mice (Welsh et al., 1987; Rodriguez and
Sriram, 1988). TMEV productively infects oligodendrocytes. Mice with H-2b
haplotype are resistant to TMEV and clear the infection. Disruption of the Ap gene of
MHC-II molecules in H-2b mice [H-2b(Ab0)], which abrogates MHC-II mediated
functions resulted in the persistence of virus in the CNS with demyelinating lesions,
which co-localised with virus-specific CD8+ T cells These results also indicate that
CD8 + T cells can function in the absence of Th cells (Njenga et al., 1996).
It is therefore possible that CD8+ T cells generated as a result of Visna infection may
play a role in neuropathology in vivo, culminating in neurological deficits. However,
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there is no direct evidence to correlate the presence of CD8+ T cells with lesion
formation in lentiviral-associated neuropathies. Moreover, there are limited reports of
lentivirus- infected oligodendrocytes and neurones, which may act as cellular targets
for CTL activity.
The discrepancy between the frequency of productively infected cells and extent and
character of pathological lesions indicates that mechanisms other than the direct effect
of the virus may be involved in neuropathies associated with lentiviruses, referred to
as "bystander" damage. For example, in experimental infections with Visna, the
number of viral antigen-positive cells was very low, even in areas showing the highest
density, i.e., choroid plexus. This was estimated to be 1 in 103 to 1 in 104 cells (Hasse
et al., 1977; Georgsson et al., 1989). The discrepancy between infected cells and
pathology is most profound in autopsy of brain tissues from HIV+/AIDS patients,
where sparse pathology was found in samples from patients that had profound
cognitive impairment (reviewed by Budka, 1989).
1.14.1,5 Activated cells may cause bystander damage
In MVV infection of the CNS, the perivascular infiltrates are mainly of CD4+ T cell
phenotype (Torsteindottir et al., 1994). However, perivascular infiltrates in visna are
not unique to the brain vasculature. In chronic arthritis because of MW infection, an
overall increase in all T cell subsets in synovia has been observed, which was
concomitant with an increased MHC-II expression on cell layer lining the synovium
(Anderson et al., 1994). Moreover, in a similar study, T cells were found to have an
IL-2R-negative phenotype (Wilkerson et al., 1995). Similarly, a population of
CD8+/MHC-II+/IL2-R" T cell was detected in the lymph node of acutely infected
animals (Blacklaws et al., 1995)
In HIV-1 infection, impaired proliferative responses to recall antigens, pokeweed
mitogen (PWM), anti-CD3- or anti-CD2-antibody treatments have been reported
(Hofmann et al., 1989).
A lack of response by lymphocytes to various stimuli has been reported in
immunosuprression caused by Measles virus. Measles virus is able to block mitogen-
induced proliferation of PBMC (McChesney et al., 1988). The decrease in
proliferation was not due to lack of T cell growth factor, IL-2, but rather a defect in
the expression of IL-2Ra subunit (Bell et al., 1997). Moreover, the IL-2R" phenotype
of PMBC in the measles study appeared to have no adverse effect on the secretion of
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cytokines, for example IL-2 and IFN-y from T cells (Bell et al., 1997). It is
noteworthy that one of the major inducers of adhesion molecules on BBB is INF-y, in
particular ICAM-1. Moreover, IFN-y is a potent inducer of both MHC-I and II
molecules, and activates monocyte/macrphages, NK cells and CTL.
A nonglycosylated protein with a molecular weight of 54-64 kDa, named lentivirus-
interferon (LV-IFN; also refereed to as lentiferon), has been identified from co-
cultures of MW-infected macrophages and lymphocytes, with similar biological
activities to IFN-a and IFN-y. Neither the infected macrophages nor lymphocytes
alone could produce LV-IFN. Moreover, use of monoclonal antibodies to MHC-II
blocked production of LV-IFN. The activated phenotype of macrophages (MHC-II+)
observed in LN, maedi lungs, arthritic joints and visna might be a function of LV-
IFN, because direct infection of macrophages with MW does not result in increased
expression of MHC-II. Intracerebral infusion of crude LV-IFN preparation into
visna-infected brains increased the CNS lesions. Paradoxically, LV-IFN also
inhibited viral transcription and differentiation of monocytes into macrophaes
(Narayan et al., 1985; Zink andNarayan, 1989).
Whether the cytotoxicity is mediated by LV-INF, other cytokines or the source of this
cytokine (lymphocytes or infected macrophages) is not known. The complexity of
biological properties associated with LV-IFN is most probably due to several factors
in the supernates from the co-cultures of lymphocytes and infected macrophages.
1.15 Do lentiviruses infect astrocytes?
In visna, there is a single report of viral transcripts detected in astrocytes (Stowring et
al., 1985). However, this observation has not been substantiated (Georgsson et al.,
1989).
An early description of paediatric AIDS was demonstrated by the rare presence of
viral particles in astrocytes (Epstein et al., 1984). Moreover, the non-productive
infection of paediatric astrocytes has been linked to the presence of the early viral
transcripts nef. It is therefore, proposed that astrocytes may function as a reservoir of
infection in HIV-l(Erfle etal., 1991).
HIV-1 infection of human foetal astrocytes and astrocytoma cell lines can result in a
persistent and non-productive infection. However, infection of primary cultures of
human astrocytes has been negative (Sharpless et al., 1992).
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1.16 Do lentiviruses infect oligodendrocytes?
In visna, there is a single report of viral transcripts detected in oligodendrocytes
(Stowring et al., 1985). However, more recent studies have failed to show viral
products in oligodendrocytes (Georgsson et al., 1989; Brodie et al., 1995).
In HIV-1 infections of the CNS, oligodendrocytes appear to be targets for neuropathy.
Although cultured oligodendrocytes may support a productive infection in vitro, direct
proof of infected oligodendrocytes in vivo remains elusive (Sharpless et al., 1992;
Albright et al., 1996).
1.17 Do lentiviruses infect neurones?
There are no reports that lentiviruses directly infect neuronal cells. For example,
intracerebral infection with a highly neurovirulent strain of visna did not result in
infections of neurones (Georgsson et al., 1989).
Neuronal damage is frequently observed with lentiviral neuropathies. In visna,
shrinkage and sclerosis of nerve cell bodies or swelling and/or chromatolysis,
sometimes accompanied by stallitosis, is occasionally noted in inflammatory foci, but
may also occur independently of lesions (Gerogsson et al., 1976). In HIV-1 infection
of the CNS, extensive loss of neuronal complexity of up to 50% has been reported
(Masliah et al., 1992).
1.18 Visna-meditated CNS pathology
Lentivirus-mediated neuropathology in the absence of specific immune responses has
been demonstrated by use of in vitro models and in transgenic mice. For example,
expression of HIV-1 genome under the human neurofilament-L (NF-L) promoter in
mice, resulted in expression of the transgene in neurones concomitant with
neurological syndrome (Thomas et al., 1994). In similar experiments, neural
expression of HIV-1 env under the NF-L promoter in transgenic mice also resulted in
abnormal dendritic swellings in neurones. Interestingly, reactive astrocytosis, a
common finding in lentivirus infections of the CNS, was also observed (Berrada et
al., 1995). Furthermore, intra-cerebral inoculation of HIV-1 infected monocytes into
SCID mice resulted in gliosis and neuronal injury (Persidsky et al., 1996).
The MW env gene has also been studied as a transgene in sheep (Clement et al.,
1994). In these experiments, transgenic sheep were constructed that expressed the env
gene (also containing rev) under the control of MW LTR. Three animals were
identified that expressed the Env glycoproteins (and Rev protein). Interestingly,
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monocytes from transgenics did not express the Env glycoproteins until
differentiation into macrophages. These animals had shown no obvious clinical
abnormalities by the time these results were published. There has been no update on
the progress of this study.
1.18.1 Neurotoxicity of Visna Tat protein
The MW Tat protein is a 10 kDa protein, which predominates in the early phase of
infection in vitro (see section 1.4.8). Use of synthetic peptide homologues of Visna
Tat has led to the identification of an arginine-rich domain with neurotoxic properties.
This neurotoxic domain resides in the N-terminus of the protein (Fig. 1.3). Similarly,
a neutrotoxic domain has also been identified in the HIV-1 Tat protein (Hayman et
al., 1993; Philippon et al., 1994).
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Fig.1.3 The neurotoxic domains of MYV and HIV-1 Tat proteins
Both MVV and HIV-1 Tat proteins contain neurotoxic domains, which are
schematically represented in red. A common feature of neurotoxin domains is the
presence of arginine residues (depicted in bold-type). The neurotoxic domain of
MW is an arginine-rich stretch of 18 amino-acid peptide. N and C correspond to









1.19 Breed susceptibility to visna
The susceptibility to clinical visna appears to be breed-specific. In contrast to
Icelandic sheep, which are highly prone to visna, European breeds very rarely develop
visna. Maedi is by far the most common clinical outcome of infection with MVV in
British breeds (N. Watt, pers. comm.). Intracerebral inoculation of Icelandic strain of
MW, K1514, into British breeds (Corriedale, Dorset, and Hampshire) resulted in a
transient localised CNS inflammation and demyelination, followed by scar formation
(astrocytosis) and recovery. Although virus could be isolated from the brains of these
animals up to one year post-infection, no viral RNA could be detected (Zink et al.,
1987).
1.20 Summary
Host-specific lentivirus infections may result in an insidious and protracted persistent
infection, with the inevitable tissue-specific pathology. This protracted course of
infection has been demonstrated to be partly due to the restricted replication of viral
genome in cells of monocyte/macrophage lineage.
The presence of virus-positive cells has been associated with tissue pathology. The
CNS is one of the main organs that is both infected and pathologically affected in all
lentiviral infections. The pathology in the CNS is directly linked to the virus
infection. Although T-tropic lentiviruses may infect the CNS in primate lentiviruses
and FIV, overwhelming evidence indicates that M-tropic lentiviruses are the main
virus variants that infect the CNS early in the course of infection.
MW does not infect T- or B-lymphocytes and it appears to be solely an M-tropic
lentivirus. Moreover, MW, like other lentiviruses results in CNS pathology (visna),
and with similar, although not identical, brain lesions.
The pathological appearance of the CNS lesions because of visna infection (and other
lentiviruses) would indicate that immune mediated responses contribute to
neuropathology. This is feasible, at least for the initial stages in the course of
infection. This specific immune-mediated damage in the CNS may be either direct,
for example by CTL, or indirect via release of soluble factors, for example cytokines.
The protracted course of infection would also suggest that these virus-specific
immune-mediated responses might contribute to restricted replication of lentiviruses.
The low frequency of productively infected cells in the CNS, the presence of lesions
removed from sites of inflammatory lesions and virus antigen-positive cells have lent
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support to the bystander damage hypothesis. Therefore, the neuropathology because
of lentivirus infections may be categorised into two interconnecting mechanisms:
1.20.1 Immune-mediated neuropathology
Specific immune-mediated responses may result in tissue damage. The presence of
CD8+ T cells in visna CNS is an example. However, tissue damage by antigen-
specific T cells may also result in bystander damage, via release of cytokines. This is
best exemplified by murine EAE models of MS. In addition, the presence of
cytokines in the CSF of ADDS patients would support this hypothesis. Damage to the
cells of BBB either directly or indirectly, may have an additional role in CNS
pathology. However, the presence of CNS lesions concomitant with severe
immunosuppression in primate lentiviruses would suggest that mechanisms other than
specific immune responses might play a role in disease progression in the CNS.
1.20.2 Virus-meditated bystander neuropathology
The pattern of CNS lesions and a direct correlation with infected cells and
neuropathology prompted suggestions that virus infection per se may also contribute
to neuropathology. This proposal has been strengthened by both in vitro and
transgenic models, where virus-encoded gene products can contribute to
neuropathology in the absence of immune effector cells.
Cells of monocyte/macrophage lineage have been shown to harbour viral antigens.
Microglial cells are believed to be the CNS equivalent of tissue macrophages and
therefore susceptible to lentivirus infection. The HIV-1/SIV neuropathies suggest that
brain microglial cells may play a crucial role in disease pathogenesis.
The mono-tropism of MW for cells of monocyte/macrophage lineage makes this
lentivirus an ideal model to study the role of brain microglial cells in lentivirus
infections of the CNS.
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1.21 Aims of the project
At the start of this project, there was no published report on the role of brain
microglial cells in visna neuropathogenesis/pathology. Therefore, the aims of this
research project were as follows:
1. Establishment and phenotypic characterisation of primary ovine glial cultures with
emphasis on microglial cells
2. Susceptibility of enriched ovine microglial cultures to visna infection in vitro
3. Functional alteration of microglial cells after MVV infection with emphasis on
role of cytokines as mediators of visna pathogenesis/pathology
4. Neurotoxicity of microglia as a result of infection with MW





2 Materials and Methods
2.1 Chemicals
The chemicals and reagents used in experimental procedures were obtained from the
following sources, unless stated otherwise: Sigma Chemical Company, Poole, Dorset;
Gibco/BRL, Paisley, Strathclyde; Amersham International, Amersham,
Buckinghamshire; Boehringer Mannheim, Lewes, East Sussex; Northumberland
Biologicals Ltd., Cramlington, Northumberland; Promega Ltd., Southampton,
Hampshire.
The composition of buffers and stock solutions are given in the appendix.
2.2 Molecular biology
2.2.1 Media for bacterial growth
Bacterial cultures were grown in Luria Bertani (LB) broth or on LB agar plates. The
LB medium was 1% (w/v) tryptone, 0.5% (w/v) yeast extract, and 0.171 M NaCl at
pH 7.5. For LB plates, 1.5% (w/v) agar was added to the LB medium. Cultures were
made selective by the addition of appropriate antibiotics at 50 [Jg/ml, (stock solution
at 50 mg/ml, filter-sterilised and stored at -20 °C), unless stated otherwise.
Autoclaved LB/agar solution was allowed to cool down to approximately 40-50 °C,
before the addition of antibiotic (s).
2.2.2 Bacterial transformation
Commercially obtained competent cells kept at -70 °C were thawed on ice. Plasmid
DNA at varying concentrations (20 -200 pg, and in no more than 15 pi) were added
to the cells. This was incubated on ice for 30 minutes. Cells were heat-shocked at 42
°C for one minute, and placed immediately on ice for 2 minutes. One ml of pre-
warmed LB medium was added to the transformed cells and incubated at 37 °C, with
shaking (200 rpm) for one hour. Alternatively, a richer medium [Bacto trypton (2%);
Bacto yeast extract (0.5%); NaCl (10 mM); KC1 (2.5 mM); MgCL (10 mM); MgS04
(10 mM); and glucose (20 mM)] can be used instead of LB medium. The incubation
step allows for the expression of antibiotic-resistant gene. The tube was microfuged
at top speed for five seconds, and the pellet resuspended in 100 pi of LB medium, pre-
warmed at 37 °C. Twenty-five and 75 pi aliquots were placed on agar plates with
appropriate antibiotic (s). Plates were left right side up for 15 minutes at 37 °C, for
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the medium to be adsorbed into the agar. Plates were then inverted and incubation
was continued overnight.
2.2.3 White/blue colony selection
To select for recombinant colonies, 5-Bromo-4-chloro-3-indoly-P-D-
galactopyranoside (X gal) was used. X-gal stock solution was dissolved in N-N'-
dimethyl formamide at 40 mg/ml, and 25 ul was spread on top of each LB agar plate,
prior to application of bacteria and was allowed to diffuse into the agar for one hour at
room temperature. The commonly used inducer, isopropoyl-P-D-thio-
galactopyranoside (IPTG) was not requird in TA cloning experiments, since the
competent bacterial strain INVaF' [endAl, recAl, hsdR17 (r-k, m+k), supE44, 1-,
thi-1, gyrA, relAl, f80 lacZAM15A (lacZYA-argF), deoR+, F] (Invitrogen), does no
express the lacl repressor.
2.2.4 Hirt DNA isolation
Unintegrated provirus was extracted from infected cells by the modified method of
Hirt (1967). Infected sheep chondrocyte monolayers grown in T25 tissue culture
flasks were rinsed with phosphate-buffered saline (PBS), treated with one ml of lysis
buffer (100 mM Tris-HCl pH8.0, 1 M NaCl, 10 mM EDTA, 0.2% SDS) for 10
minutes at 37 °C, and then overnight at 4 °C. Cell extracts were centrifuged at 15000
x g at 4 °C. The supernatant was treated with proteinase K (100 pg) overnight at 37
°C. DNA was extracted twice with phenol/chloroform, followed by precipitation with
1/10 volume of 3-M sodium acetate (pH 5.2), and 2.5 volumes of ethanol. After
centrifugation in a bench-top microfuge at 13000-rpm (12000 x g) for 20 minutes,
DNA pellet was dried and resuspended in 100 pi of sterile distilled water (SDW).
The concentration of DNA was determined by spectrophotometry at 260nm, and
adjusted to one mg/ml.
2.2.5 Small-scale plasmid preparation ("minipreps")
Qiagen™ columns (Hybaid Ltd.) were used for isolation of plasmid DNA. The
procedure is based on the alkaline lysis method of Birnboim and Doly (1979).
Briefly, after harvesting overnight cultures (5 ml), the bacteria were lysed in
NaOH/SDS, and in the presence of RNase A. This is based on the principle that SDS
denatures the cellular proteins, while alkaline conditions cause the chromosomal and
plasmid DNA to denature. The lysate was neutralised by the addition of acidic
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potassium acetate. The high concentration of the salts causes denatured proteins,
chromosomal DNA, cellular debris and SDS to precipitate, while shorter plasmid
DNA renatures and stays in solution. The denatured plasmid DNA was eluted with 80
pi of SDW. The minipreped plasmid DNA was analysed by restriction enzyme
digests and sequencing.
2.2.6 Restriction enzyme digests
DNA at 1-5 pg was digested with appropriate restriction enzymes, and under the
assay conditions recommended by the suppliers. Restriction digested DNA was
checked by running an aliquot (2-5 pi) on an agarose gel.
2.2.7 Agarose gel electrophoresis
Agarose gel electrophoresis was used for qualitative/quantitative analysis of DNA
(plasmid minipreps, enzyme digests, PCR bands) and RNA samples. Sigma Type I
low DEE agarose was used for casting gels. Gels were cast at concentrations of 1-2%
(w/v), in 1 x TAE buffer plus 0.5 pg/ml of ethidium bromide (EtBr). Samples were
mixed with 0.2 volume of 5 x loading buffer [15% Ficoll 400 (w/v) plus 50 pg of
Orange G (Sigma)], prior to loading in individual wells cast in the gel. The gel was
run in running buffer (1 x TAE), at 80-100 volts (5 volts/cm). Electrophoresis was
allowed to continue until the dye front had travelled at least 2/3 of distance along the
length of the gel.
For qualitative analysis of RNA, samples were treated as outlined for DNA samples,
except that RNA samples were heated to 80 °C, for 3 minutes and snap-cooled on ice
for a further 3 minutes, prior to loading into gel. This treatment prevents RNA
molecules assuming a secondary structure.
Nucleic acid bands were visualised by UV transillumination at 302 nm. An imager
was used for obtaining permanent records.
2.2.8 Alkaline transfer of nucleic acids to hybridisation membranes
To determine the specificity ofDNA bands after electrophoresis, gels were transferred
to Hybond-N+™ (Amersham) or Genescreen Plus™ (NEN, Du Pont). The alkaline
transfer protocol is based on the method of Southern (1975). The gel was pre-soaked
in denaturing/transfer solution (0.4N NaOH), on an orbital shaker for 20 minutes.
The gel was laid on a wick of 3MM Whatmann paper connecting the two reservoirs
on either side of an electrophoresis tank. The gel was then overlaid with a pre-wetted
membrane, two sheets of gel-sized 3MM paper. This construction was then overlaid
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with a pile of paper towels. A weight (~ one Kg) was placed on top of the pile to
assist the capillary motion of DNA through the gel and onto the membrane. The
transfer was allowed to proceed overnight. After the transfer, the blot was rinsed with
2 x SSC and dried in a vacuum oven at 80 °C. At this stage, the blots can be kept
indefinitely prior to hybridisation.
2.2.9 Southern (blot) hybridisation
Pre-hybridisation and hybridisation were carried out at 45 °C in a Hybaid™
hybridisation oven. The pre-hybridisation and hybridisation solution were identical,
except that hybridisation solution also contained the radiolabeled probe. The
hybridisation solution was prepared from pre-made stock solutions and used freshly.
The hybridisation solution contained 1 x DenJhardt's solution, 2 x SSC, 1% SDS and
100 pg of salmon sperm DNA (see appendix).
After incubation for one hour, the pre-hybridisation solution was replaced with the
hybridisation solution (containing the probe), and the incubation was carried on
overnight. Blots were subsequently washed with 0.5% SSC, on an orbital shaker for
15 minutes at room temperature. This was followed by a 30 minutes wash at 50 °C in
a stationary water bath. The blots were dried in a vacuum oven at 80 °C for one hour.
At this stage, either the DNA bands were visualised by X-ray autoradiography or
image analysed using a phosphoimager.
2.2.10 Radio-isotope labelling of oligodeoxynucleotide probes
Gene-specific oligonucleotide primers were end-labelled with T4 polynucleotide
kinase (PNK) (NBL) in the presence of Redivue™ 32P y ATP (Amersham, Cat.
N0.AAOO68). The PNK assay contained one microlitre of gene-specific primer (100
pM), 2.5 pi of 10 x PNK buffer [700 mM Tris-HCl (pH 7.6), 100 mM MgCU, and 50
mM DDT; provided with enzyme], 19 pi of SDW, 0.5 pi (5 U) of PNK, and 2 pi (20
pCi) of radio-isotope. The mixture was incubated at 37 °C for one hour, followed by
heat-inactivation at 70 °C for 5 minutes. The labelled probe was kept at -70 °C and
used within two weeks of synthesis.
2.2.11 Radio-isotope incorporation
The extent of isotope incorporation was monitored by tri-carboxylic acid (TCA)
precipitation. One microlitre of labelled probe was spotted onto a GF/C filter
(Whatmann). This represents the total count. Another microlitre of labelled probe
was diluted with one ml of 10% ice-cold TCA and left on ice for 10 minutes. Using a
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Biorad vacuum manifold, the second filter was washed through a filter paper with five
ml of absolute alcohol, followed by five ml of ice-cold 10% TCA. This represents the
incorporated count. Both filters were dried at 65 °C for 15 minutes. Dried filters
were placed in microfuge tubes, to which one ml of Hisafe™ scintillation liquid
(Wallac Beta counters) was added. A Wallac™ Micro-Beta counter was used. The
percentage of incorporated radioisotope ranged between 15-30%. It is recommended
that at least 106 counts per blot be used. Routinely, five microlitres of labelled probe
was used in five ml of hybridisation solution per blot.
2.2.12 X-ray autoradiography
Probed blots were autoradiographed by exposure to X-ray film (XOMAT-AR™,
Kodak), either at room temperature, or at -70 °C. In cases of PCR products, this was
limited to overnight exposures at room temperature. An automated processer was
used to develop X-ray films.
2.2.13 DNA molecular size markers
Bacteriophage X DNA, cut with EcoRI and Hindlll, was run at the final concentration
of one microgram with as molecular size marker. This commercially-obtained
reagent (BRL) gives DNA fragment sizes of 21226, 5146, 4973, 4268, 3530, 2027,
1904, 1709, 1375, 947, 831, 564, and 125 base pairs.
2.2.14 Gene Cloning
Prior to cloning the gene of interest, the PCR product was run on a 2-3% low-melting
temperature gel (LMG; Sigma) at 4 °C. Bands of interests were visualised under UV
illumination, cut out into a microfuge tube and genecleaned.
The Geneclean II™ kit (BRL) was used for gene cleaning prior to cloning procedures.
This technique is based on properties of silica matrix, which binds nucleic acids.
Gene of interest, amplified by primer-specific PCR, was run on an LMG, cut out, and
placed in a microfuge tube. To this, three volumes of six molar sodium iodide (Nal)
were added and the mixture was vortexed to dissolve the gel fragment. Five
microlitres of Glassmilk ™ per microgram of DNA was added, mixed, and kept on
ice for five minutes, with occasional mixing. The tube was microfuged at full speed
(13000 rpm), for 5 seconds, and supernatant removed. This centrifugation was
repeated once more to remove any residual Nal solution. The pellet was washed three
times with 400 pi of New Wash ™, first by vortexing, followed by microfugation at
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top speed for five seconds. The final spin was repeated to remove any residual New
Wash. The pellet was resuspended in 20 pi of Sigma water, kept at 50 °C for 2-3
minutes, and then spun at 30 seconds. Approximately 15 pi of the supernatant was
removed carefully. This (15 pi) suspension contained the "cleaned" DNA. Cleaned
DNA was checked by agarose gel electrophoresis by running an aliquot (2 pi).
2.2.15 TA cloning
The TA™ cloning kit (Invitrogen) was used for cloning of PCR fragments, after gene
cleaning. The TA system takes advantage of non-template dependent activity of DNA
polymerase, Thermus aquaticus (Taq pol) (GibcoBRL, Cat. No. 18038-026). This
enzyme is heat-stable and therefore synthesizes DNA at elevated temperature from
single-stranded templates in the presence of a primer. The enzyme lacks any 3 ' to 5'
proof reading activity, which results in addition of a single deoxyadenosine to the 3' -
end of the DNA molecule during the PCR reaction. The TA plasmid vector contains
single 3 ' -end deoxcythymidine overhangs, allowing for the ligation of PCR fragment
into the plasmid in the presence of T4 DNA ligase.
2.2.15.1 Ligation of PCR products into TA plasmid
Cleaned PCR fragments were ligated into the TA plasmid. This was achieved by
incubation of five microlitres of cleaned gene with one microlitre of vector (fragment
to vector ratio of 1:1), one microlitre of ligase buffer, and one microlitre of ligase
(lU/pl) in a total assay volume of 10 pi. A second ligation assay contained a PCR
fragment to vector ratio of 2:1, to improve the probability of ligation. The assay
mixes were incubated at 12 °C overnight. For transformation, 10 pi of ligation assay
mix was added to 50 pi of INVaF' OneShot™ bacteria (Invitrogen).
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2.2.16 RNA isolation
RNeasy™ spin columns (Qiagen) were according to the manufacturer's
recommendations for isolation of total RNA. Total RNA was eluted from RNeasy
columns with 20 pi of Sigma water. The eluted RNA was either kept at -70 °C, or
kept on ice for immediate synthesis into complementary DNA (cDNA). To check the
integrity of isolated RNA, an aliquot was run on a 2% agarose gel (see section 2.2.7).
The presence of two distinct bands corresponding to the 18- and 28-S ribosomal RNA
was indicative of an intact preparation, otherwise the preparation was deemed
degraded and therefore discarded.
The eluted material from RNeasy column also contains between 5- to 10% DNA
contaminants. Most primers were designed to span introns, which results in a
distinction between RNA-derived cDNA and genomic DNA. However, to prevent
any false signals from genomic DNA in semi-quantitative analyses of mRNA-derived
cDNA, the isolated RNA samples were pre-treated with DNase I (RNase-free;
Pharmacia Biotech, cat. No. 27-0514-01), prior to reverse transcription in order to
degrade any contaminating genomic DNA.
2.2.16.1 DNase I treatment of cellular RNA
To isolated cellular RNA (10 pl/~ 2 pg), the following was added: five pi of 5 x RT
first strand/RT buffer [250 mM Tris-HCl (pH 8.3 at room temperature); 375 mM KC1,
15 mM MgCL; provided with the enzyme]; 1.5 pi of random hexamers (InM); 2.5 pi
of dNTPs mix (ImM); one pi of DTT (50 mM); three pi of Sigma water, and 0.5 pi (4
U) of DNase I. The assay mixture was centrifuged at top speed for five seconds and
incubated at 37 °C for 15 minutes. The DNase I was heat-inactivated at 80 °C for five
minutes. The reaction mix was microfuged briefly, and snap-cooled on ice for three
minutes, prior to reverse transcription.
2.2.16.2 Reverse transcriptase (RT) of cellular RNA
Reverse transcription involves the synthesis of DNA from an RNA template. This
reaction was performed in the presence Superscript™ II RNase FL Reverse
Transcriptase (Life Technologies, Cat. No. 18064-014). This enzyme is purified from
E. coli containing the pol gene of Moloney murine leukaemia virus (M-MuLV). The
enzyme has a 3' to 5' polymersae activity without an RNase H activity. The enzyme
is genetically engineered by the introduction of a single point mutation in the RNase
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H active centre. This modification prevents the degradation of RNA in the first strand
cDNA synthesis, resulting in more full-length cDNA molecules and greater yields of
first strand cDNA.
To the DNase I-treated RNA mixture, RNasin (1 gl, 4U) (GibcoBRL), and RT (one
pi, 200U) were added. The mixture was incubated at 45 °C for one hour. The
enzyme was heat-inactivated at 95 °C for five minutes. The synthesised cDNA library
was kept at -20 °C for long-term storage.
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2.2.17 Housekeeping gene
cDNA synthesis was checked by amplifying a housekeeping gene. This was achieved
by amplification of the gene for the ubiquitous alpha sub-unit of (Na+/K+) ATPase
pump (Woodall et al., 1994). The amplification of ATPase gene was used to check
for contaminating genomic DNA, integrity of RNA preparation and cDNA synthesis
as well as the base line for semi-quantitation of stimulus-dependent genes, such as
cytokines.
Sense primer 5 ' GCTGACTTGGTCATCTGC
Anti-sense primer: 5 ' CAGGTAGGTTTGAGGGGATAC
Internal probe 5' CATCCCCTGCTGGAAGACGGAATT
Expected PCR fragment size: 167 bp
Mg CI2 (final concentration): 3.5 rnM
Hot start: 80 °C, 5 min
PCRR : 95 °C 1 min, 55 °C 1 min, and 72 °C 2 mm, 35 cycles
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Fig. 2.1 ATPase gene amplification
The ovine housekeeping gene, ATPase, was used as the internal control. Total
cellular RNA was isolated by RNeasy method. The DNAse-1-treated RNA was
amplified using the standard PCR protocol. The resolution of PCR product on
agarose gel resulted in a single band of 167bp (A). Subsequent Southern blot analysis
using the gene-specific internal probe gave a single band (B). Numbers on the left
panel refer to nucleotide base pairs of the marker DNA.
Lane M: X cut with Hindlll and EcoRI
Lane 2: Total RNA isolated from ovine CNS
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2.2.18 Polymerase chain reaction (PCR)
PCR was carried out in 0.5-ml microfuge tubes, using an Omnigene™ (Hybaid) PCR
machine. Each PCR reaction contained input cDNA, 100 pM of each primer (sense
and anti-sense), dNTPs mix (final concentration of 100 pM), MgCh at varying
concentration (1 to 3.5 mM final concentration), and PCR buffer (see appendix). The
total assay volume was 49 pi. The PCR mix was overlaid with 30 pi of mineral oil
(Sigma). To prevent mispriming, the PCR mix was "hot-started" at 80 °C for five
minutes, prior to addition of Taq pol at final concentration of one unit per reaction
tube. After the addition of the enzyme, the PCR cycles were carried out at varying
cycle numbers.
2.2.18.1 Primer design
Oligodeoxynucleotides were synthesised by Oswel DNA services, Department of
Chemistry, King's Builidings, West Mains Road, Edinburgh. Gene-specific primer
sets were designed based on the following guidelines.
1. 50-60% G+C composition.
2. Melting temperatures (Tm) of similar values, between 55-80 °C (Tm ~
2 °C per A and T, and 4 °C for G and C).
3. No complementarity between 3 ' -ends; to prevent primer-dimers.
4. No runs of Cs or Gs at 3 ' -ends; to prevent mispriming.
5. No palindromic sequences within primers.
6. Ideal length of 15-22 bp.
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2.2.18.2 Theoretical optimum annealing temperatures
The annealing temperature (Ta), is one of the important variables in a PCR reaction:
too low Ta results in non-specific binding of primers and false positive results,
whereas too high Ta may result in reduced/loss of product. Therefore, use an
optimum Ta will result in maximum product yield. Theoretical optimum annealing
temperatures (TaOPT) were calculated according to the following formulae (Rychlik et
al., 1990).
TaOPT = 0.3 Tm pnmer + 0.7 Tm product - 14.9 (i)
Tm pnmer = AH x 1000/AS + R x In (c/4) - 237.15 + 16.6 log [K+] (li)
Tm product = 81+0.4 (%G + %C) + 16.6 log [K+] - 675/1 (iii)
R x In (c/4) = 46.7
Tm pnmer is the calculated melting temperature of the product, and is based on the
nearest-neighbour model of Borer and co-workers (1974), and thermodynamic values
of Breslauer and co-workers (1986). AH and AS are the enthalpy and entropy for
helix formation, repectively (Breslauer et al., 1986) (see appendix). The total molar
concentration of the annealing oligonucleotides, c, was determined empirically to be
250 pM (Rychlik et al., 1990, 1991). R (1.984) is the molar gas constant and 1 is the
length of the PCR product in bp. [K+] is the concentration of potassium ions in the
PCR reaction, and is 0.05M.
Calculated TaOPT values were used as a guideline to arrive at a consensus annealing






















Table 2.1 Comparison of calculated empirical and annealing temperatures
Using the guidelines in designing of primer sets, similar, theoretical annealing
temperatures (51-56 °C) were obtained. This is exemplified by primer sets for MVV
genes. PCR assays were performed for MW genes, with Hirt DNA as input viral
DNA. As table shows, use of two different annealing temperatures did not result in
loss of PCR products. The standard PCR parameters were used for amplification of
MW genes.
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Table 2.2 MW PCR primers
The MW-specific primer sets were designed by comparison of all published MVV
sequences (Sargan et al., 1991; Braun et al1987; Querat et al., 1990) and the closely
related CAEV sequence (Saltarelli et al., 1990) using the PILEUP programme. The
British EV1 sequence was used as the consensus sequence. In cases of sequence
heterogeneity, the universal base inosine (I) was chosen as the preferred substitution.
Primer sequences are given in 5 'to 3 ' orientation. Plus/ minus designation
corresponds to forward and reverse primers respectively. P refers to primer sequence,
used as probe for Southern blot hybridisation.
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Fig. 2.2 Amplification of MW genes
The specificity of MW PCR primers to amplify Visna genes were tested on virus
infected sheep chondrocytes. HIRT DNA isolated from EV1-infected chondrocytes
was used to amplify MW genes using the standard PCR protocol. Ten microlitre
aliquots from each PCR reaction was run on an agarose gel satined with EtBr as
depicted in the image.
M: X DNA cut with Hindlll and EcoRI
Lane 1: Gag-1 primer set
Lane2: Gag-2 primer set
Lane3: Pol-1 primer set
Lane 4: Pol-2 primer set
Lane 5: Env-1 primer set
Lane 6: Env-2 primer set
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Table 2.3 Cytokine PCR primers
Primer for IL-lp, IFNy, TNFa, TGFpl, and GM-CSF were provided by C. Woodail
(Caledonian University, Scotland). Primers for IL-10 and IL-12 were provided by B.
Dutia (University of Edinburgh, Scotland). These primers were used in PCR assays







































Fig. 2.3 PCR assays of ovine cytokines
Cloned genes in plasmid vectors were used as positive controls for primer sets for
ovine cytokine genes. Plasmid DNA was used in each PCR reaction, using the
standard protocol (see appendix). The PCR products were run on agarose gel (A).
The specificity of each reaction was checked by Southern (blot) analysis (B).
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2.2.19 Cycle Sequencing
Automated sequencing was carried out by Mr. Ian. Bennet, Department of Veterinary
Pathology, University of Edinburgh. Use of fluorescin-cojugated primers results in
generation of labelled PCR fragments. The laser diode component of the sequencer
emits radiation at 785nm, which results in electron excitation of labelled PCR
fragments, in turn emitting radiation. This radiation is detected, amplified and finally
digitised into a signal.
2.3 Cytospining of cells
Floating cells were collected into a 15 ml Falcon tube, centrifuged at 1200 rpm for
five minutes and rinsed once with PBS. Cells were then cytospun onto Biobond™ -
coated slides, using a Shandon Cytospin II, at 500 rpm for five minutes. Cytospun
cells were chemically fixed with 4% PFA/PBS for 20 minutes, and rinsed and
maintained in PBS. Fixed cells can be kept in PBS at 4 °C for a week.
2.4 Biobond treatment of slides
Microscopy glass slides were pre-soaked in 2% Deacon for one hour, and rinsed
thoroughly in several washes of distilled water. Slides were then dried at 40 °C. Six
ml of Biobond™ (British Biocell International) (2% solution in acetone for 4 minutes)
was added to 300 ml of acetone, to which the slides were added. Slides were then
rinsed in two washes of distilled water (five minutes each), and air-dried. Treated
slides can be kept indefinitely at room temperature.
2.5 Animals
Where necessary, animal experimentation was carried out under qualified supervision
and in accordance with the guidelines set out by the Home Office, UK.
2.5.1 Lambs
Lambs of mixed breeds (Texel, Black face, and Cheviot) with the average age of three
days (not older than 7 days old) were obtained from the Moredun Research Institute,
the Bush estate, Edinburgh, Scotland.
2.5.2 Mice
Adult female mice (between 4 to 6 weeks of age) of MF1 genotype were provided by
the small animal house, department of Veterinary Pathology, University of
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Edinburgh, Scotland. Adult female mice of SCID genotype were provided by the
Department of Medical Microbiology, University ofEdinburgh.
2.6 Tissue culture
Tissue culture procedures were carried out in category II hoods. Cells were cultured
and maintained in plastic flasks and plates. Cells were maintained at 37 °C/5% CCE
in humidified incubators. All tissue culture media were treated with benzylpenicillin
(100 international U/ml), streptomycin (100 pg/ml), and Fungizone (2.5 mg/ml)
unless stated otherwise. Tissue culture media were either autoclaved at 121 °C/20
minutes or sterilised through a 0.22 p. filter.
2.6.1 Sheep chondrocyte cultures
Sheep chondrocytes from synovial membrane were propagated in Dulbecco's
minimum essential medium (DME), and as adherent monolayers in plastic culture
flasks (Corning, UK). The medium was supplemented with 8% (v/v) of heat-
inactivated foetal calf serum (FCS), penicillin/steptomycin, and 2 mM L-glutamine.
Once confluency was observed, cells were removed by trypsin treatment (0.05% in
versene). This constituted removal of culture medium, three rinses with versene,
followed by incubation with trypsin until cells were no longer adherent. Trypsin was
inactivated by addition of 5x volume of culture medium (DME/FCS). Cells were
removed from the flask and collected by centrifugation, using a bench-top centrifuge
(1500 rpm, 5 minutes). For re-seeding, cells were cultured at 30% confluency.
2.6.2 Virus titre determination
Sheep chondrocytes were used for virus titration. Trypsinised cells were resuspended
in DME/8% FCS, and seeded into wells of a flat-bottomed 96-well plate (Nunclon,
Denmark), at a density of 1 x 104 cells per well in 100 pi volumes. The cultured cells
were incubated for a few days until a confluency of 80% was attained. Viral samples
to be titrated were serially diluted in DMED/2%FCS and 50 pi were added to each
well. Each dilution was tested as a triplicate. Mock-infected control was medium
without the virus. Plates were cultured for two days, and further supplemented with
50 pi of DMED/2%FCS per well. The incubation was continued for another five
days, or until CPE in the form of syncytia was apparent. Cells were fixed and stained
with Giemsa's stain. Virus titres were calculated by using the Reed and Muench
(1938) methods, which determines the 50% tissue culture infectious dose (TCID50).
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2.6.3 Giemsa staining
Culture medium was first removed and cells were fixed for 10 minutes with 100 p.1 of
ice-cold acetone:methanol, at a ration of 1:1. The fixative was removed and replaced
with 100 (j.1 of 1% potassium dichromate (w/v) solution for 30 minutes. This was
removed and replaced with the fixative again for 10 minutes. After the removal of the
fixative, cells were air-dried for five to 10 minutes. Giemsa's stain (Gurr's improved
R66, BDH, UK), freshly diluted with water, was added in 100 pi volumes to each
well, and for five minutes. The stain was then removed and replaced with water for
one minute, after which the water was removed and plates air-dried. The CPE was
examined microscopically to determine the TCID50.
2.6.4 Ovine glial cultures
The brain stem was the source of glial cultures. This region included diencephalone,
mesencephalone, and metencephalone (excluding the cerebellum), and
myelencephalone (excluding cervical portion of spinal cord caudal to obex). After
lethal injection, brain stem was removed and placed in Leibovitz, medium
(GibcoBRL, Cat. No. 41300-021), supplemented with benzylpenecillin (100 U/ml),
strptomycin (100 pg/ml), and fungizone (2.5 mg/ml). The meninges and major blood
vessels were removed. The tissue was cut into approximately 1-2 mm fragments and
repeatedly triturated through a 10-ml glass pipette. The suspension was spun at 500
rpm in a bench-top centrifuge for one minute. The supernatant, which contains the
glial cells was removed and kept. This process was repeated four times. The
collected supernatants were pooled, and centrifuged at 1200 rpm for three minutes.
Cells were suspended in DME, supplemented with N-2-hydroxyethylpiperazine-N'-
2-ethanesulfonic acid (HEPES) (10 mM), sodium bicarbonate (NaHC03) (10 mM),
10%FCS (heat-inactivated), and antibiotics (see above). Resuspended cells were
seeded at high density. Routinely, each brain stem yielded 1-2 x 106 cells. Cells were
cultured on poly-D-lysine treated plastic dishes (35 mm), and incubated at 37 °C/5%
CO2, and in a humidified atmosphere. Cultures are extremely vibration-sensitive at
this stage, and consequently were left undisturbed for four days.
2.6.4.1 Microglial cultures
Due to the high density of cultured cells, a significant number of microglia remained
as floating cells, and therefore, did not become adherent. The culture supernatant was
removed and replaced with fresh medium. The removed supernatant, which is a rich
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source of microglial cells, was plated on plastic tissue culture dishes (35 mm), and
incubated for 15 minuets in a tissue culture incubator. This short incubation allows
the adherence of microglial cells with the minimal adherence of fibroblasts and other
glial cells, for example astrocytes. The medium was then removed, and adhered cells
were gently rinsed once with serum-free medium and cultured with DMEM/2% FCS
plus supplements (HEPES, NaHCCfi, penicillin, streptomycin, and fungizone). The
reduced FCS proved useful in prevention of rapid growth of fibroblast-like cells.
For immunostaining procedures, microglial cells were plated at 1 x 103 -104 per plate.
For total RNA isolation, microglial cells were seeded at 1 x 105 per plate. The
medium was replaced once every 3 days.
2.6.4.2 Oligodendrocyte cultures
Ovine oligodendrocytes were cultured from mixed glial cultures. Four days after the
initial seeding, the supernatant, which contained microglial and oligodendrocytes, was
removed. Pooled supernatants from 4 plates were placed in a 15-ml Falcon™ tube,
and using a bench-top centrifuge was spun at 1200 rpm for three minutes. The Pellet
was re-suspended in one ml of Ham's F-14/TJLTROSER® G medium (4% v/v)
(Gibco BRL, Cat. No.091-25950H) and plated on laminin-coated, 35-mm Petri
dishes. ULTROSER™ G is a serum substitute. The contaminating microglial cells
were removed by L-methyl ester.
2.6.4.3 Astrocyte cultures
Ovine astrocytes remain as adherent cells after the initial seeding of mixed glial cells.
Four days post-seeding, the medium was replaced with fresh DME/10% FCS plus
supplements, and every three days thereafter.
2.6.5 L-methyl ester
Microglial cells can be selectively removed from glial cultures by treatment with L-
methyl ester (LME). Cells were rinsed three times with serum-free DMEM, and then
treated with LME (7.5 mM in serum-free DME). Treated cells were incubated
between 2 hours to overnight. The medium was removed and cells were rinsed once
with serum-free medium. Finally, depending on type of cells being cultured




To increase the adherence of mixed glial and microglial cultures, culture dishes were
treated with PDL. Tissue culture grade PDL (Sigma, cat. No. P7280) was diluted in
sterile distilled water (SDW) at 0.2 mg/ml, and filter-sterilised. Culture dishes were
coated with PDL for 30 minutes at room temperature. PDL was then removed, and
culture plates rinsed once with SDW and air-dried for two hours inside a tissue culture
hood. PDL plating was carried out afresh on the day of culture. Unused PDL
solution was kept at -20 °C.
2.6.7 PoIy-D-ornithine (PDO)
PDO was used for coating of culture dishes prior to laminin coating. This procedure
was used in culturing of ovine oligodendrocytes and murine neuronal cultures. PDO
(Sigma, cat. No. P8638) was diluted in 0.15 M borate buffer (4.6g of boric acid in 500
ml of SDW, pH 8.4 with 5N NaOH) to give a final concentration of 0.5 mg/ml and
sterilised through a 0.22 pm filter. Culture plates were coated with PDO overnight
and at room temperature. The following day, PDO was removed, and culture dishes
were rinsed once with SDW and air-dried as for PDL treatment. Unused PDO was
kept under sterile conditions at 4 °C, and used within two weeks.
2.6.8 Laminin coating
Natural mouse laminin [1 mg/ml in 50 mM Tris-HCl (pH 7.4), 0.15 M NaCl, Gibco
BRL, Cat. No. 23017-015] was used. Laminin was kept as 20 pi aliquots at -20 °C.
For laminin coating, previously PDO-treated and dried culture dishes (35-mm) were
used. A 20-pl aliquot was thawed on ice for a period of 1 hour; quick thawing of
laminin may result in gelling. Thawed laminin was diluted into one ml of serum-free
Hank's buffered salt solution (HBSS) without Ca+2 and Mg+2 (Sigma, cat. No.
H8389), and mixed by repeated pipetting. Using a 200-pl Gilson™ pipette, 100-200
pi of diluted laminin was dispersed onto each dish (35-mm). This was achieved by
creating a circle within the dish, and with a diameter of approximately 30-mm. This
leaves a 3-4 mm gap to the wall of the dish. Care was taken to prevent making any
contact with the wall of the dish. Laminin-coated dishes were placed in a tissue
culture incubator for at least three hours. After the removal of laminin, plates were
rinsed with Ham's F-14 with Saito's, and kept moist with Ham's F-14Saito' to
prevent plates drying out, prior to seeding of cells.
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2.6.9 Neuronal cultures
Murine trigeminal neurones were cultured from MF1 mice. Trigeminal ganglia were
removed and placed into L-15 medium, supplemented with penicillin and
streptomycin. After the removal of connective tissue and nerve fibres, ganglia were
cut into small (1 mm) fragments. These were placed in a 35-mm petri dish with
Ham's F14 medium. Collagenase (stock solution at 1.25% and stored at -20 °C,
Sigma, cat. No. C3180), was diluted 1/10 in the medium to give a final concentration
of 0.125% (v/v). The Petri dish was placed in a tissue culture incubator for two hours.
The digested tissue was place in a 15-ml Falcon™ tissue culture tube, and spun for
one minute at 1000 rpm in a bench-top centrifuge with breaks off. The supernatant
was removed as much as possible, and discarded. The cell pellet was resuspended in
trypsin [stock solution at 1%, kept at -70 °C and diluted 1/10 afresh in HBSS (without
Ca2+ and Mg2+) to give a final trypsin concentration of 0.1% (v/v)] (Worthington
Biochemical Corporation, New Jersey, USA, code TRLVMF) and incubated in a 37
°C water bath for 20 minutes. Trypsin was neutralised with 5 ml of Saito's medium.
Cells were pelleted by centrifugation as above, re-suspended in one ml of Saito's
medium. Using a flamed Pasteur pipette, the pellet was triturated repeatedly to give a
single cell suspension. Re-suspended cells were plated in 35-mm tissue culture Petri
dishes, and incubated overnight. Routinely, neurones from four mice were cultured
per single 35-mm Petri dish.
2.6.10 Saito's medium
Saito's medium was used for culturing of neuronal cells (reviewed by Bottenstein,
1984) (see Table 2.4). Stock Saito's solution was made up and kept as 11.1 ml
aliquots at -30 °C. To make Saito's working strength solution, one aliquot (11.1 ml)
was thawed and added to 500 ml of ready made Ham's F-14 solution, and filter-
sterilised. The medium, now referred to as Saito's medium, was supplemented with
five ml of L-glutamine (200 mM, GibcoBRL, Cat. No. 25030-024), with penicillin
and streptomycin.
Due to the less adherent property of neurones compared to fibroblasts and Schwann
cells, trigeminal neurones remain predominantly as floating cells in the supernatant or
loosely adherent cells. Using a PI000 Gilson™ pipette, one ml of the supernatant
was removed, with care, and placed into a 15-ml Falcon™ tube. Cells were spun at
1000 rpm for one minute. The supernatant was removed and the pellet re-suspended
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in one ml of Saito's medium, supplemented with recombinant nerve growth factor
(NGF) (stock solution at 10 pg/ml and kept at -70 °C, diluted in the medium to give a
final concentration of 2 ng/ml) (R&D systems, Abingdon, UK, Cat. No.256-GF-100).
Cells were cultured in laminin-coated, chambered 35-mm Petri dishes (Greiner
Labortechnik, Germany).
2.6.11 Ham's F-14-based tissue culture media
Ham's F14 (Imperial Laboratories, UK, Cat. No. 3-791-35) is a carbonate-based
medium, and was used for culturing of neuronal cells. The Ham's F-14 powder (with
L-glutamine and without NaHC03), was diluted in 500 ml of SDW, and stored in 50-
ml aliquots at -30 °C. To make 1 x F-14 medium, 450 ml of SDW was added to one
defrosted 50-ml (F-14) aliquot, plus one gram of NaHC03, and pH adjusted to 6.7.
Ham'sF-14/horse serum, was used in rinsing of laminin-coated Petri dishes. Heat-
inactivated normal horse serum (Sigma, cat. No. HI 138) was added to working







Diluent Source (Cat. No.)
Path-O-Cyte 4 50 *N/A ICN Biochemicals (81001)
Putrescine
(40 mg/25 ml)
50 SDW Sigma (P 5780)
Progestrone
(1 mg/1.6 ml)
0.5 £EtOH Sigma (P6149)
L-Thyroxine
(2 mg/5 ml)
5 EtOH Sigma (T0397)
Sodium selenite
(1 mg/2.6 ml)
0.5 sPBS Sigma (S9137)
Tri-iodo-thyronine
(16.8 mg/50 ml)
5 EtOH Sigma (T6397)
Table 2.4 Saito's solution
*: Not applicable
£: Ethanol (absolute alcohol)
$: Phosphate buffered saline
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2.7 Immunohistochemistry
The following gives an account of immunohistochemical procedures used in this
thesis. The antibody diluent, where applicable, was 1% (v/v) of normal goat serum
(NGS) in PBS. The blocker was 3% NGS/PBS. For detection of intracellular
antigens, permeabliseation of cellular cytoskeleton was carried out to allow the entry
of antibody into cytosol. This was achieved by treating cells with 0.3% (v/v) Triton
X-100 in PBS (TX100/PBS) for five minutes at room temperature. The fixative was
4% (w/v) para-formaldehyde in PBS (PFA/PBS). This solution was prepared freshly
on the day of experiment by dissolving PFA in PBS, which was incubated at 60 °C for
45 minutes. To speed up dissolving of PFA, ION NaOFl was added drop-wise to the
PFA/PBS solution. The dissolved solution was then equilibrated to 37 °C by
incubation for one hour in a water bath. Where applicable, cells were fixed for 20
minutes with pre-warmed (37 °C) PFA/PBS.
All incubations were carried out in humidified chambers. In situations where light-
sensitive fluorochromes were used, the incubation was carried out in humidified
chambers and away from light.
2.7.1 Alkaline phosphaotase-based detection system
Alkaline phosphatase-conjugated secondary antibodies were used in detection of
signals in immunostaining of infected cells and in Western blot analyses. In alkaline
phosphatase (AP) detection system, the substrate (BCIP, also referred to as X-
phosphate or X-phos), in the presence of nitrotetrazolium salt (NBT) is converted into
an insoluble blue precipitate.
2.7.2 Immunostaining of cell cultures
Cells grown on 35-mm Petri dishes were used for immunostaining. For phenotypic
characterisation of cells, immunostaining was carried out at 7-10 days post culture.
All procedures were carried out at room temperature. Antibodies were either used
neat, or diluted. Cells were first rinsed with pre-warmed PBS (37 °C) and with
extreme care as not to dislodge any cells. For cell surface markers, live cells were
first incubated with the primary antibody for one hour at room temperature, rinsed
with PBS as above, and fixed with PFA/PBS. The fixative was removed and cells
rinsed with PBS as above, followed by a blocking step with NGS/PBS for 30 minutes.
Cells were then incubated with secondary antibody for one hour. Cells were then
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rinsed with PBS as above, mounted in Vectashield™ (Vector Laboratories, Cat.
No.H-1000), and viewed under microscope.
For immunostaining of intracellular antigens, cells were first fixed as above, then
permeabilised with Triton-XlOO/PBS for five minutes, before incubation with the first
antibody.
2.7.3 Terminal deoxyneucleotide transferase (TdT)-mediated UTP nick end-
labelling (TUNEL)
This technique was employed to investigate the mode and extent of cellular death in
MW-infected microglial cells. The TUNEL technique was performed on cells from
infected cultures at four days post-infection. Floating cells were obtained by cytospin.
Fixed cells were rinsed in PBS and permeabilised with X-100/PBS for 10 minutes.
Cells were then treated with DNase I buffer [30mM Tris-HCl (pFI 7.2); 140 mM
sodium cacodylate; 4 ml MgC12; 0.1 mM DDT] for 20 minutes, before DNase I digest
(5 pg/ml) in DNase I buffer at 37 °C for 30 minutes. Cells were washed with three
washes of PBS, and equilibrated with the TUNEL buffer [30 mM Tris-HCl (pH 7.2);
140 mM sodium cacodylate; ImM cobalt chloride] for 20 minuets. Equilibrated cells
were incubated with the TdT enzyme plus labelled deoxynucleotides [TdT (20U/40
pi); Digoxigenin-11-dUTP (20 pM) in TdT buffer] at 37 °C for two hours, and in a
humidified chamber. The reaction was terminated with one rinse with 2 x SSC, for
five minutes at room temperature. Samples were equliberated with PBS and then
incubated with blocker for 30 minutes, followed by incubation with sheep anti-
digoxigenin-fluorescin isothiocyonate (DIG-FITC) at 1/20 in antibody diluent for one
hour at room temperature.
For double staining of infected cells with MW, for visna p25 major core antigen and
TUNEL, cells were treated with undiluted anti-p25 mAb (VPM70), after the blocking
step in TUNEL labelling. Cells where treated with biotinylated goat anti-mouse
antibodies (1/100) in diluent for one hour. Cells were then rinsed three times with
PBS, and incubated with rhodamine-avidin conjugate (1/100) and anti-Dig FITC
(1/20) for one hour. Cells where finally rinsed in three washes of PBS and mounted
in Vectasheild.
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Specificity Species Source (cat. No.)
NF-M Rabbit anti-rat $
GFAP Rabbit anti-cow DAKO (Z0334)
A2B5 Rat anti-mouse *BM (N1300016)
04 Mouse monoclonal BM (1518925)




F4/80 Rat anti-mouse Serotec (MCAP497)
BS-Lj N/A Sigma (L2140)
Fibronectin Rabbit anti-human Sigma (F3648)
Table 2.5 Antibodies I
The rat monoclonal antibody, which recognises mouse NF-M was kindly provided by
Prof. Brophy, Preclinical Veterinary Sciences, University of Edinburgh. The
biotinylated lectin from Bandeiraes Simplicifolia BS-I isolectin B4 (BS-I4) recognises
P-N-acetyl-D-Galactose (P-NacGal).
$This antibody was a kind gift from Prof. Brophy, department of Preclinical












VPM70 P25 (MW major core protein)
*R158 and R159 Anti-Tat
Table 2.6 Antibodies II: ovine monoclonal antibodies
Ovine monoclonal antibodies raised against ovine monocyte/macrophages were
obtained from the Monoclonal Unit, Veterinary Pathology, University of Edinburgh.
All monoclonal antibodies were provided as tissue culture supernatants and were used
undiluted.
* Antisera raised against synthetic visna Tat peptides were kindly provided by Dr.
Harkiss. The anti-Tat polyclonal antibodies were used at various dilutions (1/0-1/100)
in Western blots.
81
2.7.4 Immunohistology of SCID brains
SCID mice were sacrificed by lethal injection of pentobarbitone (100 pi), and
perfused with 10 ml of saline. Perfused brains were fixed in 50 ml of 40% para¬
formaldehyde/0.05% (v/v) gluteraldehyde. The entire brain was processed into 50
|Jm free-floating sections. The cut sections were rinsed four times in PBS/Triton X-
100 (0.3%) incubated for one hour in 20% (v/v) rabbit serum. Sections were
incubated overnight at 4 °C in the primary antibody. For staining with F4/80, the
dilution of first antibody was at 1/1000, and for GFAP staining atl/2000. Sections
were then washed twice in PBS/Triton X-100, followed by incubation for one hour
with the secondary antibody. This was biotinylated rabbit anti-rat (1/50) for F4/80
and for goat anti-rabbit for GFAP (1/200). Sections were rinsed twice in PBS, and
incubated for one hour with the ABC Elite™ for F4/80at a dilution of 1/50, and ABC
Standard for GFAP at a dilution of 1/100. This was followed by two washes with
PBS, a 10-minute incubation with the substrate, DAB. Sections were finally washed
four times with PBS, placed onto gelatin-coated microscopic slides and left to air dry
for one week. Dried sections were dehydrated in alcohol washes, rinsed in xylene,
and permanently mounted in DPX.
2.8 Polyacrylamide gel electrophoresis (PAGE)
Proteins were analysed by SDS-PAGE. This method was used as a pre-requisite to
western blot analysis (see appendix). Samples were mixed with loading buffer, boiled
for 5 minutes and run on the gel. Rainbow molecular weight markers (Ajmersham,
Cat. No. CFA 756), spanning 14.3 kDa to 200 kDa in protein weights.
2.9 Western blot analysis
Western blotting was employed to analyse proteins in culture supernatants. Using a
semi-dry blotting apparatus (Biorad), proteins were transferred onto a nitrocellulose-
based Hybond- C membrane (Amersham). Gels were briefly rinsed in transfer buffer
[25 mM Tris (pH 9.5)/20% methanol]. Three sheets of 3MM filter paper, pre-soaked
in transfer buffer, were placed on the blotter, followed by the pre-soaked hybridisation
membrane. The Gel was placed on top of membrane, followed by another three pre-
soaked 3MM filters. The transfer was carried out at an electrical current of 120 mA
for one hour. All of the following incubations and rinses were carried out on an
orbital shaker. Blots were blocked with PBS/5% Marvel (fat-free protein powder) at 4
°C, overnight. They were then treated with the first antibody, either used neat or
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diluted in PBS/1% Marvel for one hour at room temperature. Blots were washed in
PBS/1% Marvel (five washes over 30 minutes) followed by incubation with AP-
conjugated secondary antibody as per first antibody.
Blots were then washed with PBS/1% Marvel (as above) and finally rinsed in two
washes of 0.1M Tris-base (pH 9.5) over 10 minutes. Blots were developed by
treatment with freshly prepared substrate mix [9 ml of Tris-HCl (pH9.5), one ml of
NBT, 100 pi of BCIP, and 100 pi of 2 M MgCb]. After the appearance of protein
bands (within 10 minutes), blots were rinsed with excess water and air-dried.
2.10 Inoculation of microglial cells into SCDID mice
Ovine microglial cells were inoculated into the striata of adult SCID mice. Each
mouse was inoculated with 15000 ovine microglial cells in a total volume of 3 pi.
The cells were injected into the right striatum of each mouse, with the left striatum
serving as an internal control. All intracerebral inoculations were performed by Miss.
I. Starling, Department of Preclinical Veterinary Studies, University of Edinburgh.
2.10 1 The inoculum
Microglial cells were infected five days after the initial seeding. Medium was
removed and cells were rinsed with serum-free medium prior to infection with the
Icelandic strain 1514K at MOI of 0.1 Control cultures were mock-infected with
serum-free medium alone. Cultures were incubated overnight. Cells were rinsed
three times with versene and incubated in HBSS (without Mg2+ and Ca2+) for one
hour at room temperature. Using a PI000 Gilson™ pipette, cells were dislodged from
the plate by gentle and repeated pipetting of medium over the cells. Detached cells
were collected into a 15-ml Falcon™ tube and centrifuged at 1200 rpm for three
minutes. The pellet was re-suspended in one ml of sterile PBS. Finally, cells were
counted and the density was adjusted to 5000 cells per one microlitre.
2.11. Tat and Ovalbumin (Ova) peptides
The 18 residue synthetic Tat peptide (MWKHGAAVRRNCGCRLC) and
Ovalbuminpm7 peptide (ISQAVHAAHAEINEAG) were dissolved in Ham's F14
medium without serum. The dissolved peptide solution was kept at -70 °C and used at
the final concentration of 27 pM.
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2.12 The virus stock
The Visna virus used throughout this thesis was the Icelandic isolate, K1514. The
stock virus (TCID50=3xl04) was kept at -70 °C.
2.13 Transmission electron microscopy (TEM)
MW-infected and mock-infected ovine microglial cells were harvested, washed once
with PBS and fixed in 3% glutaraldehyde in 0.1 M cacodylate buffer (pH 7.3), at 4 °C
for two hours. Fixed cells were then washed with cacodylate buffer and post-fixed in
1% osmium tetroxide for one hour at 4 °C. Cells were dehydrated through a gradient
acetone, and embedded in Araldite. Sections (60 nm- thick) were cut and stained with
uranyl acetone and lead citrate by the EM unit, Department of Preclinical Veterinary
Pathology, University of Edinburgh. Sections were examined by a Philip 400 EM.
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CHAPTER THREE
Phenotypic Characteristics of Mixed Ovine Glial
Cultures
3.1 Introduction
A common feature of all lentiviral infections is the extensive involvement of the CNS.
This is partly due to the complexity of brain as an organ, which performs complex
functions. This complexity of architecture and function is a product of cellular
heterogeneity and organisation.
The resident cells of the CNS parenchyma are neurones, macroglia (astrocytes and
oligodendrocytes), microglial cell and blood endothelial cells. Astrocytes are
estimated to make up as much as 50% of glial cell population (reviewed by Tower,
1988). In the CNS, astrocytes are divided into protoplasmic (Type 1;GFAP+, A2B5-)
and fibrous types (Type 2; GFAP+, A2B5+). Protoplasmic astrocytes predominate in
the grey matter and fibrous astrocytes in the white matter (reviewed by Hirano, 1985).
Type 2 astrocytes (GFAP+/A2B5 +) were proposed to have been derived from
oligodendrocyte- type 2 astrocytes (0-2A) progenitors, whereas the origin of type 1
(GFAP+) astrocytes is uncertain (Raff et al., 1983). 0-2A progenitor cells may give
rise to type 2 astrocytes in vivo (Trotter et al., 1993). However, there is experimental
evidence to suggest that a distinct astroblast progenitor cell population may be the
precursor to astrocytes rather than 0-2A progenitors (Skoff, 1990).
In the CNS, 0-2A progenitor cells proliferate in germinal zones and migrate to white
matter region, where they further proliferate, differentiate, and form myelin sheaths
around axons (Zerlin et al., 1995). Oligodendrocyte development takes place during
the late gestation and early post-natal periods, after neuronal maturation has occurred
(Skoff, 1990).
Microglial cells may constitute up to 20% of glial cells in the CNS. In rodents, it has
been demonstrated that microglia belong to the monocyte/macrophage lineage, seeded
in the CNS early in embryonic development (Perry and Gordon, 1988).
3.2 Experimental design
The experimental approach undertaken in this chapter was aimed at establishing
methods to isolate, culture and characterise primary ovine mixed glial and enriched
microglial cultures. The glial cultures would then be used to determine the
susceptibility of ovine microglial cells to MW infection in vitro. This approach was
taken to initiate tissue culture models to study neuropathogenesis of Visna virus
infection.
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The data presented in this chapter were repeated at least five times. Three approaches
were taken in culturing of glial cells. The first approach was to stain for cell markers
using mixed glial cells. Therefore, no attempt was taken to isolate any constituent cell
type. The second approach was taken to enrich for microglial cultures, since these
cells were intended for subsequent infection experiments and therefore intended to be
highly homogenous with minimal fibroblast contamination. The third approach taken
was to enrich for and drive the maturation of oligodendrocytes (see flow diagram).
3.3 Results
3.3.1 Morphology and phenotypic characteristics of mixed ovine glial culture
Mixed glial cultures were set up from the brain stem region of newly born lambs. The
staining for specific cell markers were performed on five separate brain cultures. The
morphology of the mixed cultures was dynamic and changed substantially with time.
In the initial stages post-seeding, 0-7 days in vitro (DIV), most cells had a phase-
bright appearance with very few cells with flat, fibroblastic morphology (Fig.3.1). At
later time points post-seeding, 8-28 DIV, there was a substantial proliferation of flat,
phase-dark cells that eventually formed the bed-layer. This stratification phenomenon
started with a few cells sending slender processes that radiated in all directions away
from the cell body. This in turn resulted in networks of cellular processes that
brought cells into close physical contact with each other. This networking was also
concomitant with increased proliferation (Fig.3.1).
In the early phase of mixed glial cultures (DIV 0-4), cells with astrocytic morphology
were absent. However, small phase-bright cells which stained positive with A2B5
marker were detected at DIV 4-6 (Fig.3.2). The earliest presence of GFAP+ cells was
at 7-9 DIV. This was concomitant with the presence of process bearing cells with
astrocytic morphology (Fig. 3.2). Interestingly, the cells with astrocytic morphology
also stained positive with the progenitor marker, A2B5 (Fig.3.2).
3.3.2 Oligodendrocytes in ovine glial cultures
Cells committed to oligodendrocyte lineage were detected in mixed glial cultures at
early time points post-seeding (DIV 4-5). These cells were 04+/GalC-, non-adherent
and constituted 10-20 cells in each 35 mm plate of glial cells (0.1-0.2%) (Fig. 3.3). In
ovine mixed glial cultures, mature GalC+ oligodendrocytes were not detected.
Moreover, addition of insulin at varying concentrations (l-10pg/ml) did not affect the
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maturation of 04+ precursors into GalC+ oligodendrocytes (data not shown).
However, non-adherent 04+ cells obtained from mixed glial cultures and plated on
laminin-coated plates resulted in generation of process-bearing GalC+
oligodendrocytes (Fig.3.3).
3.3.3 Morphology and phenotype of microglial cells in mixed and enriched
cultures
A cell type existed in mixed cultures that was adherent and had minimal change in
appearance over time in vitro. Unlike flat cells, these adherent cells had a phase-
bright appearance with two distinguishing features: (1) the presence of "spikes" that
radiated from the cell membrane; and (2) a large, phase-dark eccentric nucleus. This
cell population was later identified as microglial cells on the bases of morphology and
immunostaining characteristics (Fig.3.4) (Table 3.2).
In ovine mixed glial cultures maintained in high serum (10%), clusters of proliferating
CD14+ cells were present atop of the bed-layer at 21-28 DIV (Fig.3 .4). At this time
point, the bed layer consisted predominantly of astrocytes and fibroblasts. The
clusters of phase bright cells stained positive for microglial marker, CD14 (Fig.3.5).
Furthermore, on subsequent plating, these phase-bright cells gave rise to cells with
microglial morphology.
Pure (> 98%) microglial cultures were set up from mixed glial cultures at four days
post culture and by adherence on cultures plates. These cells had a distinct
morphology (Fig.3.4). The most prominent feature of enriched microglial cultures
was presence of "spikes" on cell membrane. Moreover, the morphology of these cells
also changed with time. This was in the form of elongated unidirectional processes
that extended up to 20 times the length of microglial cell body (Fig.3.4).
Enriched cultures of microglial cells were characterised by immunostaining with a
panel of surface markers. Microglial cells stained positive with markers common to
cells of monocyte/macrophage lineage rather than the phenotypic markers associated
with cells derived from the neuroectoderm (Table 3.2).
3.3.4 LME is toxic to microglial cells
Microglial cells were further characterised by their susceptibility to LME treatment.
In mixed glial cultures treated with LME, only microglial cells showed the toxic
effects (Fig.3.6). Toxic effect of LME appeared by four hours port-treatment. This
was in the form of ballooning, and was not observed in other glial cells. Moreover,
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LME treatment of mixed glial cultures resulted in specific loss of microglial cells,
which occurred by 24 hours post-treatment (Fig. 3.6).
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Fig. 3.1 Morphogenesis of ovine glial cells in vitro
Ovine glial cells were cultured from the brain stem region of newly born lambs.
Mixed glial cell suspensions were cultured in 35 mm Petri dishes. Each brain stem
was cultured in nine poly-lysine-treated plates. Mixed glial cultures exhibited
dynamic morphologies over time in vitro. The cultures constituted predominantly of
phase bright cells at 0-4 DIV (A). Cellular stratification occurred at 5-7 DIV (B).
Substantial stratification resulted in a bed layer of fibroblasts and astrocytes (C). Foci
of phase-bright cells (microglia) were observed in confluent cultures on top of bed
layer (star) at 21-28 DIV (D). White arrows indicate the presence of microglial cells
in mixed cultures (magnifications at x!25).
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Fig. 3.2 Presence of immature A2B5 cells prior to stratification by astrocytes in
mixed glial cultures
Mixed glial cells were set up as stated in the legend to Fig. 3.1. Mixed glial cultures
were fixed with PFA and immunostained for different cell markers. Progenitor cells,
which stained positive for A2B5, were detected in mixed glial cultures prior to GFAP
staining at 4-6 DIV (A). These progenitor cells appeared to result in process bearing
cells at 7-9 DIV (B). This was also concomitant with the presence of astrocytic cells,




Fig. 3.3 Mature oligodendrocytes in ovine glial cultures are derived from 04+
cells
Glial cells were obtained and cultured as stated in the legend to Fig.3.1. After four
days post-culture, immature oligodendrocytes (04+) where detected as floating cells
on top of bed layer in mixed glial cultures. Floating cells from mixed glial culture
supernatants were collected, cytospun and stained for antibody against the 04 antigen,
demonstrating lack of adherence in these cells (A). Infrequently, loosely adherent and
process-bearing 04+ cells were also observed on top of bed layer in mixed glial
cultures (B). Mature GalC+ oligodendrocytes with elaborate processes were observed
only when 04+ floating cells were cultured on laminin-coated plates (C and D).
Arrowheads point to individual cytospun cells and arrows point to elaborate
cytoplasmic membranes, cultured on laminin-coated plates for two days.
Magnifications: A x 250; B, C and D x 200).
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Fig. 3.4 Microglial cells possess distinct morphologies
Brain glial cells were obtained from the brain stem region. To enrich for microglial
cells, mixed glial suspension from one lamb was cultured in one T25 culture flask.
After four day post-culture, the supernatant was plated on 35 mm Petri dishes for 15
minutes at room temperature to allow for the adherence of microglial cells. This
approach allowed for the enrichment of microglial cultures of > 98% purity, with
minimal fibroblast and/or astrocyte contamination. Panel A shows live cells viewed
under phase contrast microscope. The presence of fibroblast-like cells was kept to the
minimum in enriched microglial cultures (red arrow). The morphology of microglial
cells changed from a round appearance to cells with spinous processes (B and C).
Black arrows point to the microglial spinous processes. Magnification x 200.
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Fig. 3.5 Microglial cells are CD14 positive throughout their morphogenesis in
vitro
Highly enriched microglial cultures were set up from brain stem region of lambs as
stated in the legend to Fig. 3.4. Microglial cells were fixed and immunostained for
surface expression of CD 14, and detected with AP-conjugated secondary antibody.
Immunostaining with CD 14 localised to the membrane spikes (red arrows) and
spinous processes (black arrows), the most prominent features observed on microglial
cells. Panels show CD 14 staining of microglial cells (A and B). Foci of microglial
(immature) cells atop of bed layer also stained positive for CD 14 (C). Star shows a
cluster of immature microglial cells. Magnification x 200.
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Fig. 3.6 LME treatment of mixed glial cultures
Mixed glial cultures were set up from the brain stem region as stated in the legend to
Fig.3.1. Mixed glial cultures were treated with the lysosomo-tropic agent LME and
morphological changes were followed by light microscopy. Only microglial cells
(spike and spinous-bearing) showed the toxic effects of LME treatment. The initial
sign of toxicity was intracellular ballooning (A, arrowhead). In contrast to microglial
























Table 3.1 Phenotypic characteristics of ovine mixed glial cultures in vitro
Mixed glial cells were obtained and cultured as stated in the legend to Fig.3.1. Mixed
glial cells were cultured in poly-lysine-treated plastic Petri dishes, fixed and
immunostained for the presence of various cell-type markers at 10-14 and 21 days
post seeding.
































Table 3.2 Phenotypic characteristics of enriched ovine microglial cells
Enriched microglial cells were set up as stated in legend to Fig.3.4. Enriched
microglial cells were fixed and immunostained with various cell markers at 7-10 days
post purification in vitro.
Key: no staining obtained; +, above background staining; +++, strong staining.
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3.4 Discussion
Ovine glial cultures were set up from the brain stem region of young lambs. These
cultures where characterised by surface markers common to glial cells in other
species.
3.4.1 Astrocytes and oligodendrocytes in ovine glial cultures are derived from
precursor cells
The 0-2A precursor cells (A2B5+) were detected in mixed ovine glial cultures prior
to GFAP+ astrocytes and galactocerebrocide-positive (GalC+) oligodendrocytes
(Fig.3.2). These progenitor cells have the capacity to become neurones, type 2
astrocytes or oligodendrocytes (Lillien et al., 1988).
A2B5 is the earliest phenotypic marker, which can recognise cells of oligodendrocyte
lineage. In defined medium, these progenitor cells may acquire GalC, a marker for
mature oligodendrocytes. A2B5+ cells commited to the oligodendrocyte lineage
develop into 04+ cells, before maturation into oligodendrocytes (reviewed by Raff et
al., 1989).
In ovine mixed glial cultures, presence of mature oligodendrocytes (GalC+) was not
observed. This was in contrast to previously reported glial cultures obtained from
caprine neural tissues (Baszler et al., 1994). Use of different growth media with a
combination of growth factors, such FGF, failed to drive the maturation of 04+
precursors into mature (GalC+) oligodendrocytes (data not shown).
Insulin and insulin-like growth factors (IGFI and IGFII) have been used to drive the
differentiation of rodent progenitor cells into GalC+ oligodendrocytes in vitro.
Insulin binds IGFI receptors and therefore can substitute for IGFI. Transcripts for
IGFI and IGFII have been detected in rat CNS during early development. Moreover,
receptors for IGF have been detected on cultured astrocytes, oligodendrocytes and O-
2A progenitor cells (reviewed by Baskin et al., 1988).
Based on above observations, insulin was used at varying concentrations (1-10 pg/ml)
in order to derive the maturation of 04+ cells into mature oligodendrocytes.
However, this approach failed to do so (data not shown).
Plating of non-adherent 04+ cells on laminin-coated plates resulted in maturation of
04+ cells into mature, GalC+ oligodendrocytes (Fig.3.3). It is known that interaction
of integrins with extracellular matrix (ECM) can result in a cascade of intracellular
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events that may affect cellular metabolism, proliferation and differentiation (reviewed
by Damsky and Werb, 1992). Unlike [3-2 integrins, [3-1 integrins are mainly involved
in interactions between cells and ECM. One such integrin, av(31, which is a receptor
for laminin, is expressed by oilgodendrocyte precursors (Milner and Fffench-
Constanat, 1994). These observations may explain the maturation of ovine 04+
precursors on laminin-coated plates into GalC+ cells.
3.4.2 Ovine parenchymal microglia share phenotypic surface markers with cells
of the monocyte/macrophage lineage
Enriched microglial culture of > 98 % purity were set up from the brain stem region
of newly born lambs. Moreover, ovine microglial cells stained positive for markers
most commonly associated with cells of monocyte/macrophage lineage (Table 3.2).
Members of [3-2 integrin family have been detected on human and rodent microglial
cells, both in vitro and in vivo (Akiyama and McGeer, 1990; Sedgewick et al, 1991;
Ford et al., 1995; Becher and Antel, 1996). Resting human microglial cells
constitutively express CDlla (LFA-1), CDllb (Mac-l, CR3), CDllc (P150, 95,
CR4), and CD 18 ((3-2), leukocyte common antigen (LCA, CD45), and the
immunoglobulin receptor FcyRl. Moreover, the immunostaining of microglial cells
for (3-2 integrins has been reported to be more intense in the white matter than in the
grey matter (Akiyama and McGeer, 1990).
Double immunostaining for integrins and leukocyte common antigen (LCA; CD45)
has resulted in the specific identification of microglial cells within the CNS. This
approach has been proposed to distinguish between perivascular macrophages
(CD45high CDllb/c*) and resident microglial cells (CD45low CDllb/c^ (Ford et al,
1995).
The characteristic phenotype of ex vivo parenchymal microglia (CD45low CD 11 c+)
corresponded to that found in situ in normal, non-inflamed human brain tissues.
Moreover, this phenotype differed from that of perivascular macrophages in situ and
monocyte-derived macrophages, which were both CD45hlgh CD 14"^ (Becher and
Antel, 1996).
The double staining approach was not employed in the phenotypic characterisation of
ovine microglial cells. However, it is highly unlikely that the cultured cells were
perivascular macrophages rather than microglial cells. Experiments using CD45
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chimeric rats have shown that in normal, non-inflamed brain, perivascular
macrophages (CD45hlgh CD1 lb/c+) constitute only seven percent of macrophage-type
cells in the CNS (Ford et al., 1996).
3.4.2.1 Presence of surface MHC molecules on cultured microglial cells
MHC molecules were detected on cultured microglial cells (Table 3.2). In normal
ovine CNS, parenchymal microglial cells have been shown to express both MHC-I
and II (Torsteinsdottir et al., 1992; Georgsson et al., 1997).
In rodent CNS, resting microglial cells constitutively express MHC-II within the
white matter (Gehrmann et al., 1991). Similarly, resting microglial cells in human
brain tissues also express MHC-II in the white matter (Hayes et al., 1988). Microglia
isolated from neonatal rats, with or without IFNy, were able to present antigen to T
cells in vitro. Astrocytes can also be primed to present antigen by pre-treatment with
IFNy, but unlike microglial cells, they are poor antigen presenters in the absence of
IFNy (Matsumoto et al., 1992). Moreover, astrocytes can be induced to express
MHC-II by, for example IFNy, however, brain microglial cells are the main
parenchymal cell type that either constitutively or inducibly express MHC-II in vivo
(Gehrmann et al., 1993).
3.4.2.2 CD14 is present on ovine microglial cells in all stages of maturation in
vitro
The cell surface marker, CD 14 was detectable throughout the life span of ovine
microglial cells in vitro (Fig. 3.5). CD14 is a receptor for the bacterial
lipopolysaccharide (LPS), an endotoxin found in the outer cell wall of Gram-negative
bacteria, and is expressed on monocytes and tissue macrophages (reviewed by
Ziegler-Heitbrock and Ulevitch, 1993).
Human parenchymal microglia in normal CNS do not express CD 14 (Ulvestad et al.,
1994). However, cultured adult human microglial cells have been shown to express
high levels of surface CD 14 (Becher and Antel, 1996). This expression of CD 14 was
concomitant with the morphological development of microglial cells. This is in
contrast to the cultured ovine microglia, which were CD 14+ regardless of their
morphological development. This anomaly may be a reflection of a species
difference and/or because neonatal brain was the source of ovine glial cultures rather
than adult tissues.
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In the inflamed CNS, there is an influx of blood monocyte-derived macrophages
(CD45hlgh/CD14++). However, the presence of CD 14 on microglial cells would imply
that brain parenchymal microglial cells contribute to CD 14+ population in the CNS
(Bercher and Antel, 1996). Interestingly, CD 14+ monocytic leukeamia cells produce
TNFa, whereas CD14-negative did not. This observation implies that CD 14
expression may have a relevance to functional properties of microglial cells (Ford et
al„ 1995).
3.4.2.3 Presence of CD1 on cultured ovine microglial cells
Primary cultures of ovine microglial cells stained positive for CDl surface marker.
The CDl family comprises four (a to c) p2-microglobulin-associated glycoproteins
expressed on most antigen presenting cells (reviewed by Porcelli, 1995). The
presence of CD lb appears to be more widespread in ovine tissues than in human and
murine tissues (S. Rhind, personal communication). CDl immunoreactivity was also
detected on apparently normal, ovine parenchymal microglial cells in vivo (S. Rhind,
collaborative work).
3.4.3 LME toxicity: a functional assay for microglial cells
The treatment of glial cultures with the lysosomotropic agent, L-leucine methyl ester
(LME) resulted in specific loss of microglial cells (Fig.3.6). The toxicity of LME is
mediated by lysosomal enzymes, which convert the LME into free amino acid
leucine. The build up of leucine within the organelles causes osmotic swelling and
rupture of lysosomes in cells of monocyte/macrophage lineage (Thiele et al., 1985).
The LME treatment of ovine microglial cultures demonstrated that these cells, in line
with other tissue monocyte/macrophages, are susceptible to the toxic effects of LME.
This functional assay also supports the notion that microglial cells are indeed derived
from the monocyte/macrophage lineage. However, the identification of ovine
microglial cells was based primarily on their phenotypic properties as determined by
immunostaining for cell surface markers, and not on the LME assay. Another
functional assay for cells of the monocyte/macrophage lineage would be the resetting
of red blood cells facilitated by membrane Fc receptors.
3.5 Summary
This is the first report on characterisation of primary ovine glial cultures in vitro.
Ovine mixed glial and purified microglial cells were established from the brain stem
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region of newly born lambs. The phenotypic characterisation of these cultures was
carried out using a panel of antibodies. Furthermore, using LME as a functional assay
demonstrated that only microglial cells were susceptible to this treatment.
Data presented in this chapter demonstrate that there is a degree of species cross-
reactivity with respect to certain cell markers, for example murine 04, human
fibronectin, and bovine GFAP with ovine tissues. However, F4/80 did not cross-react
with ovine tissues in vitro, implying that the cross-reactivity is not universal.
Cells of monocyte/macrophage lineage are the main target cells by all Antiviruses
both in vivo and in vitro. The morphological, functional and phenotypic
characteristics displayed by cultured ovine microglial cells and microglial cells from
other species imply that these cells are derived from monocyte/macrophage lineage,
and therefore possible targets for infection in vivo.
There is a lack of direct evidence that ovine parenchymal microglial cells are targets
for MW infection. The experimental design in the next chapter was aimed at




Infection of Enriched Ovine Microglial Cells with
MVY
4.1 Introduction
The isolation and phenotypic characterisation of ovine microglial cells described in
the previous chapter demonstrated that these cells share extensive phenotypic
similarities with cells of monocyte/macrophage lineage.
The combination of phenotypic and functional similarities between brain microglial
cells and other tissue macrophages, together with the tropism of all lentiviruses for
cells of the monocyte/macrophage lineage had suggested that microglial cells might
also be targets for lentiviruses in the nervous system (see Chapter 1). Moreover, use
of brain-derived in vitro cultures (cellular and organotypic) has confirmed the in vivo
observations that brain microglial cells may be targets for infection with primate
lentiviruses (Takahashi et al., 1996). Indeed, with dual tropic primate lentiviruses, the
preponderance of M-tropic virus isolates over T-tropic viruses from infected neural
tissues also supports the importance of microglia in CNS pathology.
The phenotypic assignment of MW-infected cells in vivo has largely been based on
morphological characteristics. For example, macrophage-like, CD68+ cells have been
shown to harbour viral proteins in brains of MW-infected animals (Torsteinsdottir et
al., 1992; Brodie et al., 1995; Georgsson et al., 1997).
There is, however, no direct evidence that MW infects brain parenchymal microglial
cells. This has been partly due lack of phenotypic markers that may distinguish
between microglial cells and other monocyte-derived macrophages and lack of
published protocols on isolation of parenchymal microglial cultures from ovine
brains.
4.2 Experimental design
The experiments in this chapter were aimed at investigating the tropism of MW for
ovine microglial cells in vitro. Ovine microglial cells were cultured from the brain
stem region of newly born lambs (see Chapter three). Enriched microglial cultures
were infected with the Icelandic strain, K1514, at the multiplicity of infection (MOI)
of 0.001. Infected microglial cultures were tested for the presence of virus by RT-
PCR for the pol gene, by immunostaining for the viral p25 major core protein, and by
electron microscopy (EM). The presence of infectious virus in supematants of MW-
infected microglial cultures was analysed on sheep chondrocytes.
Furthermore, the possible induction of programmed cell death (apoptosis) in cultured
microglial cultures as a result of MW infection was assessed by TUNEL staining.
The supernatants from both mock-infected and MW-infected cultures were cytospun
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and double stained for viral p25 and DNA fragmentation by TUNEL. The
experimental infections were performed on four separate brain cultures.
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4.3 Results
4.3.1 Productive infection of ovine microglial cells with MW
MW can infect brain microglial cells in vitro. Amplification of pol ORF from in
vitro infected microglial cultures resulted in generation of positive RT-PCR signals
(Fig.4.1). Moreover, in order to determine the type of infection, i.e., whether
productive or restricted, supernatants from both infected and mock-infected cultures
were tested for the presence of infectious viral particles. Supernatants from infected
cultures contained infectious viral particles, the levels of which increased with time
(Fig.4.2).
To characterise further the type of MW infection of microglial cells, both infected
and mock-infected cultures were immunostained with the viral major core protein,
p25. Only MW-infected cultures stained positive with p25 (Fig.4.3). Moreover,
syncytia, which stained positive for p25, were also observed in infected cultures
(Fig.4.3).
4.3.2 Electron microscopy of MW-infected microglial cells
Electron microscopic (EM) studies were employed to investigate the pattern and
mode of virion assembly/budding from MVV-infected microglial cells. EM studies
revealed the presence of viral particles within cytoplasmic vacuoles (Fig.4.4).
However, presence of budding virion from cell membrane proved to be a rare event.
4.3.3 Mode of death in MW-infected microglial cells
Floating cells in supernatants from MW-infected microglial cultures were analysed
for viral infection (p25) and apoptosis (TUNEL). Supematants were cytospun and
used for double immunostaining for TUNEL and p25. Cytospun cells stained positive
for both p25 and TUNEL (Fig.4.5). However, the presence of double positive cells
was rare. Less than 4% of total dead cells stained for both p25 and TUNEL. This
was in contrast to viral p25-positive cells, which constituted approximately 30% of
total dead cells.
The above observations obtained from TUNEL experiments, therefore, appear to
indicate that direct infection of microglial cells in vitro with MW was not a pre¬
requisite for apoptosis.
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Fig. 4.1 Detection of viral pol gene in MW-infected microglial cells
Enriched microglial cultures were set up as stated in the legend to Fig.3.4. Total RNA
was isolated on day four post-infection, and revese transcribed. The control RNA was
obtained from mock-infected microglial cultures. The MW pol gene was amplified
by PCR on cDNA samples. Ten microlitres from each PCR reaction was run on an
agarose gel. The lanes on the gel are:
M: X DNA marker
1: mock-infected culture (A)
2: MVV-infected culture (A)
3: mock-infected culture (B)
4: MVV-infected culture (B)
NC: negative control (Sigma water instead of input DNA)
PC: positive control (Hirt DNA obtained from MVV-infected chondrocytes)
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Fig. 4.2 Kinetics of MW infection of ovine microglial cells in vitro
Enriched microglial cultures were set up as stated in the legend to Fig.3.4. Microglial
cultures (100,000 per 35 mm Petri dish) were infected with 0.001 MOI of the
Icelandic strain, K1514. Supernatants form microglial cultures were harvested at
different time points post-infection, and the presence of infectious virus in these
supernatants was assayed on ovine chondrocytes. CPE on indicator cells included


















Fig.4.3 Immunostaining of viral p25 in MW-infected microglial cells
Microglial cultures were infected with MVV as stated in legend to Fig.4.2. Treated
cultures were immunostained on days 4-7 post-infection with the monoclonal
antibody VMP70 to stain for viral p25 protein, using an alkaline phosphotase-
conjugated secondary antibody. Punctate p25 immunostaining was detected in
cytoplasm of infected cells (A, B, and C). Infrequently, a multinucleated giant cell
(syncytium) was also detected in infected cultures (D). Mock-infected cultures did
not stain positive for p25 (E). The arrows point to the nuclei of infected cells.
Magnifications: A-D x 250; E x 200
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Fig.4. 4 Presence of virion-like structures in MW-infected microglial cells
Microglial cultures were infected with MVV as stated in legend to Fig.4.2. MVV-
infected and mock-infected microglial cells were fixed for EM studies at 5 days post¬
infection. Virion-like structures were observed in MW-infected microglial cells
(arrows). These structures had an approximate diameter of lOOnm with an electron-
dense core. These apparent MVV virions were located on cellular membrane (A) and
as clusters in compartments (vacuoles) within the cytoplasm (B). The arrowhead
points to a cytoplasmic structure similar to a mitochondrion. Magnification x 60,000.
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4.5 Presence of TUNEL and p25 double positive cells in MW-infected cultures
Microglial cultures were infected with MVV as stated in legend to Fig.4.2. Floating
cells from MVV-infected microglial cultures at four days post-infection were
cytospun and immunostained for apoptosis by TUNEL (red) and viral p25 (green) (A
and B). Double positive cells (yellow) constituted a small percentage of infected cells





The results obtained in this chapter demonstrate that MW could infect ovine brain
microglial cells. This was based on PCR, virus titre assay, immunostaining, and EM
studies.
The infection experiments in this thesis were carried out with the Icelandic strain of
MVV, K1514 and at the MOI Of 0.001. This was because the stock virus was at MOI
of one. This stock virus was prepared by infection of cultured sheep skin fibroblasts,
and therefore would be expected to contain fibroblast-derived cytokines and viral
factors (membrane glycoproteins). Theoretically, these components (contaminants)
could affect the expression of cytokines by microglial cells. The ideal infection
experiment would be to use purified infectious virions with no contaminating cellular
debris. However, previous attempts at purifying MW virions by high-speed
centrifugation had been unsuccessful (D.J. Roy, personnal communication). The aim
of infection experiments was to analyse the potential effects of virus infection on the
expression of microglial-derived cytokines. Therefore, the virus was used at 1:1000
dilution of the stock virus. This approach was expected to reduce the potential effects
of cellular and viral contaminants on the expression of microglial-derived cytokines.
4.4.1 Virion assembly/budding of MW from infected microglial cells
The morphological classification of lentiviruses is based on transmission electron
microscopy applied to all retroviruses. Virion particles within cytoplasmic vacuoles
were observed with MVV-infected microglial cells (Fig.4 4). This finding closely
resembles the observation made with CAEV-infected caprine microglial cells in vitro
(Baszler et al., 1994).
Intracytoplasmic type A (ICA) particles, i.e., electron dense nucleocapsid without
outer lipid membrane, have been reported in alveolar macrophages and monocyte-
derived macrophages infected with the British maedi-visna isolate, EV-1 (Lee et al.,
1996). ICA particles have also been detected in EIAV, CAEV and SIV infected cells.
This is in contrast to MW-infected microglia, where no ICA particles have been
observed. Similarly, no ICA particles have been reported in HTV-1 infections.
Moreover, in HIV-1 infected monocytes and brain macrophages, virion
assembly/budding is predominantly localised within cytoplasmic compartments,
identified as Golgi elements (Ornstein et al., 1988).
Viral determinants may influence the mode of virion assembly/egress in infected
cells. Parallel infection of monocyte-derived macrophages with British EV-1 and
120
Icelandic K1514 strain resulted in different virion assembly/egress (Lee et al., 1996).
ICA particles were not observed in monocyte-derived macrophages cells infected with
K1514. Interestingly, K1514 was also the virus isolate used in this thesis to infect
ovine microglial cells in vivo. Therefore, it has been postulated that difference in the
viral-coded sequences may influence virion production and assembly. For example,
progressive deletion of HIV-1 gag ORF at the carboxy-terminal resulted in change of
virion assembly, normally at the cell membrane, to become intracytoplasmic. The
other virus-coded determinant, which may influence virion assembly, is the
hypervariable env ORF.
Cellular determinants may also influence the mode of virion assembly/budding.
Unlike monocytes, HIV-1 infection of T lymphocytes results in exclusive surface
assembly of viral particles (Ornstein et al., 1988). The precise reason for this
anomaly is not entirely clear. However, it is known that cells of different lineage may
process intracellular proteins differently. This may influence the cellular location of
virion assembly/budding.
The morphological classification of lentiviruses is far from clear. SIV more closely
resembles Type D than Type C retroviruses, with pronounced surface spikes, similar
to Mason-Pfizer monkey virus (Munn et al., 1985). However, immature HIV
particles have the appearance of type C, whereas mature virion with eccentric
spherical nucleoid within a conical or tubular core shell. In this context, MVV virion
may share similarities with type B, C, and D during its maturation, depending on the
experimental conditions employed (Lee et al., 1996).
4.4.2 Mode of cellular death in MW-infected microglia
Apoptosis, or programmed cell death (PCD), is a genetically controlled cellular event.
In viral infections, PCD may limit the progeny spread. Several DNA viruses have
evolved mechanisms, via expression of oncoproteins, whereby they can interfere with
PCD, primarily at the p53 level (reviewed by Teodoro and Branton, 1997).
In contrast to both DNA viruses and oncogenic retroviruses, lentiviruses do not code
for oncoproteins, and do not evoke cellular DNA synthesis for their progeny.
Unscheduled, virus-induced DNA synthesis is one of the mechanisms that may induce
PCD. However, apoptosis has been observed in HIV patients, and it has been
demonstrated that T cells from such patients are sensitive to activation-induced
apoptosis (Groux et al., 1992). HIV-induced apoptosis bypasses the p53 pathway,
and involves Fas (CD95)/FasL (CD95L) interaction. HIV/SIV Tat proteins and
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HTLV Tax protein are believed to induce the expression of FasL, leading to
apoptosis, via activation of interleukin converting enzyme (ICE)-like proteases.
Similarly, membrane expressed HIV envelope glycoprotein has also been shown to
induce PCD in uninfected CD4+ T cells (reviewed by Teodoro and Branton, 1997)
The TUNEL staining of infected cultures on days 4-5 post-infection demonstrated that
only a small proportion (approximately 4%) of viral antigen positive microglial cells
were also undergoing apoptosis (Fig.4.5). This observation would imply that direct
infection of microglia cells is not necessarily a pre-requisite for apoptosis.
In HIV-1-infected patients, infected cells appear protected from apoptosis, whereas
bystander cells show increased apoptosis in lymph nodes of infected individuals
(McCloskey et al., 1997). Furthermore, in myelomonocytic cells infected with HIV,
the viability of cells was not affected by Fas-mAB treatment, unlike infected T cell
lines (Okamoto et al., 1997). These observations imply that infected myelomocytic
cells are more resistant to the Fas-mediated aoootosis. Inhibition of aooDtosis in HIV-
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1-infected cells may enhance virus production and facilitate persistent infection
(Anton et al., 1995). Presence of cytokines, for example TNFa may reduce the
resistance of infected myelomonocytic cell to Fas-mediated apoptosis (Okamoto et
al., 1997).
The result obtained from infected microglial cells may imply that direct infection is
not a prerequisite for cellular damage/death. HIV-1 infection of primary brain
cultures has been shown to result in apoptosis of neurones and astrocytes in vitro.
However, apoptosis was not significantly induced until one to two weeks after the
time of peak virus production. This result suggested that induction of soluble factors
rather than direct viral infection was responsible for apoptosis. These observations
support the notion that bystander damage may take place in virus-infected tissues.
Interestingly, aDODtosis of neurones and astrocytes has been observed in AIDSW J ' A Jl j
patients with dementia at sites removed from viral positive microglial cells (Shi et al.,
1996).
Lentiviruses may also directly interact with apoptotic pathways. Infection of
macrophages with HIV-1, in vitro, has been demonstrated to result in upregulation of
pro-apoptotic gene, Bax, and downregulation of anti-apoptotic genes, for example
Bcl-2 (Krajewski et al., 1997).
4.5 Summary
Data presented in this chapter show, for the first time, that ovine microglial cells
could be infected with MW in vitro. Moreover, this observation is in agreement with
previous reports of tropism of MW for cells of the monocyte/macrophage lineage in
other tissues, for example alveolar macrophages, and blood monocytes.
Observations made with the TUNEL method reinforce suggestions that indirect
bystander cellular damage may play a role in MW-induced neuropathology. Cellular
soluble factors (cytokines) have been proposed, as part of the bystander damage
model, culminating in neuropathology.
Brain macrophages/microglial cells are believed to be a major source of neurotrophic
factors (neurokines) in the CNS. The presence of pathogens in the CNS, such as visna
may have adverse effects on the expression of these neurokines, culminating in
disease. Fibroblast growth faetor-2 (FGF-2, basic FGF; bFGF) is a neurokine that is
widely expressed in the CNS. This neurokine has also been implicated in vascular
diseases.
There are no data available on leniiviral infections and possible changes in expression
of neurotrophins in the CNS. The experimental design in chapter four was intended to
clone ovine FGF-2 from brain tissues in order to generate reagents that could be used
as part of a panel of assays in deciphering the visna-mediated neuropathology.
CHAPTER FIVE
Molecular Cloning of Neural Ovine Basic Fibroblast
Growth Factor Gene
5.1 Introduction
There is growing evidence for the presence of growth factors, neurotrophic factors
and cytokines, collectively referred to as neurokines. which maintain homeostasis in
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the CNS.
Glial cells (astroglia and microglia) are the major sources of brain-derived cytokines
and neurokines. For example, microglial cells have been shown to be a rich source of
TGF-p, platelet-derived growth factor (PDGF), epidermal growth factor (EGF),
insulin like growth factors, and FGF-2 (Rappolee et al., 1988; Shimojo et al., 1991).
Activated brain macrophages have also been shown to secrete nerve growth factor
(NGF) (Mallat et al., 1989).
Glial cells are also responsive to trophic factors. For example, microglial cells are
responsive to BDNF and neurotrophin-3 (NT-3). Interestingly, the same study also
showed that NT-3 induced phagocytic activity of microglial cells, indicating that these
factors are closely associated with functions carried out by glial cells in vivo, both as
autocrine and paracrine factors (Elkabes et al., 1996).
FGF-2 was first described by Gospodarwicz (1974), and is a potent angiogenic agent
that stimulates the proliferation of wide range of mesodermal and neuroectodermal-
derived cells as well as cultured fibroblasts (reviewed by Gospodarwicz et al., 1990).
In addition to its effect on vascular endothelium, FGF-2 also promotes neuronal
survival and increases neurite extension in foetal rat hippocampal neurones (Morrison
etal, 1986; Walicke, 1988).
FGF-2 immunoreactivity has been mapped in the CNS, in the neucortex and also in
the pituitary (Fuxe et al., 1996). Biological activities attributed to FGF-2 include
differentiation, proliferation, and maintenance of cells in the CNS (Giordano et al.,
1992).
Although the emphasis in CNS pathology has been largely focused on "immune
cytokines" such as TNFa, there is minimal data on effects such viral infection may
have on brain-derived growth factors. This is particularly relevant to lentiviruses,
which have the capacity to infect brain microglial ceils, a cell type with magnitude of
functions in the CNS. One such factor is FGF-2.
5.2 Experimental design
The aim of this chapter was to molecularly clone one such factor, FGF-2, to generate
reagents in order to study the effect of MVV infection on the expression of this brain-
derived cytokine/survival factor in cultured microglial cells. Therefore, consensus
PCR primers were designed from the comparison of bovine and human FGF-2 genes.
Using brain tissues from an adult ewe resulted in amplification and susequent cloning
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Human GGCirCTTCCTGCGCATCCACCCCGACGGCCGAGTTGACGGGGTCCGGGA
Bovine GAAGAGCGACCCACACATCAAACTACAACTTCAAGCAGAAGAGAGAGGGG




I I I I I I I I I I I I I I I II I I I I I I I I lllllllllll II I I I! I I III
Human TTGTGTCTATCAAAGGAGTGTGrGCTAACcGTrACCTGGCrATGAAGGAA
Bovine GATGGAAGATTAGrAGCTTGrAAATGTGrTACAGACGAGTGnTCTTnT
I I I I I I II I I I I I I I I I I I I I I I I I I I I I I I II I I II II I I I I I I I I
Human GATGGAAGATTACTGGCTTCTAAATGTGTTACGGATGAGrGri'i'Ci i'i'l'i'
Bovine TGAACGATTGGAGTCTAATAACTACAATACTTACCGGTCAAGGAAATAGT
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Human AAAACAGGACCTGGGCAGAAAGCTATACTTTTTCTTCCAATGTCTGCTAA
Bovine GAGCTCATCTTAATGGCAGCATCTGATCriGATITTA
II I II I I I I I I I I I I I I I I I I I I I I I I I I I I
Human GAGCIGATTTTAATGGCCACATCTAATGTCATTTCA
Fig. 5.1 Comparison of bovine and human FGF-2 eDNA sequences
The cDNA sequence of bovine FGF-2 (accession number ml3440) was piled-up
against the human FGF-2 sequence (accession number m27968), to allow for design
of consensus PCR primers for amplification of ovine FGF-2 homologue. The forward
and reverse PCR primers (M7263/M7264 for outer PCR and M7265/M7266 for
nested (inner) PCR) were chosen from the most conserved regions and are underlined.
The internal primer sequence (M7267) was used as a probe in Southern blots (see










Primer Sequence Prilarif*/JL UlMl At,J
M7265 TCTTCCTGCGCATCCACC sense
M7266 CAGTGCCACATACCAACTG antisense






Table 5.1 Primer design and PGR parameters for cloning of ovine FGF-2 from
neural tissues
The table shows the primer sequences, annealing temperatures and expected PGR
products for the ovine FGF-2 homologue. The gene specific primers for ovine FGF-2
were designed from the pile-up of published bovine and human FGF-2 sequences




Fig. 5.2 Amplification of FGF-2 from ovine brain tissue
Brain tissues were obtained from different anatomical regions of an adult Cheviot ewe
(aged two). Total cellular RNA was isolated using the RNeasy columns, and used for
RT-PCR using FGF-2 primers designed from comparison of bovine and human
sequences. One microlitre aliquots were taken from the first round of RT-PCR
reactions and used in a nested-PCR with an internal primer set (see table5.1). Ten
microlitre aliquots were run on an agarose gel from each PCR reaction (A). Panel B
is Southern blot of the gel shown in panel A, using the sequence-specific probe
M7267. The expected products generated with external primer set and the nested
primer set are 381 bp and 264up, respectively.
M: X DNA cut with HindHI and EcoRI
Lane 1: Pituitary (external primer set)
Lane 2: Pituitary (nested PCR)
Lane 3: Olfactory bulb (external primer set)
Lane 4: Olfactory bulb (nested PCR)
Lane 5: Cerebral cortex (external primer set)
Lane 6: Cerebral cortex (nested PCR)
Lane 7: Hypothalamus region (external primer set)
Lane 8: Hypothalamus region (nested PCR)
Lane 9: Hypothalamus region (external primer set)
Lane 10: Hypothalamus region (nested PCR)
 
Ovine ATCCACCCCGACGGCCGAGTGGACGGGGTCCGCGAC-AAGA
I I I I II II II II I I I I I II II I I I I I I II I II I I I I I II I
Bovine ATCCACCCCGACGGCCGAGTGGACGGGGfTCCGCGAGAAGA
Ovi ne GCGACCCTCACATCAAACTACAACTTCAAGCAGAAGAGAGAGGGGITGTG
I I I I I I I II I I I I II I I I I I II I I I I I I I I I I I I I I II I I I I I I I I I II
Bovine GCGAC C CACACATCAAACTACAACTTCAAGCAGAAGAGAGAGGGGTTGTG
Ovine TCTATCAAAGGAGTGTGTGCAAACCGTTACCTTGCTATGAAAGAAGATGG




I I I I I I I I I I I I I I I II I II I I I I II I I II II I II II I II II I I II I I I
Bovine GATTGGAGTCTAATAACTACAATACTTACCGGTCAAGGAAATACTCCAGT
Ovine TGGTATGTGGCACTGAAGC
I I I I I II I II I I I I I II I
Bovine TGGTATGTGGCACTGAiiAC
Fig. 5.3 Sequence comparison between bovine FGF-2 and the ovine FGF-2
Using consensus PCR primers derived for bovine and human FGF-2 genes, a PCR
product was amplified from the brain tissue of an adult female ewe (see legends to
Fig.5.1 and 5.2). The amplified PCR product was cloned into the TA cloning plasmid
and sequenced. The sequence of the cloned PCR fragment was compared with the
published FGF-2 sequences from different species. The pile-up is the comparison
between bovine sequence (accession number m 13440) and the cloned ovine gene.
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Table 5.2 Sequence similarities between the ovine FGF-2 homologue and FGF-2
in other species
The ovine FGF-2 homologue was cloned and sequenced from the brain tissues (see
legends to Fig.5.1-3). The sequence of ovine FGF-2 gene was compared to FGF-2
DNA sequences from other species, demonstrating a high degree of evolutionary
conservation in the FGF-2 gene.
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5.4 Discussion
The resident brain cells are now believed to be sources for cytokines, chemokines and
growth factors, which may play a role in the repair and pathology as a result of virus
infection of the CNS. One such cytokine is the FGF-2.
The brain tissues obtained from different neuroanatomical sites of an adult ewe were
used to clone the ovine homologue of FGF-2 gene. Using a PGR approach, an FGF-
2-specific gene was amplified. The sequence analysis of the cloned PCR product
demonstrated that this gene was highly homologus to the FGF-2 sequences from other
species.
This is the first report of the ovine CNS-derived FGF-2 sequence analysis. Ovine
FGF-2 mRNA was detected, albeit in varying amounts, in different anatomical
regions of the CNS.
Most brain regions tested positive for the FGF-2 gene. However, certain regions for
example the pituitary, showed an abundance of message compared to others, where
nested PCR was necessary to obtain a product. This differential distribution of FGF-2
mRNA may be associated with the function and/or abundance of cells which
transcribe this neurokine.
The ovine FGF-2 gene showed a high degree of sequence similarity with other
oublished FGF-2 seauences from other SDecies. The exceDtionallv hiehlv conserved
r ± a r j j
FGF-2 sequences between different species is indicative of a very strong selective
pressure to maintain its biological activities. The sequenced ovine gene lacks the N-
termina! putative leader peptide sequence reported in other species. This is because
only the highly conserved sequences internal to the putative leader sequence was
taken into consideration in designing of PCR primers. Bovine FGF-2 is a single
chain, non-glycosylated protein of 16.5 kDa molecular weight (Esch et al., 1985).
Bovine FGF-2 is believed to be derived from a 155 amino acid protein with an amino
terminal extension of nine amino acid (Met^-Ala^-Ala^-Gly^-Ser^-Ile^-Thr^-Thr"2-
Leu"'-Pro+l) not found on the mature 146 amino acid protein.
5.4.1 Relevance of neural FGF-2 to visna pathology
One of the common features of lentiviral pathology is the extensive involvement of
vascular endothelium, in the form of perivascular cuffs. In the CNS, this may result
in permeability of BBB and extravasation of inflammatory cells into
neuroparanchyma. In AIDS, up to 30% of patients develop severe hyperplasia of
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vascular endothelium and presence of spindle cells (Ensoli et al., 1991). It has been
shown that inflammatory cytokines (IL-ip, TNFa, and IFNy) released from activated
T cells stimulate the growth of vascular endothelia, which in turn produce
chemoattractant platelet activating factor (PAE), and high levels of FGF-2 (Sciacca et
al., 1994; Samaniego et al., 1995). Moreover, the presence of inflammatory cytokines
also results in upregulation of adhesion molecules on hyperplastic endothelial cells
(Kaaya et al., 1996).
The inter-relationship between the FGF-2 and other cytokines/growth factors in the
CNS is a complex one. Increased expression of FGF-2 in the CNS induces the
expression of NGF by astrocytes, which also helps neurones to respond to NGF
(Gomez-Pinilla et al., 1992). Furthermore, IL-1 (3 increases FGF-2 mRNA expression
in adult rat brain and in organotypic hippocampal cultures (Rivera et al., 1994).
FGF-2 in combination with PDGF has been shown to result in generation of rapidly
dividing 0-2A progenitor cells in adult rat optic nerve cultures. Moreover, FGF-2
treatment inhibited oligodendroglial apoptosis (Grinspan et al., 1996). Further, FGF-
2 immunoreactivity has been reported in microglial cells in vivo (Gomez-Pinilla et al.,
1992).
The growth promoting properties of FGF-2 may assist in remyelination in the CNS.
This is significant, since damage to myelin is a common finding in lentiviral
infections of the CNS. However, FGF-2 may also have adverse effects in concert
with other proinflammatory cytokines in the CNS. Therefore, FGF-2 reagents
described in this chanter will be used as Dart of a Danel of cytokines to studv the direct
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effect of MW infection on ovine microglial cells, and its possible implication in
visna neuropathology.
CHAPTER SIX
Infection of Microglia with MVV: Effect on Cytokine
Gene Expression
6.1 Introduction
Data presented in chapter three demonstrated that ovine microglial cells, like
microglia from other species, share extensive phenotypic markers with cells of the
monocyte/macrophage lineage. Moreover, the productive infection of microglia with
MVV presented in chapter four adds to previous observations with respect to the
tropism of other lentiviruses for brain microglial cells.
Presence of virus-positive cells in the CNS is a prerequisite for lentiviral
encephalopathies (Georgsson et al., 1976; Shaw et al., 1985; Shearere et al., 1985;
Hurtel et al., 1991; Schindelmeiser and Gullotta, 1991; Dow ei al., 1992; Zink et al.,
1990; Takahashi et al., 1996). However, there appears to be no correlation between
lentivirus antigen-positive cells and extent of pathology in the CNS (Kure et al., 1991;
Petito et al., 1994; Georgsson et al., 1997). It is, therefore, unlikely that direct MW
infection of tissue macrophages/microglial cells (and M-tropic primate lentiviruses),
is the main cause of CNS pathology. This is because of the highly restricted nature of
lentiviruses in vivo.
A common finding in experimental infection of monocyte/macrophages with
lentiviruses is that infection appears to alter, but not abrogate, the capacity of infected
cells to express cellular factors and cytokines (Gruber et al., 1995; Rossol et al., 1992;
Yoo et al., 1996; Valentine et al., 1992; Sasseville et al., 1996; Pulliman et al., 1994;
Dereuddre-Bosquet et al., 1997; Lechner etal., 1997; Legastelois et al., 1997).
Soluble factors released from activated macrophages and microglial cells, due to
direct infection or via virus-coded proteins may contribute to neuropathology (Nuovo
and Alfieri, 1996; Tyor et al., 1992; Merrill et al., 1992; Nottet et al., 1996; Karsten et
al., 1996; Genis et al., 1992; Dollard et al., 1995; Tyor et al., 1993; Pullirnan et al.,
1991, Yoshika et al., 1995; Nottet et al., 1997). For example, proinflammatory
cytokines have been detected in the CNS of patients with HIV (Nuovo and Alfieri,
1996; Burkinsky et al., 1995). Interestingly, such signals co-localised with both
virus-positive and virus-negative cells (Nuovo and Alfieri, 1996). Similarly,
measurements of CSF from such patients have also revealed increased levels of
proinflammatory cytokines and neurotoxins (Tyor et al., 1992; Nottet et al., 1996).
Microglial cells may constitute up to 20 % of glial cells in the CNS. Moreover, they
are the main cell-type most commonly infected with primate lentiviruses in vivo.
6.2 Experimental design
The experiments in this chapter were aimed at asking the question of whether
infection of microglial cells with MW could result in an altered cytokine expression,
which may in turn contribute to neuropathogenesis/pathology in vivo. Therefore,
enriched cultures of ovine microglial cells were subjected to infection with MVV in
vitro, followed by semi-quantitative RT-PCR assays for a panel of ovine cytokines.
To allow for the semi-quantitative analysis of cytokine RT-PCRs, mRNA for the
housekeeping gene ATPase was used as the internal control. A series of PCR cycles
were performed to obtain a calibration curve. The data presented in this chapter were
obtained from four separate brain cultures.
6.3 Results
6.3.1 Analysis of gene expression in cultured microglial cells by semi-quantitative
PCR
A reverse-transcriptase-PCR (RT-PCR) approach was employed to measure the levels
of a panel of cytokines by cultured microglial cells. The PCR signals normalised
against the housekeeping gene, ATPase. A series of PCR cycles were carried out on
ATPase gene derived from microglial cells, and a cycle corresponding to the linear
part of the calibration curve was chosen for subsequent PCR reactions (Fig.6.1).
RT-PCR signals were detected for TNFa, IL6 and TGFp. However, no signals were
detected for IL-lp, GM-CSF, IL-10 and IL-12, and FGF-2 in both mock-infected and
MW-infected microglial cultures (Fig.6.2). In contrast to message levels for TNFa
and IL-6, which appeared to exist in minute quantities, TGFp was expressed at
relatively high quantities, exceeding the message levels for ATPase.
6.3.2 MW-inediated alteration s in expression of cytokines by cultured
microglial cells
Infection of ovine microglial cells with MVV resulted in significant up-regulation of
TNFa at transcription level in vitro (Fig. 6.3). This direct effect of MW on
microglial cells may have implications in the neuropathology of visna. This is
because TNFa has been implicated in several demyelinating diseases, Similarly,
interleukin-6 mRNA was significantly elevated in MW-infected microglial cultures
(Fig.6.4).
In contrast to TNFa and IL-6, whose expression was elevated by MW infection, the
expression of message for TGFP appeared to be reduced (Fig.6.5). Although
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statistical analyses showed no significant reduction in TGF|3 mRNA after infection
with MW, nevertheless, a reduced trend was observed.
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Fig. 6.1 Calibration curve of RT-PCR for the housekeeping gene ATPase
A series of ATPase PCR cycles were performed on total RNA isolated from
microglial cultures, in order to obtain a standard curve for the housekeeping gene.
Ten microlitre aliquots from each PCR cycle was run on an agarose gel., followed by
Southern blot, using an ATPase-specifrc probe. The blot was scanned using a
phosphoimager. The graph shows the result of the Southern blot.
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Fig. 6.2 mRNA profiles of ovine microglial cells infected with MW in vitro
Fluctuations in cytokine mRNA levels of cultured microglial cells because of MW
infection were assesed by RT-PCR. Enriched microglia (100,000 cells per culture),
either mock-infected (-) or MW-infected (+) with 0.001 MOI of K1514. Total RNA
was isolated from treated cultures at four days post-infection. The identities of PGR
signals were ascertained using gene-specific radioisoptope-labelled oligonucleotide
primers followed by Southern blot analysis. The figure is an example of a Southern






Fig. 6.3 Effect of MW infection on TNFa mRNA expression by cultured
microglial cells
Enriched microglial cultures were infected with K1514 at MOI of 0.001. The levels
of TNFa mRNA expression in mock-infection and MW-infected microglia
(100,000 per culture) were analysed at four days post-treatment. Microglial cells
were either mock-mfected or MW-infected as outlined in the legend to Fig.6.2.
TNF-alpha-specific RT-PCR was performed on RNA samples from treated cultures.
Ten microlitre aliquots were run on an agarose gel. The agarose gel was Southern
blotted with TNF-alpha-specific probe. Probed blots were then scanned using a
phosphoimager. Data were obtained from four separate brains, and presented as mean
+/-1 SD. Statistical analysis was performed by students t test.





Fig. 6.4 Effect of MVV infection on IL-6 mRNA expression by cultured
microglial cells
Enriched microglial cultures were infected with K1514 at MOI of 0.001. The levels
of IL-6 mRNA expression in mock-infection and MVV-infected microglia (100,000
per culture) were analysed at four days post-treatment. Microglial cells were either
mock-infected or MVV-infected as outlined in the legend to Fig.6.2. IL-6-specific
RT-PCR was performed on RNA samples from treated cultures. Ten microlitre
aliquotes were run on an agarose gel. The agarose gel was Southern blotted with IL-
6-specific probe. Probed blots were then scanned using a phosphoimager. Data were
obtained from four separate brains, and presented as mean +/- 1 SD. Statistical
analysis was performed by students t test.





Fig.6.5 Effect of MW infection of TGF{3-1 mRNA expression by cultured
microglial cells
Enriched microglial cultures were infected with K1514 at MOI of 0.001. The levels
of TGFJ3-1 mRNA expression in mock-infection and MVV-infected microglia
(100,000 per culture) were analysed at four days post-treatment. Microglial cells
were either mock-infected or MW-infected as outlined in the legend to Fig.6.2.
TGF(3-1-specific RT-PCR was performed on RNA samples from treated cultures.
Ten microlitre aliquotes were run on an agarose gel. The agarose gel was Southern
blotted with TGFp-1-specific probe. Probed blots were then scanned using a
phosphoimager. Data were obtained from four separate brains, and presented as mean
+/- 1 SD. Statistical analysis was performed by students t test.













This is the first study on direct interactions of MW with ovine microglial cells in
vitro. Cytokine profiling was performed on mock-infected and MVV-infected ovine
microglial cells in vitro. Moreover, the infection of microglial cells resulted in altered
cytokine phenotype. PCR signals were detected for TNFa, IL-6 and TGFp.
Conversely, under conditions used, PCR signals were not detected for bFGF (FGF-2),
IL-ip, GM-CSF, IL-10 and IL-12 (Fig. 6.2). The elevated expression of TNFa and
IL-6 by microglial cells and because of infection with MW may have implications in
visna pathogenesis/pathology.
TNFa is a pleiotropic cytokine that is primarily produced by activated macrophages,
but also by T cells (reviewed by Tracy and Cerami, 1994). TNFa has been shown to
be directly toxic to oligodendrocytes in vitro, which may take place in demyelinating
disorders (Robbins et al., 1987; Selmaj et al., 1988; Frei et al., 1997). This may be of
importance, because in visna neuropathology, secondary demyelination similar to MS
have been observed (reviewed by Georgsson, 1994). Moreover, activation of
microglial cells and astrocytes in vitro results in increased expression of TNFa
(Lafortune et al., 199; Chao et al., 1995;Lee et al., 1993; Sheng et al., 1995; Hetier et
al., 1991).
TNFa has been closely associated with HIV-induced central and peripheral
neuropathies (Tan et al., 1996; Neuovo et al., 1996). Moreover, in murine EAE,
TNFa niRNA and protein have been identified in the CNS in the acute phase of the
disease (Renno et al., 1995). Administration of soluble type I receptor for TNFa, as
well as antibodies to TNFa and the related molecule, TNFP, prevented the
development of EAE (Ruddle et al., 1990; Selmaj et al., 1995).
In AIDS brains, TNFa expression has been associated with perivascular
macrophages, microglia, endothelia and astrocytes (Dereuddre-Rosquet, et al., 1997).
Moreover, microglia isolated from SIV-infected macaques produced more TNFa
when compared to uninfected controls (Sopper et al., 1996). There is also some
evidence that plasma levels of TNFa in FflV-infected patients correlates with disease
progression (Chollet-Martin et al., 1994; Than et al, 1997). This, however, has been
disputed by others (Tan et al., 1996).
Interleukin-6 (formerly B cell stimulatory factor-2, hepatocyte stimulating factor,
hybridoma-plasmocytoma growth factor, and IFNp-2), is a multifunctional
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glycoprotein and a member of a large family of proteins including leukaemia
inhibitory factor (LIF, formerly differentiation inhibition activator or DIA), oncostatin
M (oncM), ciliary neurotrophic factor (CNTF), and IL-11 (Neddermann et al., 1996).
IL-6 is best characterised in the periphery as a proinflammatory cytokine, with
biological functions overlapping with those of IL-1(3 and TNFa. IL-6 is also a potent
inducer of acute phase proteins (Le et al., 1989, Hirano et al., 1990).
IL-6 is one of the cytokines synthesised in the CNS as part of the neurokine family of
proteins. In normal CNS, IL-6 is found in ependymal cells, astrocytes, in processes
adjacent or attached to the ventricles, and in cellular processes in the white matter
(astrocytes and microglial cells) (Le Vine et al., 1997). Cortical and hippocampal
neurones also synthesise IL-6 (Ringheim et al., 1995; Pousset, 1994).
Preliminary results obtained from infection of cultured caprine microglial cells with
CAEV also showed an increase in IL-6 (Baszler et al., 1994). However, there are
conflicting reports with respect to induction of IL-6 by mononuclear cells after
infection/stimulation with HIV or viral proteins (Molina et al., 1990; Berman et al.,
1994; Navikas et al., 1995, Lafreine et al., 1997). Microglial cells isolated from
healthy macaques produced more IL-6 than macrophages. Moreover, production of
IL-6 by microglia infected with SIV increased with time, despite the fact that very few
cells contained replicating virus (Sopper et al., 1996).
Infection of cultured microglial cells did not appear to significantly alter the
transcription of TGFp-1 in vitro, although a reduced trend was apparent (Fig.6.5).
Interestingly, in CAEV-infected macrophages a decrease in TGFf3-l mRNA has been
reported (Lechner et al., 1997).
Cultured ovine microglial cells constitutively expressed TGFP-1 mRNA at relatively
high levels. Similarly, cells of monocyte/macrophages have been shown to
constitutively express TGFP mRNA (Biron, 1994). Constitutive expression of TGFP-
1 mRNA has also been observed in cultured astrocytes (Morganti-Kossmann et al.,
1992). However, human brain tissues do not appear to express TGFP-1 protein under
normal conditions (Wahl et al., 1991).
The discrepancy between high levels of mRNA and translation of TGFP-1 is because
of the biology of this protein. Unlike most cytokines where induced levels of message
parallels translated protein, TGFP protein is produced as inactive precursor molecules
and must be processed to become biologically active. Consequently, expression of
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TGFp can be regulated at transcriptional, translational and post-translational levels
(reviewed by Biron, 1994). It is therefore difficult to draw definitive conclusions
based solely on TGFp-1 mRNA levels in vitro.
Immunoreactive TGFP has been detected in the brain tissues of patients with HIV
(Wahl et al., 1991). TGFp-positive cells co-localised with infected and uninfected
macrophages and astrocytes in HIV-infected brains samples (Morganti-Kossmann et
al., 199). Both Tat and Env-derived glycoproteins of HIV have been shown to
stimulate TGFP-1 expression in glial culture. It is, therefore, postulated that release
of viral components from infected cells may therefore stimulate the neighbouring glia
to express TGFp-1 (C-upp et al., 1993; de Cimha et al., 1995).
In maedi lungs, an increase in TGFp-1 immunopositive cells was noted compared to
control lungs. However, TGFP-1 expression was down regulated in more advanced
disease (Moreno et al., 1997). This reversal of TGFp-1 expression may parallel the
degree of lymphocytic infiltration, in which case T cell-derived cytokines, for
example IFNy may play a regulatory role.
6.5 Summary
Infection of cultured microglial cells with MVV resulted in altered expression of
TNFa and IL-6. These two cytokines have been implicated in the neuropathology of
several viral infection of the CNS, and may also contribute to visna pathology.
The ability of MVV to induce the expression of TNFa and IL-6 may suggest that
presence of virus in neuroparenchyma can contribute to pathology via bystander
damage, and independent of an active immune response.
Gliosis and neuronal damage are common occurrence in lentiviral infection of the
CNS. The direct effect of MVV on expression of pro-inflammatory cytokines
demonstrated in this chapter, may have implications in the neuropathology of visna.
For example, TNFa has been shown to result in astrogliosis and proliferation and
activation of microglial cells in vitro (Selmaj et al., 1990; Merril et al., 1991).
The experimental approach in the next chapter was aimed at testing the hypothesis
that whether virus-mediated responses, independent of a specific immune system can
contribute to neural changes associated with visna infection of the CNS.
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CHAPTER SEVEN
Infection of Microglia with MVV: Implications for
Gliosis and Neurotoxicity
7.1 Introduction
In previous chapter, infection of microglial cells with MVV was shown to result in an
altered cytokine profile, which may have implications in visna-mediated
neuropathology.
A common histopathological feature of visna infection is astrocytosis and formation
of microglial nodules, with astrocytosis being more pronounced in inflammatory foci
than microglial nodules. Moreover, in visna, demyelinating lesions similar to MS
have been observed (Georgsson et al., 1982, 1990). In EAE models of MS,
astrocytosis coincides with the onset of clinical disease and inflammation. However,
astrocytosis may also persist after clinical recovery (Smith et al., 1983; Aquino et al.,
1988).
The presence of gliosis within inflammatory foci in EAE models of MS and in visna
would suggest a possible association between astrogliosis and release of
proinflammatory cytokines by infiltrating lymphocytes and mononuclear cells.
Moreover, cytokines (IFNy, TNFa, IL-la/p, IL-6, IL-7, IL-10, GM-CSF and MCP-1)
have been shown to promote activation of astrocytes (Balasingam et al., 1994; Giulian
et al., 1988; Yong et al., 1991; Rostworowski et al., 1997; Glabinski et al., 1996;
Balasingam et al., 1996).
The interaction between lentiviruses and cells of the monocyte/macrophage lineage,
either by direct infection and/or via release of viral and cellular factors may result in
activation of these cells. For example, an activated phenotype has been associated
with microglial cells in visna infected brain tissues (Georgsson et al., 1997).
Astrocytosis has been associated with the presence of activated
macrophages/microglial cells both in vitro and in vivo (Giulian et al., 1994;
Balasingam et al., 1996; Taupin et al., 1997). Furthermore, attenuation of astrogliosis
has also been correlated with reduced CDllb/CD18 (Mac-1, CR3) immunoreactivity
of macrophage/microglia, suggesting a role for microglial cells in initiating
astrocytosis (Balasingam and Yong, 1996).
Another feature of lentiviral pathology is neuronal damage in the absence of an
apparent direct viral infection of the neurones (see Chapter 1). Infection of
monocyte/macrophage cells with HIV-1 has been shown to result in release of soluble
toxins when tested on brain cultures (Pulliam et al., 1991; Giulian et al., 1990).
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Lentiviral proteins, Tat and membrane glycoproteins can also have neurotoxic
properties (Gordou et al., 1990; Sabatier et al., 1991; Philippon et al, 1994; Budka et
al., 1989; Wu et al., 1996). Interestingly, neurotoxicity is significantly enhanced in
the presence of microglial cells (Lipton, 1992). Furthermore, only HIV-infected
macrophages rather than HIV-infected T lymphocytes appear to produce toxins
(Pulliam et al., 1991). This observation suggests that cellular factors independent of
viral products (but related to virus infection) might mediate neurotoxicity.
The above observations would imply that activated macrophages/microglial cells
could potentially contribute to neuropathological features (gliosis and neuronal
damage/loss) associated with lentiviral infections of the CNS.
7.2 Experimental design
The experiments in this chapter were aimed at deciphering the direct role of MW-
infected microglial cells in gliosis (microgliosis and astrogliosis), independent of
acquired (specific) immune responses. For this purpose, mice with severe combined
immunodeficient (SCID) genotype incapable of mounting specific immune responses
were used. Adult SCID mice (sex and age-matched) were used. Cultured ovine
microglial cells, mock-infected and MVV-infected with 0.1 MOI of the K1514 starin,
were grafted into the striata of SCID mice. Brains were harvested on day three post-
injection and the extent of gliosis was assessed by immunostaining for murine
microglial and astrocytic cell markers using F4/80 and GFAP antibodies, respectively.
The presence of microglial-derived neurotoxic factor (s) because of MW infection in
vitro was assessed. Primary cultures of murine trigeminal neurones were set up.
Supernatants from mock-infected and MVV-infected microglial cells were harvested
on day 4-5 post-infection and tested for neurotoxic factor (s) on murine trigeminal
culture over a period of three days. Neurotoxicity was assessed by loss of neurones
and morphological changes.
7.3 Results
7.3.1 Grafting of ovine microglial cells into SCID brains
To address the possible role of MVV-infected microglial cells in activation of
microglia and astrocytes in vivo, enriched cultures of microglial cells (>98% pure)
were inoculated into the neuroparenchyma of SCID mice. Both mock-infected and
MVV-infected microglial grafts resulted in increased staining of astrocytes and
microglial cells in injected hemispheres at three days post-inoculation (Fig.7.1).
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7.3.2 MW-infected microglial cells initiate gliosis in SCID brains
To assess gliosis in SCID brains because of MVV infection, immunostained sections
were image analysed. Significant increases (p<0.05) were observed in levels of F4/80
(microgliosis) and GFAP (astrogliosis) in SCID brains inoculated with MVV-infected
ovine microglial cells (Figs. 7.2 and 7.3).
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Fig.7.1 Intrastriatal injection of ovine microglial cells into SCID brains
Ovine microglial cells, mock-infected or MVV-infected with MOI 0.1 of K1514 and
were injected into the striata of SCID mice (15000 cells per mouse in total volume of
three microlitres). Brains were fixed at three days post-injection and floating sections
immunostained with GFAP or F4/80. Each group consisted of three sex and age-
matched adult female mice. Panel A details the site of injection into the striatum;
Panels B, C and D show GFAP stained brain sections. B is the uninjected, control
side, whereas C is the injected striatum. The lesion site (arrowhead) is magnified in
panel D. L is the location of lesion. Abbreviations: am, amygdala; cc, corpus
callosum; dg, dentate gyrus; ec, external capsule; fi, fimbria; fr, frontal cortex; hi,
hippocampus; hy, hypothalamus; ic, internal capsule; ij, interventricular junction; lv,




Fig.7.2 Effect of MW-infected microglial cells on murine microglia in vivo
Ovine microglial cells, either mock-infected or MVV-infected were injected with as
stated in the legend to Fig.7.1 were injected into SCID brains (15,000 cells per brain)
one day post-infection in vitro, and brain tissues harvested as outlined in the legend to
Fig.7.1.. Sections were stained with F4/80 for murine brain microglial/macrophages.
Stained sections were image analysed using the NIH IMAGE software. Each group
consisted of three age- and sex-matched SCID mice.
Data presented as mean +/- 1 SD.










Fig.7.3 Effect of MW-infected microglial cells on murine astrocytes in vivo
Ovine microglial cells, either mock-infected or MVV-infected (TCID50 = 3000) were
injected into SCID brains (15,000 cells per brain) one day post-infection in vitro, and
brain tissues harvested as outlined in the legend to Fig.7.1.. Sections were stained
with GFAP for astrocytes. Stained sections were image analysed using the NIH
IMAGE software. Each group consisted of three age- and sex-matched SCID mice.
Data presented as mean +/- 1 SD.






















7.3.3 Release of neurotoxins from MW-infected microglia
To assess the possibility that MVV infection of microglial cells may result in release
of neurotoxins, supernatants from both mock-infected and MW-infected cultures
were tested on primary neuronal cultures derived from murine trigeminal ganglia.
Treatment with supernatants derived from MVV-infected microglial cells resulted in
loss of neurones in vitro (Fig.7.4). Moreover, the morphological abnormalities, for
example neurite atrophy and formation of short fascicles, were apparent in cultures
treated with supernatants derived from MW-infected microglia. These microscopic
abnormalities were apparent at approximately 10 hours post-treatment. In later time
points, neurones treated with supernatants from MW-infected microglial cultures
also showed cytoplasmic vacuolation (Fig7.5).
7.3.4 Characterisation of MW-mediated microglial neurotoxin (s)
The neurotoxicity experiments prompted attempts to semi-characterise the soluble
neurotoxin (s) in supernatants from MVV-infected microglial cultures. To assess the
possible proteinaceous nature of neurotoxin (s), supernatants from treated microglial
cultures were subjected to heat treatment. However, this approach proved
inconclusive in deciphering the physical nature of neurotoxin. This was probably
because heat-treatment resulted in loss of nutrients and non-specific loss of neurones
treated with both mock-infected and MVV-infected supemaiants.
Experiments were carried out to determine the dilution necessary to sustain
neurotoxicity. However, dilution of supernatants from MVV-infected microglial
cultures resulted in loss of neurotoxic properties, suggestive of minute quantity of the
putative neurotoxin (s) present in infected supernatants.
7.3.5 Visna Tat could replace the neurotoxicity observed with supernatants from
MW-infected microglial cultures.
To assess whether visna-derived products could also mediate neurotoxicity on
trigeminal neurones, a synthetic peptide derived from the tat ORF of visna was used.
The treatment of the arginine-rich Tat peptide and not the control peptide resulted in
morphologial abnormalities similar to those observed with cultures treated with
supematants from MW-infected microglial cells (Fig.7.6).
Western blot analyses were performed to determine the possible presence of Tat in
supernatants from MW-infected microglial cells, which may mediate neurotoxicity.
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Supernatant from sheep chondrocytes infected with MVV (TCID50 = 30,000) was
used as positive control for Tat. Blots were immunostained with anti-Tat peptide
antibodies. However, repeated attempts failed to detect Tat-related products in
supernatants from either MW-infected sheep chondrocytes or microglial cells (Data
not shown)
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Fig 7.4 Neurotoxicity of MW-infected microglial cells on trigeminal neurones
Ovine microglial cells were mock-infected and MVV-infected with MVV in vitro, as
outlined in the legend to Fig.6.2. Supernatants from microglial cells were harvested at
4 days post-treatment. Primary cultures of murine trigeminal neurones were treated
with neat supernatants from mock-infected (closed square) and MVV-infected (open
square) ovine microglial cells. Changes in morphology and numbers of treated
trigeminal neurones were observed over time under a light microscope. Data
presented as mean +/- 1 SD.
** Denotes a significant (p<0.05) loss of neurones in cultures treated with













Fig. 7.5 Morphological changes in murine trigeminal neurones treated with
supernatants from MW-infected microglia
Trigeminal neurones were treated with supernatants from mock-infected and MVV-
infected ovine microglia as outlined in the legend to Fig.7.4. Treated neurones were
fixed on day 2 post-treatment and stained for NF-M followed by immunoflurescence
microscopy, using anti-rabbit FITC-cojugate as the secondary antibody. The
morphological abnormalities in cultures treated with supernatants from MVV-infected
microglia included ballooning of cytoplasmic membrane (A and B; arrows), loss of
arborisation (arrowheads in panel A, and C), pits in cytoplasm (arrows in D), and
thickening of neurites (D). Supernatants from mock-infected microglia did not show
these morphological abnormalities (E). Magnifications at x 125.
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Fig. 7.6 Morphological changes associated with trigeminal neurones treated with
Visna Tat peptide
Trigeminal neurones were treated with supernatants from either Tat or Ova peptides.
Neurones were fixed on day 2 post-treatment and stained for NF-M, as outlined in the
legend to Fig.7.5. Morphological abnormalities in cultures treated with Tat included
ballooning of cytoplasmic membrane and loss of arborisation (B). Cultures treated
with Ova peptide did not show these morphological abnormalities (A). Arrows
indicate cell healthy looking cell bodies in Ova treated cultures. Arrowhead indicates





7.4.1 MW-infected ovine microglial cells promote activation of microglia and
astrocytes in vivo independent of specific immune responses
Intracerebral inoculation of SCID mice with MVV-infected ovine microglial cells
resulted in apparent increased immnostaining of F4/80 (Fig.7.2) and GFAP (Fig. 7.3).
The induction of gliosis in SCID mice illustrates that non-specific inflammatory
responses independent of a lymphocytic infiltrate can take place in the CNS.
Similar observations have been made with HIV-1-infected monocytes inoculated
intracerebrally into SCID mice (Persidsky et al., 1996). Moreover, an association
between gliosis and activated phenotype of resident murine microglial cells (presence
of microglial nodules) was observed in the CNS of these mice (Persidsky et al.,
1996). This observation also indicates that a direct viral infection is not a prerequisite
for activation of microglia in vivo.
7.4.2 Possible signals for gliosis in vivo
The ability of MW to induce the expression of IL-6 in vitro may signal for gliosis
(see Chapter 6). Over-expression of IL-6 in murine CNS has been shown to result in
reactive astrocytosis and an increase in ramified (process-bearing) microglial cells
(Fattori et al., 1995). Moreover, in HIV/SCID experiment, activated resident murine
microglia were a source of neural IL-6 (Persidsky et al., 1996).
Activated astrocytes have been shown to synthesise and release the (3-chemokine
MCP-1 (Hayashi et al., 1995). This chemokine is a potent chemoattractant for both
blood-derived monocytes and microglial cells in the neuroparenchyma (Calco et al.,
1996; Hayashi et al., 1995). Moreover, in an EAE model of MS, astrocytic
expression of MCP-1 was closely associated with the clinical disease (Ransohoff et
al., 1993; Hulkpwer et al., 1993). Other cellular sources of MCP-1 in EAE models of
MS are macrophages, lymphocytes, and endothelial cells (Berman et al., 1996).
TNFa has been shown to directly upregulate MCP-1 at both mRNA and protein levels
(Hurwitz et al., 1995). The inoculated human macrophages in SCID brains frequently
stained positive for TNFa (Tyor et al., 1993). Similarly, MW-infection of ovine
microglial cells elevated the expression of TNFa at the message level (see chapter 6).
Moreover, intrastriatal injection of visna Tat peptide resulted in elevated levels of
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endogenous proinflammatory cytokines (IL-lf3, TNFa, IL-6) and iNOS (Philippon et
al, 1994).
Visna and HIV-1 Tat proteins have neurotoxic properties when tested in vivo and in
vitro (Gordou et al., 1990; Sabatier et al., 1991; Philippon et al., 1994; Hayman et al.,
1993; Nath et al., 1996). These observations suggest that neurotoxicity may be
mediated independent of virus infection. Use of peptide homologues have shown that
Tat can be directly toxic to neurones (Strijbos et al., 1995; Nath et al., 1996). The
neurotoxicity of lentiviral Tat has been specified to an arginine-rich motif in the basic
domain. Intrastriatal injection of the arginine-rich synthetic peptide was sufficient to
induce gliosis and loss of neurones in vivo (Hayman et al., 1993; Philippon et al.,
1994). Moreover, Tat-mediated gliosis was significantly reduced by inhibitors of
iNOS and TNFa (Philippon et al., 1994; I.Starling, personal communication).
In the CNS, all three isoforms of NOS have been identified (reviewed by Yun et al.,
1996). Since arginine is a substrate for NOS, it has been proposed that arginine
residues in lentiviral Tat may serve as substrates for NOS in generation of NO in
neural tissues (Philippon et al., 1994).
7.5 Summary
This is the first report to demonstrate that MVV-infected parenchymal microglial cells
can promote activation of astrocytes and microglial cells in the CNS, and independent
of specific immune responses. Similar results have been obtained with MVV-infected
monocyte-derived macrophages injected into SCID brains (I. Starling, personal
communication).
Release of neurotoxin (s) from MW-infected ovine microglial cells mediated
neurotoxicity when tested on murine trigeminal neurones in vitro. Interestingly, the






The involvement of lentivirus infections of the CNS has been well documented.
However, the mechanisms of neuropathology are poorly understood. Further, the
underlying mechanisms may differ in infections of the CNS with host-specific
lentiviruses. As outlined in the introduction to this thesis, this difference is apparent
in neuropathologies observed in HIV-1 encephalitis and visna.
8.2 Consequences of MW infection of microglial cells
Data presented in this thesis show that ovine brain microglia are closely related to
cells of the monocyte/macrophage lineage and can support a productive infection with
MVV in vitro (Chapter 3). Ovine parenchymal brain macrophages/microglia
(CD68+) also stained positive for MVV antigens in experimental infections in sheep
(Torstiendottir et al, 1992, Georgsson et al., 1997).
Infection of cultured ovine microglial cells with MW in vitro resulted in increased
expression of TNFa and IL-6 at the transcription level (Chapter 6). Both of these
cytokines (TNFa and IL-6) can potentially mediate pathological changes in the CNS
(Chapter 6).
The ability of MVV to induce the expression of IL-6 in vitro may signal for gliosis in
vivo, as observed in SCID experiments (Chapter 7). Over-expression of IL-6 in
murine CNS has been shown to result in reactive astrocytosis and an increase in
ramified (process-bearing) microglial cell (Fattori et al., 1995). It is not clear whether
elevated gliosis observed in SCID brains injected with MVV-infected microglia was a
result of ovine microglial-derived IL-6. In F1IV/SCID experiments, activated resident
microglia were a source ofneural IL-6 (Persidsky et al., 1996).
It is also feasible that viral proteins shed by infected cells may promote gliosis.
Injection of HIV-1 and visna Tat into brain parenchyma of mice resulted in
inflammation and gliosis. PCR signals for proinflammatory cytokines (TNFa, IL-
la/[3, IL-6), and iNOS were elevated in lesioned hemispheres, and chemical
inhibition of TNFa expression resulted in a decreased lesion volume (Philippon et al.,
1994).
There are conflicting reports with respect to the neurobiology of TNFa (Chapter 6).
Over-expression of TNFa by neurones or astrocytes in transgenic mice was sufficient
to trigger chronic CNS inflammation involving a reactive glial response, infiltration
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by activated T cells and macrophages, and loss of white matter and neurodegeneration
(Probert et al., 1997). In contrast, TNFa was found not to be directly toxic on mixed
foetal glial cultures in vitro, but the toxicity of TNFa was found to be NO-mediated,
released by astrocytes and macrophages/microglia (Chao et al., 1995; Ding et al.,
1988). Similarly in a murine model of MS, double deficient tnf/lta SLJ/J (H-2S) mice
still presented with CNS lesions indicating that either TNFa and TNFP are not
essential for demyelination and/or a degree of redundancy exists in TNFa/TNFp
deficient mice (Frie et al., 1997). Further, in mice infected with Theiler's virus
encephalomyelitis, another model of MS, the administration of recombinant TNFa
reduced the extent of demyelination without influencing the CNS virus titres (Paya et
al., 1990). More recently, TNFa has also been shown to have neuroprotective
properties in vivo (Bruce et al., 1996).
The anomalies observed in biological properties of TNFa are partly because of dual
receptor usage by this cytokine (reviewed by Vandenabeele et al., 1995). There is
also lack of information with respect to possible preferential receptor usage in the
CNS.
Another complicating matter is a degree of cross-species barrier that may exist
between ovine and murine systems. Hence, it is also not clear if ovine cytokines can
also mediate pathological changes (gliosis) in murine brains. Whether ovine TNFa
and IL-6 can transduce cellular signals through receptors in murine CNS remains to
be seen. Further, the receptors for ovine IL-6 and TNFa have yet to be identified.
Another approach will be to inject recombinant ovine cytokines (TNFa and IL-6) into
ovine or murine brains, followed by immunohistological examination of neural
tissues.
8.3 The putative neurotoxin
Treatment of murine neuronal cultures with supernatants obtained from MW-
infected microglia resulted in morphological abnormalities and eventual loss of
neurones (Chapter 7). Unlike HIV-1, visna is not generally regarded as a neuronal
disease, based on EM studies (Georgsson et al., 1976). However, data presented in
Chapter 7 warrant a closer examination of neurones in Visna infection. Perhaps the
first step would be to use ovine neuronal culture instead of murine cells. Further, use
of neurone specific reagents, for example antibodies against neurofilaments, and more
sophisticated imaging system can help to clarify this point.
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Ample evidence exists to support the neurotoxic potential of lentiviral components,
for example Tat. Tat was previously shown to promote gliosis in vivo and neurotoxic
properties both in vivo and in vitro (Gourdou et al., 1990; Sabatier et al., 1991;
Philippon et al., 1994; Nath et al., 1996). Tat can be shed from infected cells (Ensoli
et al., 1993). Furthermore, Tat non-specifically binds cell surface at high densities
(Mann et al., 1991). An RGD motif in HIV-1 Tat has been proposed to meditate
cellular aggregation (Kolson et al., 1993). However, this motif does not exist in the
sequence of K1514 strain used throughout this project. The neurotoxicity of a Tat
peptide rich in arginine residues was reproduced with trigeminal neurones in vitro
(Chapter 7). Repeated attempts with two polyclonal antibodies raised against the Tat
peptide and subsequent Western blot analysis failed to demonstrate the presence of a
Tat component in MW-infected microglial supernatants.
It is not clear if Tat, possibly shed from infected microglia, contributed to
neurotoxicity in vitro. This was because of lack of a positive control for anti-Tat
antisera, for example recombinant Tat protein. If the sensitivity of Western blots was
the underlying cause i.e., due to minute quantities of this protein in medium, then a
more sensitive approach such as immunoprecipitation would be more appropriate.
An amine, Ntox, produced by mononuclear cells isolated from HIV-1 infected
patients was neurotoxic both in vivo and in vitro (Giulian et al., 1996). Interestingly,
only supernatants from monocytic cell lines rather than a lymphoid cell line had
neurotoxic properties in vitro, and was independent of viral products (Guilian et al.,
1990). Other small molecules with similar characteristics, such as amino acids and
their metabolites (glutamine, cysteine and QUIN) have also been shown to mediate
neurotoxicity via NMDA receptor-mediated channels (reviewed by Giulian et al,
1990, 1996).
8.4 Microglia as antigen presenting cells: implications for visna pathogenesis
The presence of MHC surface molecules on microglial cells poses the question of
antigen presentation in the CNS. This in turn has interesting possibilities, since a
cellular inflammatory response is a prominent component of visna neuropathology.
There are, however, conflicting reports with regard to the role of parenchymal
microglial cells as APC. Parenchymal microglial cells (CD45low/CDl lb/c+), isolated
from adult rat brains and activated in vivo failed to induce proliferation of
encephalitogeneic myelin basic protein-specific CD4+ T cells. This was in contrast to
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perivascular macrophages (CD45high/CDll/b/c+) and thymic dendritic cells (Ford et
al., 1996). This observation has been contradicted by human parenchymal microglial
cells isolated and characterised by a similar protocol employed by Ford and co¬
workers. Isolated human microglial cells supported a mixed lymphocyte reaction in
vitro (Bercher and Antel, 1996). The notion that brain microglial cells may function
as APC was reinforced by the presence of co-stimulatory molecule B7.1 (CD80) on
human microglial cells (Bercher and Antel, 1996). Furthermore, microglial cells
isolated from adult human brain tissues were capable of supporting a
lymphoproliferative response to recall antigens (Dhib-Jalbut et al., 1996). In the latter
study, the isolated microglial cells were phenotyped on basis of CD45 expression.
Similar observations have been made with murine resident microglial cells (Havenith
et al., 1998).
If brain microglia can present viral antigens similar to MMV-infected monocyte-
derived macrophages, then the role of T cell immune responses in visna will become
better understood.
8.5 Future work
Experiments carried out in SCID mice this thesis reinforce the usefulness of this
system. Interestingly, similar observations have been made with SCID mice
inoculated with MW-infected monocyte-derived macrophages (I. Starling, personal
communication).
Data obtained from SCID mice are preliminary and need to be followed up. SCID
mice can be used to ask fundamental questions regarding virus-initiated mechanisms
leading to pathogenesis/pathology. In addition, what are the long-term effects of
injected microglial cells in SCID brains in the absence of a cellular immune response?
Data presented in this thesis support the notion that virus-initiated responses,
independent of acquired immune responses, may contribute to visna neuropathology.
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APPENDIX
Table A1 Stock solutions
Common stock solutions, reagents and chemicals used in this thesis are listed in the
table. Buffers were prepared with distilled water, whereas reagents used in enzyme
assays, for example dNTP mix, was prepared with Sigama water. Reagents were














































































































































































































































































































































ATPase PCR Cytokine PCR MW PCR
Sigma water 325 [il
Primers (forward and , _ , » ,
. 10 m of each
reverse)
10 x dNTPs




35 nl (3.5 mM)
340 jil
10 ^1 of each
50 |il
50 Hi





15 H1 (1-5 mM)
Table A2 Master PCR mixes
Master mixes were prepared and stored at -20 °C, and used repeatedly. Both the 10 x
PCR buffer and magnesium chloride solutions are provided with the enzyme. Primers
were used neat as supplied. This is usually at 100 pM. However, primers can be
diluted and used at 30-50 pM. All PCR reactions were performed by a hot-start at 80
°C for five minutes prior to addition of Taq pol. After the addition of enzyme,
amplification was performed by denaturing at 95 °C for one minute, annealing at 55
°C for one minute and extension at 72 °C for two minutes. After the required cycles,
an extension step at 72 °C for five minutes preceded the end of PCR reactions














Table A3 Thermodynamic values used for calculating Ta 0PT values
Thermodynamic values refer to the disruption of the interaction in an existing duplex
at 1 M NaCl, pH 7, and 25 °C. The units are per mole of interaction between given
combinations of bases (Rychlik et ai, 1990, 1991).
D
Main gel Stack gel
Bis (0.8%)/AcryIamide (30%) 3 ml 1 ml
S1 M Tris-HCl 1.5 ml 1.25 ml
Distilled water 1.5 ml 6.2 ml
10% SDS 60 |il 100 pi
10% Ammonium persulphate 19 pi 50 pi
TEMED 2.5 pi 10 pi
Table A4 SDS-PAGE mix
Gel ingredients were mixed afresh and poured into a Biorad mini-gel protein II
apparatus to give two 15% gels. This was gently overlaid with SDW, and allowed to
set for one hour at room temperature. The stack gel was made up just prior to being
poured over the main gel. The gel was run in at 200 volts for 40 minutes in lx
running buffer.
$: In the main gel, the pH of 1M Tris-HCl is 8.7, whereas in the stack gel, the pH is
6.8.
E
